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Abstract 
Introduction: Compression garments (CGs) are becoming increasingly popular in many 
sports as they are believed to aid performance and recovery. Likewise the use of ice therapy 
is one of the most used recovery strategies by athletes and sports people. Purpose: The 
purpose of these studies was to examine the effect of CGs on physiological, biomechanical 
and perceptual measures of performance and recovery after 10 km running; and to assess 
the combined use of compression and ice on recovery post eccentric exercise. Method: Two 
separate studies were conducted; Phase 1 was a randomised control study in which thirteen 
recreationally competitive male 10 km runners (Age (median): 26 years (19-48 years), 
Height: 178 ± 5 cm, Mass: 76.2 ± 6.5 kg, V̇O2Max: 50 ± 5 ml.kg-1.min-1) undertook four 10 km 
runs. The interventions were; CON (no intervention), EX (CGs during run), REC (CGs for 12 
hours post run) and EXREC (CGs during and 12 hours post run). During the runs heart rate 
(HR), rating of perceived exertion (RPE), blood lactate and performance time were 
measured. Post run (24 hours) creatine kinase (CK), C-reactive protein (CRP), calf girths, 
and perceived pain were measured. A separate muscle oscillations test was also performed; 
where participants completed two 30 second runs at 12 km.h-1, wearing CGs (CG) and no 
CGs (CON). During the runs peak velocity, peak acceleration, average velocity and peak 
displacement of the calf muscle was measure using a 3D infrared camera system.  Phase 2 
was a randomised control study in which nine healthy male volunteers (Age (median): 23 
years (20-27 years), Height: 178.7 ± 5.3 cm, Mass: 78.2 ± 14.4 kg) completed 3 trials: CON 
(no intervention), REC (CGs for 12 hours post run) and ICE (ice protocol and CGs for 12 
hours post run). Each trial consisted of an eccentric muscle damage protocol followed by a 1 
km time trial 48 hours post exercise. Perceptual measures of muscle pain, perceived ability 
and perceived recovery were measured at 24, 48 and 72 hours post eccentric exercise, with 
a questionnaire. Muscle damage (CK), calf girths and 1 km performance time were 
measured 48 hours post run. Results: Phase 1; there were no significant differences in 10 
km run time, HR, RPE, lactate, CK, CRP, calf girths, perceived pain, peak or average calf 
muscle velocity, or peak acceleration of calf muscle with any application of CGs compared to 
the control (p > 0.05). During the muscle oscillation test a significant reduction in calf muscle 
displacement was found with CGs (p < 0.05). Phase 2; there were no significant differences 
in 1 km run performance, CK or calf girths, 48 hours post run (p < 0.05). There were 
inconsistent improvements in muscle pain, perceived recovery and perceived maximum 
ability in the REC and ICE trials compared to control (p < 0.05). Conclusion: Neither CGs 
nor ice had any physiological effects on performance or recovery. Compression reduced the 
displacement of the calf muscle during running, which could lead to increased efficiency over 
longer duration races such as marathons. Compression garments and ice improved some 
perceptual measures or recovery; however, these results were inconsistent and likely to 
represent a placebo effect. 
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Chapter 1: General Introduction 
Compression garments (CGs) are becoming more popular in many sports, ranging from 
running and triathlon to mixed martial arts (French et al., 2008). There are many claims 
about the possible performance benefits of CGs, these include; decreased heart rate during 
exercise (Dascombe, Hoare, Sear, Reaburn & Scanlan, 2011), increased time to fatigue 
(Varela-Sanz, Espana, Carr, Boullosa & Esteve-Lanao, 2011), decreased risk of injury 
(Bernhardt & Anderson, 2005), slower lactate accumulation (Driller & Halson, 2013), and 
improved performance and power output (Kemmler et al., 2009).  
While performance outcomes are the central focus for most athletes and sport scientists, 
there is also a need for fast recovery in athletes who train or compete multiple times per 
week, often required to perform consistently without a rest day (Wallace, Slattery & Coutts, 
2008).  Recovery can be measured in many ways such as; repair of muscle damage, return 
of maximal force production or maximum performance capability (Jeffrey, 2005). It is 
possible therefore, that some ergogenic aids may be beneficial in increase recovery and 
repeat performance, while not affecting maximal fully rest performance. Indeed, there is 
some evidence that CGs may behave in this way (Duffield, Cannon & King, 2010). 
Furthermore, compression garments have been linked with; decreased muscle damage, 
reduced delayed onset muscle soreness (Davies et al., 2009), reduced inflammation 
(Trenell, Rooney, Sue & Campbell, 2006) and increased maintenance of power (Driller et al., 
2013); all of which could be considered markers of recovery. However, while there are many 
studies supporting the proposed benefits of CGs the evidence remains equivocal, as there 
are many studies with contradicting findings including studies that have shown no beneficial 
effects whatsoever (Sperlich et al., 2010). There are also benefits purported that have little 
evidence to support them; therefore, gaps in knowledge are still evident (Born, Sperlich & 
Holmberg, 2013).  
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Another ergogenic aid that is suggested to improve markers of recovery and consequently 
repeat performance is ice therapy. Ice therapy is used extensively by athletes and 
recreational sports people for treatment after exercise as it is believed to increase recovery 
by; reducing muscle damage and inflammation (Bleakley et al. 2012) and reducing post 
exercise muscle soreness (Oakley, Pardeiro, Powell, Millar & Audrey, 2013). Limited 
research has been conducted into the combined use of compression and ice together. It has 
been suggested that this combination could elicit a greater benefit to recovery than either 
therapy alone (Sloan, Hain & Pownall, 1989).  
This thesis describes two studies conducted to investigate the effect of compression and ice 
application on performance and recovery. The thesis contains seven chapters; Chapter two 
reviews the current literature surrounding the use of compression garments and ice for 
performance and recovery. Chapter three describes general methodology used during all 
testing procedures. Chapter four outlines pilot testing conducted before the main studies 
were completed. Chapter five outlines phase one: The effect of knee high compression 
garments on 10 km run performance, and recovery in competitive recreation endurance 
athletes. Chapter six outlines phase two: the effect of combined compression and ice 
therapy on recovery after eccentric exercise. Finally, Chapter seven evaluates the findings 
from both phases in relation to the current literature.  
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Chapter 2: Literature Review 
2.1 Literature Search Strategy  
This review aims to examine the current literature relating to the use of CGs and ice therapy, 
and to evaluate potential benefits and mechanisms of action.  Furthermore, the methods 
used to assess these benefits and mechanisms are discussed. To achieve this, a computer 
based literature search was performed, ending in June 2015, using three online databases 
(PubMed, Web of Science and Web of Knowledge). Combinations of the following terms 
were used: Compression, compression garment, compression clothing, compression 
stocking, performance, heart rate, blood lactate, perceived exertion, running, endurance, 
muscle oscillations, blood flow, ice therapy, ice pack, ice bath, cryotherapy, cryo-cuff, 
cryocompression, cold compression, recovery, EIMD, muscle damage, creatine kinase, 
inflammation, CRP, DOMS, algometry, muscle soreness and eccentric exercise. The 
reference lists of obtained articles were examined in order to identify further relevant studies.  
2.2 Acute Running Performance 
An athlete’s performance in a single bout of endurance exercise is influenced by a large 
number of key factors and confounding variables; however, the main physiological 
determinants of endurance exercise are: Maximum oxygen consumption (VO2Max), 
percentage of V̇O2Max at Lactate threshold (LT), and running economy (Bassett & Howley, 
2000). While the ability to buffer hydrogen ions can be important in athletic performance, 
during self paced endurance running this has been shown to be less critical (Creasy, 2008). 
V̇O2Max 
An athlete’s V̇O2Max is defined as the highest rate at which oxygen can be taken in and 
utilized by the body (Bassett & Howley, 2000). This variable is one of the most commonly 
tested in athletes as a predictor of future performance and a measure of training effects 
(Noakes, 2000). A long standing debate exists about the limiting factor of maximal oxygen 
uptake. Specifically, the debate questions whether it is the capability of the muscles to take 
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in and utilise oxygen (peripheral factors) or the ability of the cardio-pulmonary system to 
delivery sufficient oxygen to the muscle (Central factors), that is the limiting factor. It is now 
largely accepted that is healthy individuals performing maximal full body exercise, that 
central factors limits V̇O2Max (Noakes, 2000). This conclusion was reached largely due to 
research that augmented the cardio-pulmonary systems ability to deliver oxygen, through 
blood doping and use of hyperoxic gas; the results of these studies showed a concurrent 
increase in V̇O2Max that would not have been present if the muscle was the limiting factor 
(Bassett & Howley, 2000). Moreover, research has shown that the main limiter in the 
cardiopulmonary system is likely to be cardiac output, more specifically as a consequence of 
stroke volume (Noakes, 2000). This result is supported by research that has shown that the 
training induced increases in VO2Max are due to an increase in stroke volume and 
consequently blood flow to the active muscles (Ekblom, Astrand, Saltin, Stenberg & 
Wallstrom, 1968; Saltin et al., 1968). 
Lactate Threshold 
Lactate threshold (LT) indicates the percentage of an athlete’s maximum performance that 
can be sustained for a long period of exercise (Midgley, McNaughton, & Jones, 2007). The 
percentage of V̇O2Max at LT indicates the amount of oxygen (V̇O2) that is available to the 
athlete at this sustainable work intensity; sometimes referred to as the performance V̇O2 
(Bassett & Howley, 2000). If an athlete’s work rate exceeds this level, then reliance on an-
aerobic energy pathways will be increase; as will hydrogen ion accumulation and 
consequently blood lactate concentration (Noakes, 2000). Accumulation of hydrogen ions 
causes a reduction in cell pH, that interferes with the function of key enzymes, such as 
phosphofructokinase (PFK) and muscle cross bridging leading to exercise fatigue (Robergs, 
Ghiasvand & Parker, 2004). Additionally, when exercising above LT the rate of glycolysis is 
increased, due to changes in cellular charge; this increase in carbohydrate usage can also 
be a limiting factor during endurance exercise as carbohydrate stores become exhausted 
(Bassett & Howley, 2000). Unlike V̇O2Max, an athlete’s lactate threshold is largely governed 
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peripheral factors; namely by the muscle capillerisation density, number of mitochondria and 
oxidative enzyme concentrations (Bassett & Howley, 2000); all of which can be increased 
with training (Midgley et al., 2007). 
Running Economy 
Running economy refers to an athlete’s efficiency at converting the available energy in 
running speed (Midgley et al., 2007), or more specifically it is the amount of work (distance 
covered) that can be done per unit for oxygen (Bassett & Howley, 2000). As such, if two 
athletes have the same maximal oxygen uptake but different running economy, the athlete 
with the higher economy will have a higher maximum running speed, as they are able to 
cover more distance (do more work) for the same amount of oxygen delivery (Noakes, 
2000). An athlete’s running economy and percentage V̇O2max at LT combine to determine the 
running speed at LT and consequently the maximum sustainable running speed during 
endurance performance (Figure 1). This maximum sustainable speed has been shown to be 
the most important and accurate single indicator of endurance running performance (Midgley 
et al., 2007).  
Between-subject variance in running economy is due to a wide range of physiological and 
biomechanical factors for example: body mass, skeletal structure and running technique. 
However, the greatest factor affecting an individual’s running economy during endurance 
exercise is their ability to utilise the muscles as an elastic return system, through the stretch 
shortening cycle (SSC) (Noakes, 2000); this elastic return of energy allows the muscle to 
produce less torque while maintaining the same power output, therefore increasing efficiency 
(Paavolainen, Nummela, Rusko & Häkkinen, 1999). The SSC during activities such as 
walking, hopping and running utilises gravity to lengthen the muscles involved in the 
movement. Pre-activation of the muscle allows an eccentric contraction to occur during the 
lengthening phase, which is then followed by a concentric contraction phase (Paavolainen et 
al., 1999). The pre activation and eccentric phases of the SSC have the effect of storing 
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elastic energy which is then used to enhance the performance of the muscle during the final 
concentric phase; when compared to an isolated concentric phase (Komi, 2000). The ability 
of the muscle to use this stored elastic energy is limited by the: amount of pre activation and 
stiffening of the muscle, velocity and magnitude of the stretch phase, and the time delay 
between the eccentric and concentric phases (Paavolainen et al., 1999). Fatigue of the SSC 
is believed to be a major factor contributing to decreases in running performance during 
endurance events and in the subsequent muscle damage experienced post exercise (Komi, 
2000). The time between eccentric and concentric phases of the muscle movement and 
consequently ground contact time, have been shown to increase concurrently with a 
reduction in running economy and maximal performance during the latter stages of 10 km 
running time trials (Paavlainen et al., 2000). Training interventions and ergogenic aids that 
could reduce SSC fatigue during exercise could benefit endurance running performance, 
through increased maintenance of running economy (Noakes, 2000). 
Motivation 
The three physiological factors discussed above (V̇O2max, % V̇O2max at LT and Running 
economy) have been shown to account for more than 70% of the between-subject variance 
in long distance running performance (Midgley et al., 2007). However, this physiological 
model, of the determining factors of endurance exercise performance, fails to acknowledge 
the role of psychological factors such as motivation. Conscious effort and motivation play a 
key role in exercise performance; as shown in previous research that has demonstrated 
performance increases during placebo interventions (Noakes, 2000). Moreover, it has been 
shown that reduced motivation due to mental fatigue, adversely affected endurance running 
performance (Marcora, Staiano, & Manning, 2009). Therefore, it is clear that motivation level 
has a key influence on performance and any model hoping to outline determinants of 
performance should include motivation (Figure 1); however, due to the complicated 
interactions of physiological and psychological variables, the mechanisms by which 
psychological factors affect endurance performance remain unclear (Noakes, 2000). 
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Figure 1: Factors determining endurance running performance. Adapted to include 
motivation (Bassett & Howley, 2000; Midgley et al., 2007).  LT = Lactate Threshold. 
2.3 Ergogenic Aids to Performance  
Ergogenic aids are used extensively by professional athletes and recreational sports people, 
to aid sport and exercise performance (Ali et al., 2007). These include nutritional aids such 
as supplements, physical aids such as clothing, and psychological aids such as visualisation 
and increased motivation (MacRae et al., 2011).  Compression garments are now one of the 
most popular ergonomic aids used for endurance events, such as running and triathlon 
(Bakken et al., 2011). Despite this, the rationale for their use and evidence for their benefit 
remains somewhat equivocal (MacRae et al., 2011). 
2.3.1 Compression Garments 
Compression garments are tight elastic garments, varying from socks to arm sleeves, used 
to apply compressive force to segments of the body. Compression was originally designed 
for use in hospitals to aid recovery (Wilkins, Mixter, Stanton & Litter, 1952) by increasing 
venous blood flow (Lawrence & Kakkar, 1980), decreasing venous stasis (Gandhi & Palmer, 
1984) and to prevent thrombosis (O’Donnell & Rosenthal, 1979) in the legs of bed ridden 
V̇O2Max % V̇O2Max at LT 
V̇O2 at LT Running 
Economy 
Speed at 
LT 
Motivation 
Distance Running 
Performance 
Maximum Sustainable 
Running Speed  
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patients. The thrombosis preventing properties of knee high compressive socks were then 
utilised by people on long haul flight, to help prevent deep vein thrombosis. The sporting 
community then began using CGs to aid performance and recovery (Berry & McMurray, 
1987), with the use of compression shorts, knee high compression and full leg compression 
becoming a common sight at running and triathlon events (Creasy, 2008).  
2.3.1.1 Compression Garment Type 
There are many different types of compression garment used in sport today (Table 1), 
including upper body, arm sleeves and leg compression. The focus of this review is lower 
body compression. The different forms of lower body compression are often described by 
many different names, this combined with the infrequent statement in the literature of the 
exact area covered by the garment (MacRae et al., 2011), has led to some confusion. For 
clarity, this review refers to compression garments by the names described in table 1; in the 
event that it was unclear which type of CG was used in a piece of research, the author’s 
description was used. 
Table 1: A summary of compression garment types and descriptions 
Description Area of Body Covered 
 
Upper Body 
Arm sleeves Arm from the wrist to below shoulder 
T shirt Torso and upper arm above the elbow 
Full upper body Torso and entire arm to the wrist 
 
Lower Body 
Calf Sleeves Lower leg from the ankle to below the knee 
Socks Foot and lower leg to below the knee 
Thigh High Leg from ankle to the mid thigh 
Stockings Foot and leg to the mid thigh 
Shorts From the knees to the hips 
Full length tights From the ankles to the hips 
Description= the term used to describe the compression garment within this thesis 
The efficacy and advantages of different types of compression garments have not been 
studied extensively. Several studies have compared the effect of knee high compression 
compared with above knee compression on blood flow. Lawrence et al. (1980) found no 
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difference in venous return when comparing knee high to thigh length or full length 
compression. They also suggested that below the knee is the most important area to be 
compressed for increasing blood flow. However, this study was conducted on patients with 
venous insufficiencies in the supine position; therefore the results may not be transferable to 
a healthy population (Byrne et al., 2001), while standing or when muscles are actively 
contracting (Creasy, 2008). No research was identified that evaluated the effect of 
compression length on any other variable. Consequently the effect of different compression 
types on the other proposed benefits of CGs remains unclear. 
2.3.1.2 Graduated Compression 
When testing CGs the definition and measurement of the compression is important. Medical 
compression and the majority of sport compression claim to provide graduated compression, 
where the greatest pressure is applied distally and the pressure reduces proximally. The 
pressure of compression socks and calf sleeves are measured in millimetres of mercury 
(mmHg) at the ankle and calf. Therefore, a sock labelled 15-20 mmHg is eliciting 20 mmHg 
at the ankle and 15 mmHg at the calf. Medical compression socks are normally rated around 
20-40 mmHg (Hirai, Iwata & Hayakawa, 2002).  
Early efficacy research 
Stanton et al. (1949) showed that non graduated ankle to knee compression of 20 mmHg 
increased venous velocity in patients with venous insufficiencies. The first record of 
graduated compression use was Scurr, Machin and Bailey-King (1977); who showed that 
graduated stockings (GCS) significantly reduced the incidence of deep vein thrombosis 
(DVT) in post operative patients. However, Scurr compared the GCS to an untreated control 
leg, rather than a non -graduated control and this may have influenced the results. Lawrence 
& Kakkar (1980), compared different ranges of compression gradient and found that 18 
mmHg at the ankle and 8 mmHg at the mid thigh was optimum for increasing deep venous 
blood flow without inhibiting subcutaneous blood flow. They also suggest that the graduation 
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ensured there was no tourniquet effect and that graduation was critical to the function, 
contradicting the earlier findings by Stanton. The use of graduated compression garments 
became widely used in hospitals following a meta-analysis of 12 studies conducted by Wells, 
Lensing and Hirsh (1994), which concluded that graduated compression significantly 
decreased post-operative venous thromboemolisms by 68% (p = 0.0001).  
Adoption into sport 
Despite the limited research supporting graduated over non-graduated compression, it was 
soon adopted into sport and its use investigated. Berry and Bailey (1990) studied the effects 
of elastic compression garments on eight healthy males following high-intensity exercise 
(110 per cent V̇O2max) for up to three minutes on a treadmill. There was no significant 
difference in energy requirement, heart rate (HR) or blood lactate concentration at rest or at 
5, 15 or 30 mins post-exercise, when compared to a control. However, Wallace et al. (2008) 
criticised the study for not having the minimum required compression of 18 mmHg at the 
ankle and 8 mmHg at the mid thigh needed to encourage venous return (Lawrence et al., 
1980). Bringard, Perry and Belluye (2006b) compared CGs to elastic tights and found a 
reduced energy cost at 12 km.h-1, for both conditions when compared to a loose fitting short. 
However, Bringard and colleagues did not state the level of compression applied by either 
garment. Berry et al. (1990) stated that elastic tights did not affect blood lactate, HR or 
oxygen consumption during cycling and recovery because they do not apply sufficient 
pressure to enhance venous blood flow. Despite this, no study has been identified that 
compared graduated compression garments to non-graduated garments of 20 mmHg as 
shown by Stanton et al. (1949) to increase blood flow. 
Graduated vs. non-graduated compression 
Despite being identified as an important parameter, it is rare to find an adequate definition of 
the mechanical properties of the CGs used (MacRae, Cotter & Laing, 2011). Many studies 
fail to supply a figure for compression (Bringard et al., 2006b), others give single number 
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compression values making it unclear whether the compression was graduated (Sperlich et 
al., 2010), or values are presented with no clarification about their origin. Ali, Creasy and 
Edge (2011) defined the compression used in their study as; control 0 mmHg, low 12-15 
mmHg, medium 18-21 mmHg and high 23-32 mmHg. The low and medium CGs resulted in 
greater maintenance of leg power after endurance exercise compared to the control and 
high CG trials. However, how they measured the pressure is not explained. It is unknown 
whether pressure readings were an estimate, based on size of garment or size of leg; or if 
pressure was measured directly on the participant’s leg. Due to wide individual variance in 
leg sizes and shapes, if a study does not measure compression directly on the participant’s 
leg, the level of compression and gradient being applied can only be estimated and 
measured pressures frequently differ from the level intended (MacRae et al., 2011). 
Consequently, results that appear to support the use of graduated compression may not be 
valid, unless the pressure gradient was measured on the participant’s leg.  
Recently, Hill, Howatson, van Someren, Leeder and Pedlar (2013) conducted a meta-
analysis of 12 compression studies and concluded that CGs are beneficial for recovery; 
however, analysis did not suggest that the compression should be graduated to give these 
benefits. Born et al. (2013) conducted a meta-analysis that suggested that CGs may assist 
athletic performance and recovery in given situation, of the 31 studies analysis by Born et al. 
(2013), 16 reported the use of graduated compression and 15 did not. Further research is 
necessary into the efficacy of graduated compression compared to non- graduated 
compression, and the effect of a pressure gradient on mechanisms of performance and 
recovery in addition to blood flow. 
2.3.2 Mechanisms of Action during Performance 
2.3.2.1 Muscle oscillations 
Muscle oscillations are the displacement of muscle tissue, caused by acceleration forces, 
produced when the supporting skeletal structure impacts a surface. For example, the 
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muscles of the thigh are displaced longitudinally when the feet hit the floor following a jump 
(Kraemer et al., 1998).  Compression shorts have been shown to significantly reduce muscle 
oscillations compared with loose fitting shorts, when performing countermovement jumps 
(Doan et al., 2003). Furthermore, when participants were wearing compression shorts, 
Kraemer et al. (1998) found a significant decrease in muscle oscillations during repeated 
jumps, using a high speed video system. Similarly, Bakken (2011) used accelerometers 
placed on the left thigh and found decreased muscle acceleration during running. Borras et 
al. (2011) evaluated the effects of compression shorts on leg muscle oscillations and 
showed a significant reduction in thigh muscular displacement in those wearing CGs. 
Reductions in muscle oscillation have been suggested to give benefits in performance and 
recovery. 
Performance increases found by Kraemer et al. (1998), were explained by increased 
maintenance of power due to decrease muscle oscillations. It was also suggested that the 
reduced muscle oscillations allowed for a shorter ground contact (Kraemer et al., 1998), 
which could increase the efficiency of the SSC and increase running economy (Komi, 2000). 
This is supported by Doan et al. (2003), who found improved jumping ability was due to 
reduced muscle oscillation upon ground contact. This could be explained by reduced 
interruption of neurotransmission and more optimum mechanics of the muscles at a 
molecular level, with reduction in muscle oscillation (McComas, 1996). These increased 
mechanics have been suggested to help maintain efficiency of the SSC during fatiguing 
exercise, which could maintain force output and running economy, which consequently could 
benefit performance as the bout of exercise continues (Duffield et al, 2008). However, 
research into muscle oscillations is still very limited and the benefits of reduced muscle 
oscillations are hypothesised but not proven. In terms of CG use research has shown a trend 
for thigh musculature to oscillate less with compression shorts; however, a direct link 
between this and performance has not been established (Bakken, 2011). Furthermore, no 
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studies have examined muscle oscillations in other muscle groups, or with any other type of 
CG. 
If reduced oscillations were shown in the calf musculature, during running; this would 
support a possible mechanism by which knee high CGs could aid performance. Further 
research should explore the link between this stabilisation of the muscle, the force produced, 
and the effect on exercise efficiency. 
2.3.2.2 Blood flow 
As described above, CGs were originally developed to augment blood flow; as such the 
proposed mechanisms and suggested benefits of CGs on blood flow forms a large 
proportion of the current compression literature (MacRae et al., 2011) and is often quoted as 
a major benefit of wearing compression by many of the companies who supply the garments 
for exercise (2XU, 110% Harder, Skins). This has led to a wide range of mechanisms being 
suggested to explain how CGs may increase blood flow at rest and during exercise.  
Myogenic Response 
The myogenic response (Bayliss effect) suggests that arteriolar vessels constrict in response 
to an increase in transmural pressure and dilates in response to a fall in transmural pressure 
(Bochmann et al., 2005). Transmural pressure is the difference in pressure inside and 
outside of the vessel. Compression garments exert pressure directly on underlying tissues; 
this is proposed to increases the pressure outside arterioles, which reduces the transmural 
pressure (Bochmann et al., 2005). When the transmural pressure is reduced the wall of the 
arterioles are constricted, causing calcium channels to close. This causes a reduction in 
contraction force of the smooth muscle in the arterioles’ wall. Leading them to dilate and 
subsequently increase blood-flow (Davies et al., 2009; O'Donnell et al., 1979). Lundvall and 
Lanne (1989) studied the application to negative pressure (2-50 mmHg) to the forearm of 15 
volunteers, they found that the pressure was transmitted almost fully to the tissue below and 
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that transmural pressure was affected proportionally. Bochmann et al. (2005), found external 
pressure from made to measure stockings, increased resting perfusion and peak blood flow 
in the forearm. Maximal flow effect was induced by a pressure of 20 mmHg. Arterial flow 
significantly increased with CGs from 3.7 ± 0.9 to 8.8 ± 2.0 ml.min-1.100ml-1 tissue (p < 
0.001). The flow increase was consistent for 3 hours of constant CG use and also during 
simultaneous low intensity hand grips; blood flow returned to normal when CGs were 
removed.  
Venular-Arteriolar Communication 
While compression is suggested to cause arterioles to dilate, it is also suggested that veins, 
which are softer and contain blood at a lower pressure are forced to contract (Bochmann et 
al., 2005). As a result of the reduced lumen diameter in the veins the blood flow may exert 
an enhanced shear stress, which could trigger the release of endothelial dilators for example 
Nitric Oxide. In a process known as venular-arteriolar communication, these dilators may 
reach neighbouring arteries by diffusion and further reduce arteriol resistance (Hester and 
Hammer, 2002). 
Skin Vasomotor Reflex 
Another mechanism by which CGs are suggested to increase blood flow is the skin 
vasomotor reflex. It has been hypothesised that the application of pressure to the skin 
surface may activate non-nociceptive skin receptors or proprioceptors in under lying tissue 
causing an increase in microcirculatory flow (Abraham, Fromy, Merzeau, Jardel & Saumet, 
2001). Bochmann et al. (2005), believe that the role of skin vasomotor reflex and venular-
arteriolar communication need to be studied further and that the myogenic response is most 
likely to be responsible for the blood flow increase with compression.  
However, none of the above mechanisms are suggested to be reliant on graduation of 
compression. Indeed, Bochmann et al. (2005) stated that the maximal flow effect was 
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induced by a pressure of 20 mmHg; there was no suggestion that a pressure gradient was 
applied, or that one would be necessary to induce this response.  
Blood Pooling 
When a person stands there is an increase in hydrostatic force of between 80 and 100 
mmHg due to gravity (Born et al., 2013). This causes superficial veins to expand and blood 
to pool in the legs. Agu, Hamilton and Baker (1999) showed that standing increased the 
concentration of deoxygenated haemoglobin in the calf. CGs were shown to reduce this 
venous pooling in patients with Chronic venous insufficiencies (CVI) at rest (Hirai et al., 
2002). During exercise the skeletal muscle pump works to counter this, using muscle 
contractions in the lower leg to squeeze blood through the one way valves in the veins. 
Venous return is also helped by the respiratory pump, cardiac suction, and expansion of the 
atria due to ventricular contraction (Brooks, Dubouchaud, Brown, Sicurello & Butz, 2001). 
Agu et al. (1999) found that tip toe exercise reduced deoxygenated blood pooling, but not as 
much as wearing CGs did during rest. However, Mayberry, Moneta, De Frang and Porter 
(1991) stated that a rapid increase in venous blood flow and mechanical action of the 
skeletal muscle pump ensures an adequate supply of blood is returned to the heart to 
maintain cardiac output during exercise, in healthy individuals. It is therefore unclear if 
compression affects blood pooling in to healthy people during exercise. 
Venous Return 
Blood pooling is reduced and venous blood velocity increased by reduction of total venous 
cross section area (Morris et al., 2004; Stanton et al., 1949). This is achieved through 
shifting of the blood from superficial veins, that are more susceptible to stretching, to deeper 
veins (Lawerence et al., 1980) and through reduced lumen size due to the compressive 
effect on the tissue (Bochmann et al., 2005). Mayrovitz and Sims (2003) found a significant 
reduction in skin blood perfusion in healthy supine patients, with use of ankle to knee 
compression. It was concluded that increased venous resistance at the ankle was 
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responsible for the reduced superficial perfusion. A reduction in lumen size is also 
hypothesised to help support and increase the function of the one way valves in the leg by 
allowing them to close properly (Lewis et al., 1976). This deeper blood flow, increased 
velocity, reduced lumen diameter and supported valves is said to reduce venous stasis, 
coagulation (Sajid et al., 2006), reflux and stagnant blood behind vein valves (Lewis et al., 
1976). This has been shown to reduce chances of thrombogenesis (Lewis et al., 1976; Scurr 
et al., 2001). A reduction in vein diameter has also been shown to reduce the risk of intimal 
tears (Sajid et al., 2006) which could help prevent further damage. O’Donnell et al. (1979) 
found no difference in venous return time with CGs, however there was a reduction in 
systolic venous pressure. O’Donnell et al. (1979) concluded that this pressure reduction 
could be beneficial to post phlebitis patients. The above factors, relating to the displacement 
of blood to deeper veins, have been shown to be beneficial in patients with venous 
insufficiencies and could reduce the risk of further venous damage during exercise; but 
limited evidence has been shown for increased venous return in resting supine healthy 
individuals. However, it is difficult to draw conclusions from studies on resting patients or 
patients with venous insufficiencies that are applicable to a healthy population (Byrne et al., 
2001) during physical activity or exercise (MacRae et al., 2011).  
Blood Flow during Exercise 
Agu et al. (2004) used near infrared spectroscopy to monitor venous function and calf 
muscle oxygenation; they found that with CGs total haemoglobin and limb oxygenation was 
reduced during tip toe exercise and walking. This reduction in blood pooling was greater 
than when any of these interventions was used on its own. Similarly Ibegbuna, Delis and 
Nicolaides, (2003), found that graduated CGs significantly improved haemodynamics during 
walking by reducing residual volume fraction (RVF); this was suggested to indicate an 
increase in muscle pump function with CGs (Eberhardt and Raffetto, 2005). In contrast, 
Mayberry et al. (1991) found that neither below knee or above knee CGs significantly 
improved venous pressure, venous refill or maximum venous pressure. It was concluded 
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that CGs did not improve deep venous haemodynamics during exercise. However this 
measurement was performed on a non compressed leg immediately following exercise, 
therefore the effect the compression had during exercise on the compressed leg is unclear.  
Bringard et al. (2006a) showed an increase in blood flow induced by CGs caused an 
increase in oxygen supply to the muscles; It was suggested that this blood flow change 
could increase metabolite clearance, for example lactate, which would ultimately lead to an 
increase in performance and reduced energy cost.. However, this was purely hypothetical, 
as these results were observed at rest. In a meta-analysis positive effect sizes were found 
for: lactate removal, metabolic clearance and nutrient supply (Born et al., 2013). It was 
suggested that this may support an improvement in haemodynamics, especially during high 
intensity training. If these increases are present during high intensity training, it is likely that 
this mechanism would affect maximal running performance, by increasing the intensity of 
exercise that could be maintained without hydrogen ion accumulation. However the same 
meta-analysis found that CGs had no effect on cardiac output, stroke volume, heart rate or 
performance; which could bring the previous findings in to doubt. Likewise, Dascombe et al. 
(2011) observed an increase in regional blood flow and a reduction in heart rate; however 
they did not find an increase in performance or tissue oxygenation with lower body 
compression. Dascombe concluded that these improvements were trivial for athletes, as 
they did not correspond to any improvement in endurance running performance.  
Despite large volumes of literature, advertising and media coverage surrounding the effects 
of compression on blood flow, no study has shown CGs to increased blood flow or venous 
return in healthy participants at exercise intensities matching training or competition 
(MacRae et al., 2011). The reason for this gap in the current research is largely due to 
methodological difficulties; the current methods, as described above, to measure blood flow 
cannot be conducted on moving participants. Additionally, the most common method used to 
measure blood flow is the measurement of the diameter of major blood vessels and the 
velocity of the blood passing through them. However, the validity of equating this to total 
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venous return has been questioned (MacRae et al., 2011). MacRae et al., (2011) suggested 
that these variables do not necessarily indicate changes in flow volume per unit time. 
Furthermore, there is also little evidence that blood pooling or blood flow benefits are reliant 
on pressure gradient; and unless markers of performance or recovery increase concurrently 
then blood flow increases are irrelevant. 
Due to the methodological difficulties described above, it is outside the remit of this research 
to attempt to measure blood flow during exercise. However, the proposed benefits of 
increased blood flow to other systems during exercise can be measured, for example: 
reduced heart rate, reduced lactate and increased performance. If differences in these 
markers are found with knee high CGs, this would support increased BF as a possible 
benefit to recreationally trained athletes during endurance running.  
2.3.2.3 Heart rate  
The measurement of heart rate has been suggested to give an accurate measure of venous 
return (Baron, Decaux-Jacolot, Edouard, Berdeaux & Samii,1986). It is suggested that the 
baroreceptors reflex control of heart rate is affected by venous return. This is based on the 
Frank–Starling law of the heart (Starling’s Law), which states that stroke volume increases in 
response to an increase in the volume of blood filling the heart (end diastolic volume); this 
increase stroke volume could allow heart rate to decrease while cardiac output is 
maintained.  It is suggested that reduced blood pooling and increased venous return as a 
result of CG use, may increase the end diastolic volume of the heart and therefore increase 
stroke volume. As a result previous studies have used HR as an indirect measure of blood 
flow (Creasy, 2008). However, stroke volume has been shown to be a limiting factor in 
endurance exercise performance (Bassett & Howley, 2000), therefore it is possible that 
during hard endurance exercise HR would remain unchanged while cardiac output is 
increased. Additionally, the use of HR changes during exercise to measure blood flow, fails 
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to take into account other factors that could affect HR during exercise for example cardiac 
drift, body temperature or changes in running economy.  
While the use of HR as a measure of blood flow during exercise is tenuous; heart rate is a 
valid measure of intensity of effort (Laukkanen & Virtanen, 1998) and energy expenditure 
(Strath et al., 2000); therefore, if a lower heart rate can be maintained at a set exercise 
intensity, or if exercise intensity or performance can be increased without a change in HR, 
this would support mechanism for increased efficiency and running economy; for example 
increased blood flow or reduced muscle oscillations. Therefore the current study measured 
HR during performance as a measure of exercise intensity and when combined with 
performance results, a measure of running economy.  
Varela–Sanz et al. (2011) and Dascombe et al. (2011) showed decreased heart rate during 
maximal runs, when using knee high and full length CGs respectively. Ali et al. (2007) also 
found trained athletes had lower heart rates during 10 km time trials when wearing knee high 
compression. However, these results are conflicted by other studies that found no effect of 
CGs on HR (Ali et al., 2011; Creasy, 2008; Duffield et al., 2010; Goh, Laursen, Dascombe & 
Nosaka, 2010). Born et al. (2013) concluded that in healthy subjects it is questionable 
whether the low area of muscle compressed by knee high CGs has an effects on central 
circulation. Likewise, MacRae et al. (2011) concluded that submaximal and maximal HR 
appeared unaffected by compression. These conflicting results bring into question the 
suggested mechanisms by which CGs may increase physiological efficiency and economy, 
and suggest that reductions in HR found in previous research may be due to the placebo 
effect (Born et al., 2013; MacRae et al., 2011). 
2.3.2.4 Blood Lactate 
Lactate accumulation is the result of hypoxia in the muscle; hypoxia and the associated 
acidosis (pH decrease) have been found to be limiting factors in maximal exercise (Fitts, 
2008). Lactate build up itself is not a limiting factor, as lactate does not cause acidosis but 
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acts as a hydrogen ion buffer (Lindinger, Kowalchuk & Heigenhauser, 2004; Robergs, 
Ghiasvand & Parker, 2004). It has also been suggested that lactate does not cause muscle 
soreness, as was previously hypothesised (Robergs et al., 2004). However lactate can be 
used as an accurate measure of hypoxia and therefore work intensity. Therefore, reduced 
lactate accumulation may indicate the capacity for the athlete to work at a higher work rate; 
this could then lead to a performance increase; furthermore, if lactate accumulation is 
unchanged but exercise intensity increased, this could lead to an increase in endurance 
exercise performance (Bassett & Howley, 2000). Lactate and H+ ions are co-transported out 
of muscle cells, via the mono-carboxylate transporters (MCT) 1 & 4, to increase the pH of 
the cells and attenuate acidosis. Lactate can then be converted back into Pyruvate, by 
muscle cells, when oxygen is available, used by the heart or brain for energy, or can be 
converted to glucose, through the Cori cycle, in the liver or kidneys. It is proposed that 
decreased blood pooling and increased blood flow, with the use of CGs, could facilitate 
greater oxygen delivery to the muscles and greater lactate clearance from the peripheries to 
the core where it can be converted (Berry et al., 1987; Chatard & Atlaoui, 2004); this 
reduced production and increased clearance of hydrogen ions at a set intensity and could 
allow a higher work output and improved performance (Bringard et al., 2006a). 
Many studies into the effects of CGs have examined blood lactate levels. Compression was 
shown to reduced blood lactate concentration during maximal exercise on a bicycle 
ergometer (Berry & McMurray, 1987). Kemmler et al. (2009) and Chatard and Atlaoui (2004) 
both found CGs lowered blood lactate levels significantly during maximal running and cycling 
respectively. Recently, further studies have supported these results (Kraemer et al., 2010: 
Diller et al., 2013). A contradictory study by Rimaud, Messonnier, Castells, Devillard and 
Calmels (2010), found increased blood lactate during maximal exercise in eight healthy 
males using compression socks, with maximum compression of 22 mmHg on the calf and 
minimum of 12 mmHg at the ankle. However, this compression is opposite to that 
recommended in other studies (Gandhi  & Palmer, 1984; Lawrence & Kakkar, 1980; 
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O’Donnell et al., 1979) and could created a negative pressure across the one way valves in 
the veins of the leg, which could cause increased peripheral resistance or venous occlusion. 
Despite this, MacRae et al. (2011) concluded that there was little conclusive evidence for 
decreased lactate with CG use. 
Given the potential of blood lactate concentration for measuring hypoxia and exercise 
intensity; lactate accumulation will be measured in the current study during exercise, as a 
means of testing the potential for performance enhancing mechanisms such as: reduced 
muscle oscillations, improved oxygen supply or improved haemodynamics. 
2.3.3 Efficacy of CGs for performance 
Many claims have been made, within the sports community and scientific literature, about 
the benefits of wearing CGs to increases performance; however, there is limited data 
available to support these claims (MacRae et al., 2011). Studies have used a varying range 
of different sports and exercises to examine the effect of compression on performance 
(Table 1). In moderately trained men, Kemmler et al. (2009) found increases in maximal 
voluntary running performance and time to fatigue with CGs, compared to wearing normal 
running socks. Similarly, Varela-Sanz et al. (2011) found an increase in time to fatigue, when 
running at 105% of 10 km pace, with use of compression socks. However, it could be argued 
that time to fatigue is not be a valid measure of performance, as there are no races or events 
of this nature. Therefore, a sport protocol, race or time trial performance would give more 
ecologically valid results for the athlete’s that will be using these garments.  
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Table 1: A summary of current compression garment research including: garments used, exercise type and findings 
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Ali et al.  2007 Knee High 24 10 km road run ↑ 
     
↑ 
       
Ali et al.  2010 Stockings 10 40 min treadmill run 
 
∞ 
   
∞ ∞ 
 
∞ 
     
Ali et al.  2011 Knee High 12 10 km run outdoor track ∞ 
          
↑ 
  
Berry et al. 1990 Tights 8 110% V̇O2max run 
     
∞ ∞ 
 
∞ 
    
∞ 
Bakken et al. 2011 Short&Stockings 11 Run to exhaustion ∞ ∞ 
 
↑ 
  
∞ 
 
 
   
 
∞ 
Bernardt et al. 2005 Shorts 13 Jumps and Joint range test ∞ 
         
∞ 
   
Boras et al. 2011 Shorts 9 Downhill running 
 
↑ ↑ 
 
↑ 
         
Born et al 2013 Meta-Analysis of 31 studies ↑ ↓ ↑ 
 
↑ ↓ ↓ 
 
∞ 
 
↑ ↑ ↑ 
 
Bringard et al. 2006a Knee High 12 Standing and supine 
        
↑ ↑ 
    
Bringard et al. 2006b Full Length 6 Track running 
       
↑ 
 
↑ 
   
↑ 
Carling et al. 1995 Arm Sleeves 23 Eccentric arm curls 
  
∞ 
 
∞ 
     
∞ 
   
Chatard et al. 2004 Knee High 12 5 min maximal cycling 
    
↑ ↑ 
     
↑ 
  
Connolly et al. 2003 CG DOMS treatment literature review 
    
↑ 
         
Creasy et al. 2008a Stockings 12 10 km run outdoor track ∞ 
    
∞ ∞ 
    
↑ 
  
Creasy et al. 2008b Stockings 10 40 min treadmill runs 
     
∞ ∞ ∞ 
      
Dascombe et al. 2011 Full Length 11 Maximal tests ∞ 
     
↑ 
  
↑ 
    
Davies et al. 2009 Full Length 11 Drop jumps ∞ ↑ 
  
↑ 
   
∞ 
     
Doan et al. 2003 Shorts 20 Sprints and jumps ∞ 
  
↑ 
      
↑ 
  
 Driller et al. 2013 Full Length 10 2 x 30 min cycling time trial 
  
↑ 
  
↑ 
  
 
  
↑ 
  Duffield et al. 2008 Full Length 14 Sprints (simulated rugby) ↑ ∞ 
      
 
 
∞ 
 
  Duffield et al. 2010 Full Length 11 Sprints and Plyometrics ∞ 
     
∞ 
 
 
   
  French et al. 2008 Full Length 26 Sprints and jumps 
 
∞ 
 
∞ ∞ 
         
Gill et al. 2005 Full Length 23 Rugby Match 
 
↑ 
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Table 2: A summary of current compression garment research including: garments used, exercise type and findings cont. 
Author Date Compression  
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Goh et al. 2010 Shorts 10 20 min treadmill run & to max  
       
↑ 
 
   
↑ 
 Hill et al. 2013 Meta-analysis of 12 studies 
 
↑ 
  
↑ 
      
↑ 
  Higgins et al. 2009 Full Length 10 20m sprints & Jumps ↓ 
           
 
 
Jakeman et al. 2010 Full Length 17 10 x 10 plyometric drop jumps  
∞ 
  
↑ 
      
↑ 
 
 
Kemmler et al. 2009 Knee High 21 Stepwise treadmill test ↑ 
           
↑ 
 
Kraemer et al. 1998 Shorts 40 Jumps & 30 min runs 
   
↑ 
      
∞ ↑ 
  
Kraemer et al. 2001 Arm Sleeves 20 Eccentric arm curls 
 
∞ ↑ 
 
↑ ↑ 
     
↑ 
  
Kraemer et al. 2010 Whole body 20 Whole body resistance  
  
↑ ↑ ↑ 
         
MacRae et al. 2011 Lit review 
  
∞ ↑ 
  
∞ ↑ 
 
↑ 
 
↑ 
  Montgonmery et al. 2008a Full Length 18 2 day basketball tournament 
  
↑ 
 
↑ 
        
 
Montgonmery et al. 2008a Full Length 18 3 day basketball tournament 
          
 
↑ 
  
Perry et al. 2008 1 leg Stocking  8 Eccentric walking 
 
↑ 
  
↑ 
         
Pruscino et al. 2013 
 
8 Match simulation 
 
∞ ∞ 
 
∞ 
      
∞ 
  
Rimuauld et al. 2010 Stockings 8 Maximal bike tests ∞ 
    
∞ ∞ ∞ 
      
Scanlan et al. 2008 Full Length 12 Max tests and 1h time trials ∞ 
    
∞ ∞ 
 
 
 
↑ 
   
Schornstein et al. 2011 Full Length 11 5 kilometre pace to exhaustion 
      
∞ ∞ ↑ 
   
∞ 
 
Sear et al. 2010 Whole body 8 45min non-motorized treadmill ↑ 
       
 
     
Sperlich et al 2010 Full body 15 70% V̇O2 and max runs ∞ 
    
∞ 
  
↑ 
   
∞ 
 
Trenell et al. 2006 1 leg full  11 30 mins downhill walking 
  
↑ 
           
Varela–Sanz et al. 2011 Knee High 16 105% of 10 km pace treadmill ∞ 
     
↑ 
 
∞ 
   
↑ 
 ↑=  Positive effect , ↓= Negative effect, ∞= no statistical difference found, Musc. Dam.= muscle damage, Musc. Oscill.= muscle oscillation, DOMS= delayed 
onset muscle soreness, Lactate= blood lactate concentration, RPE= rating of perceived exertion, Oxygenation= tissue oxygenation, Power Maint.= power 
maintenance, Energy Expend.= energy expenditure.  
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Power exercises such as sprinting and jumping have shown mixed results for performance 
benefits with CGs. Some studies have found an increase in maximal jump height or power 
output with full length CGs (Higgins et al., 2009) and compression shorts (Jakeman et al., 
2010; Kraemer et al., 1998). It has been hypothesised that mechanisms for improvements in 
jump height may be; improved warm-up via increased skin temperature and an increase in 
flexor and extensor torque at the end of range, due to the elasticity of the CGs over the joint 
(Doan et al., 2003). Born et al. (2013) concluded that the previous evidence showed a 
positive effect of CGs on performance during single and repeated bouts of power exercises 
such as sprints and vertical jumping. However, the demands and mechanisms of power 
exercise are different to those of endurance exercise; therefore, generalisations of 
performance benefits across exercise types should not be made.   
Unlike power exercise, the effect of CGs on performance during endurance exercise is less 
clear; several studies have looked into long distance running and endurance performance 
with contradictory results. Ali, Caine and Snow (2007) found that 10 km run time decreased 
with the use of knee high CGs. This was supported by Sear, Hoare, Scanlan, Abt and 
Dascombe (2010) who found an increase in distance covered during a maximal 45 min run, 
wearing whole body compression. However, these results are conflicted by Ali et al. (2011) 
and Creasy (2008) who found no difference in 10 km running performance with knee high 
CGs. Scanlan, Dascombe, Reaburn and Osborne (2008) also found no difference in 
distance covered during a one hour running time trial, when using full length tights. Ali et al. 
(2001), Creasy (2008) and Scanlan et al., (2008) used highly trained participant’s; whereas, 
Ali et al., (2007) used recreational runners and Sear et al. (2010) trained team sports players 
who were unaccustomed to the 45 minute continuous running protocol that was tested; 
therefore, these contradictory results may be due to differences in training status and/or 
familiarisation with the exercise protocol. Furthermore, a recent meta-analysis concluded 
that CGs did not affect submaximal or maximal running performance (Born et al., 2013) and 
inconsistencies in findings prompt further investigation with a moderately trained population.   
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Limitations of CG performance research 
Previous research examining the effect of CGs on exercise performance has demonstrated 
many conflicting results, making conclusions difficult; indeed, meta-analyses and reviews of 
literature examining the same variables often reach different conclusions (Born et al., 2013; 
MacRae et al., 2011). It is possible that these contradictory results are caused by a number 
of limitations in the methodology and reporting of these studies. Firstly, the type of 
compression used varies between studies, including: area of the body being covered, 
amount of pressure applied, and use of a pressure gradient (Born et al., 2013). Results from 
these studies are often compared despite the differences in muscle mass and joints that are 
affected. For example, no studies have been identified that supported the use of knee high 
CGs for reducing muscle oscillation, muscle damage, inflammation, or increasing 
proprioception. Despite this, many of the proposed benefits have been generalised to the 
use knee high CGs.  Moreover, the characteristics of the garments are often not reported 
sufficiently for an informed comparison to be made (MacRae et al., 2011). Training status of 
the populations used in research, may also yield differing results.  The majority of the 
benefits demonstrated with CG use have been demonstrated in untrained individuals and it 
has been shown that untrained participants are likely to gain a greater benefit from wearing 
CGs than trained (Creasy, 2008; Kraemer et al., 1998); as trained individuals may have 
training adaptations that negate the proposed benefits of the CGs (French et al., 2008).  
Therefore, comparison across training statuses is not advised and the benefits of CGs to 
these populations should be considered separately. Additionally, research examining 
performance has used a wide range of modalities and exercise types; that rely of different 
physiological systems and mechanisms to improve performance (Born et al., 2013). To avoid 
confusion performance benefits should be assessed separately based on the physiological 
demands of the exercise being undertaken (MacRae et al., 2011). Furthermore, many of the 
protocols used are not ecologically valid and care should be taken when generalising these 
results to real life exercise events.   
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However, the greatest confounding variable in compression garment research is suggested 
to be the placebo effect (Born et al., 2013; MacRae et al., 2011). A placebo is a beneficial 
effect of an intervention or treatment that cannot be attributed to the intervention itself. A 
placebo effect may improve the positive effect of a treatment when compared to a control 
simply because the participant believes the intervention will be more effective (Moerman et 
al., 2002). This psychobiological phenomenon is not fully understood and it is suggested that 
multiple mechanisms are involved that may differ depending on the conditions and 
parameters being investigated (Benedetti, Mayberg, Wager, Stohler & Zubieta, 2005). It is 
suggested that the expectation or conditioning into believing a treatment is effective is 
enough to stimulate several physiological mechanisms resulting from preceding central 
nervous system (CNS) alterations, as well as psychological changes (Beedie, 2007; 
Benedetti et al., 2005). Such systems of the human body affected include the cardiovascular 
system, respiratory system, pain reception, and motor performance (Pollo et al., 2003). 
Recently, Ross, Gray & Gill (2014) demonstrated that in a well-trained population of male 
runners, a placebo injection significantly improved 3km race time by 1.2% with no 
improvement in the control group. Participants for this study also reported reductions in 
physical effort with increased motivation and improved recovery. Cycling performance over 
10km has also been shown to be positively affected by placebo displaying a limited dose-
response relationship between levels of expectancy. In this study by Beedie, Stuart, 
Coleman & Foad (2006), power increased by 1.3% and 3.1% when participants believed to 
be administered with 4.5mg/kg or 9mg/kg of caffeine, respectively. In compression research 
correlations have been shown between a participant’s belief in the treatment and 
subsequent performance (Duffield et al., 2008: Kraemer et al., 1998). Therefore, in 
laboratory trials it is important to blind participants to the treatment conditions with 
consideration of the potential placebo response. In practical terms, finding a placebo 
comparison to some treatments is challenging and it is likely that many individuals are able 
to determine if they are in a treatment or placebo group (Gibson et al., 2013). Likewise, 
ensuring a placebo treatment mimics an intervention whilst not exerting its own effects can 
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be difficult (Enck, Benedetti & Schedlowski, 2008). As such, the implementation of sufficient 
blinding of trials or placebo trials in compression research has proven difficult. It has been 
suggested that while double blind, placebo controlled studies are desirable; they are 
impractical as it is impossible to blind the participants to the compression treatment 
(Kraemer et al., 2001). In compression research, some studies have attempted to implement 
a placebo trial with the use of a non compressive garment; however, participants in those 
studies were consistently able to identify which garments were the most and least 
compressive (Ali et al., 2011; Creasy, 2008); therefore, it was not a true blind placebo trial. 
Furthermore non-compressive garments may not be fully inert, as both compressive and non 
compressive garments present a barrier to heat transfer (Born et al.,2013), which has been 
suggested to enhance an athlete’s warm up and could affect performance (Doan et al., 
2003). Likewise, compression as low as 7.8 mmHg has been shown to elicit a physiological 
response, so even if a placebo garment is not fully non-compressive, other confounding 
effects may be experienced. These barriers to effective blinding have led researchers to 
hypothesise that reductions in perceived exertion during exercise may be due to the 
participants expectations of benefits and therefore psychological effects have resulted in the 
reported improvements in performance (Born et al., 2013). 
The current research was unable to blind participants to the interventions they were 
receiving. As the perceived comfort of the garment/intervention has been shown to influence 
the level of placebo effect experienced (Born et al 2013); this research recorded perceived 
comfort, perceived tightness and pain induced by the garment during each intervention (Ali 
et al., 2007; Ali et al., 2010; Creasy, 2008), to allow comparison of performance and 
perception of the intervention. 
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2.4 Post Exercise Recovery 
There are many factors by which recovery can be measured, for example: normalisation of 
physiological function, muscle damage, muscle soreness, glycogen resynthesis or maximum 
force production (Jeffreys, 2005). More widely, it could be considered: the ability to meet or 
exceed the demands of a particular activity (Driller et al., 2013). For many athlete’s the 
demands of subsequent training and performance sessions must be met, often with little 
time to recovery; as such, it is common for athletes to use ergogenic aids to try and reduce 
the time needed for recovery.  
2.4.1 Exercised Induced Muscle Damage & Inflammation 
Following bouts of high intensity or unaccustomed exercise microscopic muscle damage 
(MD) or exercise induced muscle damage (EIMD) is common. The most widely accepted 
theory for the initial cause of EIMD is that mechanical force during contraction and loading 
causes: microscopic tears of the muscle fibres and sarcolemma (Creasy, 2008), alongside Z 
line streaming within the sarcomere (Armstrong, 1984) and damage of the transverse 
tubules (Proske et al., 2001). This leads to an imbalance in calcium homeostasis within the 
muscle cell and to small scale cell necrosis (Cheung, Hume & Maxwell, 2003). This initial 
damage triggers an acute inflammatory response which further damages the muscle (Stupka 
et al., 2000). As a result of the inflammatory response, there may also be free radical 
damage to the muscle, caused by immune cells such as neutrophils (Connolly, Sayers & 
McHugh, 2003). This increased free radical damage has been connected to a loss of muscle 
function after exercise-induced muscle damage due to elevated lipid peroxidation (Close, 
Ashton, Cable, Doran, Maclaren, 2004). Electrical stimulation of fatigued muscle has shown 
that the post-exercise reductions in maximum force are due to muscle damage, not 
decreased motivation or muscle recruitment (Clarkson & Hubal, 2002; Davies & White, 1981; 
Newham, Jones & Clarkson, 1987).  
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Inflammation and adaption 
It is widely believed that to maximize any given exercise performance, the symptoms of 
EIMD should subside before an athlete competes or exercises at a high intensity again 
(French et al., 2008). As a result, many recovery strategies attempt to reduce the muscle 
damage, inflammation and secondary muscle damage experienced post exercise, to help 
reduce recovery time. This reduction of inflammation post exercise could be beneficial as 
large increases in reactive oxygen (ROS) and nitrogen (RNS) species may lead to an 
increased level of cell apoptosis causing immunosuppression, fatigue and 
underperformance. (Lewis, Howatson, Morton, Hill & Pedlar, 2015). However, muscular 
fatigue (Helson et al., 2014), inflammatory and low to moderate amounts ROS and RNS play 
a key role in muscle adaptation to endurance training (Lewis et al., 2015). Therefore, if an 
intervention reduces inflammation below this level it may also reduce the adaption to 
exercise that the athlete undergoes. This has raised questions within exercise recovery 
research about the efficacy of inflammation reduction as a recovery aid in athletes; 
especially as research examining this area is limited and the results are still inconclusive. 
In a study on the effect of ice application following high intensity running, muscle cooling was 
shown to reduce inflammatory blood markers; however, the intervention also caused a 
reduction in anabolic hormone levels such as growth hormone and insulin like growth factor 
(Nemet et al., 2009). Therefore, it was suggesting that the reduction in inflammation could 
cause or be concurrent with a negative effect on adaptation and future athletic performance 
(Nemet et al., 2009). Despite this conclusion, long term adaptation was not monitored in this 
study and therefore the results remain speculative. In contrast, Ice application three times 
per week during a 3 week training programme was shown to have no negative effect on 
adaptations when compared to a control (Halson et al., 2014). However the ice protocol 
used in this study was relatively mild; each intervention was 15 minutes submerged in 15°C 
water. Whereas, the majority of current studies use interventions of 20 minutes bouts of icing 
and aim to induce a target skin temperature between 10-15°C. While skin temperature was 
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not measured in this study, the intervention cannot have induced a skin temperature lower 
than 15°C. Moreover, Yamane et al. (2002) conducted a study using a 6 week endurance 
training programme focused on the legs. In this study cold water therapy at 5°C was applied 
to one leg after each training session, three times per week. The cold water was applied for 
two 20 minute bouts separated by 30 minutes. The results showed that significant 
adaptations to the training were three times more frequent in the control leg when compared 
to the cooled limb.  It is possible that the colder temperatures and longer exposure times in 
this study induced a greater reduction in inflammation than the previous study. These results 
prompt further research to examine the effect of reduced muscle damage and inflammation 
on adaptation to exercise, as benefits to short term recovery may not be sufficient to justify 
the use of an ergogenic aid if long term adaptation is affected.  Additionally, the intensity and 
duration of interventions may need to be adjusted to balance the effect on short term 
recovery and long term adaptation. 
Creatine Kinase 
Creatine kinase (CK) is an enzyme found in tissues including; skeletal muscle, cardiac 
muscle and brain tissue. Creatine kinase catalyses the phosphorylation of adenosine 
diphosphate to adenosine triphosphate for energy (Apple and Rhodes, 1988). It is released 
into the blood during muscle damage (Clarkson & Hubal, 2002; Nosaka & Clarkson, 1996). 
Consequently, CK concentration is used extensively in research as a marker of post 
exercise muscle damage (Born et al., 2013). Various modes of exercise have been linked 
with an increase in CK levels. Clarkson and Tremblay (1988) found maximal eccentric 
forearm exercise produced temporary, repairable muscle damage and raised CK levels. CK 
levels ordinarily peak between 24-48 hours post exercise (Peterson et al., 2001); this is 
thought to be due to the delay in the immune and inflammatory response (Nosaka et al., 
2008). Despite its regular use in exercise studies, CK has been shown to have high inter and 
intra subject variability (Connolly et al., 2003); with levels affected by age, race, mass, 
physical activity and pathological conditions (Brancaccio, Maffulli & Limongelli, 2007). 
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Additionally, there are individuals who are prone to high or low CK responses; these high 
and low responders will always have a relatively extreme high or low CK response to the 
same intensity of exercise, irrespective of the confounding variables listed above (Clarkson, 
Kearns, Rouzier, Rubin & Thompson, 2006). It should also be noted that serum CK levels 
are a reflection of both diffusion and clearance, therefore if clearance is increased CK level 
will decrease giving a false low indication of the level of muscle damage present (Jones, 
1985). Likewise, serum CK is also a global measure of all muscle damage in all muscle 
groups; it is impossible to distinguish from CK results where the muscle damage is or which 
muscle groups are contributing most heavily (Connolly et al., 2003). 
A further consideration when using CK as a blood marker of muscle damage is participant 
gender. Studies on animals have shown that females experience more muscle damage than 
males (Amelink & Bar, 1986; Bar, Dressen & Rikken, 1985; Schneider, Correia & Cannon, 
1999; Tiidus & Bombardier, 1999). Moreover, Miles, Naukam, Hackney & Clarkson (1999) 
examined the CK response of non–weight-trained women and men, and found that women 
showed a greater increase than men after eccentric muscle damage. Serum CK levels have 
also been shown to be elevated during the second half of the menstrual cycle (Bundey, 
Crawley, Edwards & Westhead, 1979). Consequently, studies measuring CK levels over a 
number of weeks may have false elevated results in female subjects.  
These weaknesses in serum CK as a marker of muscle damage mean that care must be 
taken when collecting and interpreting data (Hill et al., 2013). However, despite these 
limitations, CK concentration is considered to be a valid measure of the severity of post 
exercise muscle damage in healthy individuals (Brancaccio et al., 2007; Clarkson et al., 
2006); and is still used extensively as a marker of EIMD in compression literature (MacRae 
et al., 2011). Muscle biopsies and MRI are suggested to be the gold standard methods of 
measuring muscle damage (Connolly et al., 2003; Jones et al.,1985)., however these 
methods are not possible in the current research therefore creatine kinase will be used, in 
conjunction with inflammatory markers and muscle pain. 
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C-Reactive Protein 
As suggested above, muscle damage during exercise may cause an acute inflammatory 
response to occur; as leukocytes and monocytes infiltrate from the bloodstream into muscle 
tissue degradation may be caused by the release of proteolytic enzymes (Friden & Lieber, 
2001). Acute phase proteins, such as C-reactive protein (CRP) are synthesised and 
released, as part of the acute inflammatory response. Release is from the liver and adipose 
tissue, when triggered by cytokines; for example interleukin 6 (IL-6). CRP then binds to 
phosophocholines expressed on the surface of dead or damaged cells and triggers the 
complement system via C1Q. The complement system leads to destruction of damaged cells 
via the membrane attack complex, then through chemotaxis, leads to an increased number 
of in phagocytic cells and subsequently an increase in reactive oxygen species (ROS), which 
are believed to cause increased muscle cell damage (Connolly et al., 2003). Consequently, 
the level of serum C-reactive protein is an accurate measure of inflammation, with levels 
normally peaking around 24 hours after exercise (Strachan, Noakes, Kotzenberg, Nel & de 
Beer, 1984). Connolly et al. (2003) suggested that CRP may be a more accurate measure of 
muscle damage that CK. However, as with CK, CRP has some limitations; Serum CRP 
levels are the sum of total production and clearance and therefore results can be changes in 
clearance mask increases in diffusion (Jones, 1985). It has also been suggested that as 
serum CRP is a measure of total diffusion from all muscle groups, that increases in this 
systemic results post exercise are not proportional to localised increases in the active 
muscles, as measured with muscle biopsies (Marklund et al., 2013); consequently, a 
doubling in serum CRP could represent a far greater increase in inflammation in the active 
muscles.   
Muscle Girth 
Another method of measuring inflammation is by the measurement of muscle girth before 
and after exercise. Nosaka and Clarkson (1996), found an increase in upper arm girth with 
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eccentric muscle damage, and along with CRP suggested girth measurement as an 
accurate measure of inflammation. Likewise, high reliability of repeated muscle girth 
measurements have been shown for both intra (Hart, Swanik, & Tierney, 2005) and inter 
tester results (Soderberg, Ballantyne & Kestel, 1996). However, a measurement can be 
reliable without being valid (Soderberg et al., 1996) and the majority of the studies that have 
explored muscle girth use have tested reliability.  Doxey (1987), conducted validity testing on 
muscle girths as a measure of localised inflammation and concluded that while muscle girths 
are a somewhat inaccurate and insensitive measure, they remain clinically useful. Muscle 
girths have been used extensively within exercise recovery research (Driller et al., 2013; 
French et al., 2008; Kraemer et al, 1997; Montgomery et al., 2008); as such muscle girths 
will be used as an inexpensive and accessible method of monitoring localised inflammation 
to compliment the CK, CRP and muscle pain results. 
2.4.2 Muscle Soreness 
Perceived muscle soreness (PMS) is a dull aching pain that makes muscles feel tender and 
stiff (Creasy, 2008). If there is a delay in the start of muscle pain post exercise, and the pain 
is accompanied by loss of muscle function, then this is referred to as delayed onset muscle 
soreness (DOMS) (Clarkson & Tremblay, 1988; Newham et al., 1987). Delayed onset 
muscle soreness (DOMS) and perceived muscle soreness (PMS) are experienced after 
bouts of unfamiliar or intense exercise and can be associated with reduced repeat 
performance. Muscle soreness is commonly experienced most strongly 24 to 72 hours after 
the exercise (Nosaka, 2008). A correlation has been found between muscle damage and 
DOMS (Armstrong et al., 1984; Byrnes et al., 1985; Stupka et al., 2000); it is likely that the 
delay in muscle soreness corresponds to the delay in maximum muscle damage (Nosaka, 
2008). Armstrong et al. (1984) suggested that it could take up to 48 hours for the imbalance 
in calcium ions, caused by structural muscle cell damage, to cause peak cell necrosis. This 
causes accumulation of intercellular materials and ROS from immune cells in the interstitial 
space; which stimulates free nerve endings leading to muscle soreness (Armstrong et al., 
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1984). During this time, muscle function is inhibited to ensure further muscle damage is not 
caused and to allow the muscles time to repair and restore pre-exercise muscle function 
(Armstrong, Warren & Warren, 1991); this results in a reduction in joint range of motion, 
maximum voluntary peak torque and the ability of the muscle to absorb shock (Cheung et 
al., 2003). 
Visual analogue scale and Algometry 
The two most commonly used methods of measuring muscle pain post exercise are: rating 
of perceived pain using a visual analogue scale at rest or rating muscle pain while direct 
pressure is applied to the muscle using a pain algometer (Creasy, 2008). The use of visual 
analogue scales is the simplest and easiest method of measuring muscle pain in the 
laboratory and in the field with no specialist equipment needed. However, the use of visual 
analogue scales has been shown to have a potential for high inter and intra subject variance, 
(Burnett et al., 2010). These perceived measures have also been shown to be affected by 
the placebo effect, in trials that have shown equal decreases n muscle pain in placebo and 
aspirin treated groups (Cook, O’Conner, Eubanks, Smith & Lee, 1997). Despite this, 
Perceived scales have been shown to have an inter subject reliability of between r = 0.88 to 
0.98 (Cook et al., 1997). In an attempt to use a less subjective method of measuring muscle 
pain, algometry has been used extensively in previous research. Pain algometry is a semi-
objective method that uses a force gauge with a 1 cm2 rubber disk, used to apply pressure 
(80 N) directly to affect muscle tissue; participants are then asked to rate the pain induced by 
the pressure. Algometry has been shown to be a valid (Fischer, 1987) and reliable method 
for quantifying local muscle pain and tenderness (Fischer, 1987; Pontinen, 1998); however, 
the reliability and validity of results are dependent on the use of standardised methodology 
and equipment between measurements (Pontinen, 1998). For example, it has been shown 
that the rate at which the force is applied to the muscle must be consistent to obtain reliable 
results (Kinser, Sands & Stone, 2009). Additionally, as with all perceived measures, 
algometry is subject to interference from the placebo effect (Cook et al., 1997). Despite the 
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weaknesses of these methods they are still useful to measure perceived pain, and both 
method will be used in the current research to allow comparison of results. Standardised 
protocols will be used to increase reliability in accordance with previous literature that have 
used these methods (Creasy, 2008; Kraemer et al., 1997; Prasartwuth, Taylor, & Gandevia, 
2005). 
2.5 Post-exercise Recovery Strategies  
A number of modalities have been investigated in the search for a treatment that may reduce 
the effects of EIMD or accelerate recovery (Hill et al., 2013). Compression garments and ice 
have been used individually and in combination for soft tissue injuries for some time (Kowal 
et al., 1983), as part of the well-known acronym, RICE; representing: rest, ice, compress and 
elevate (Kraemer et al., 2001). Compression and ice are now two of the most commonly 
used recovery and regeneration methods among athletes and recreational sports people 
looking to accelerate recovery post exercise (Mac Auley et al., 2001). As a result of this 
popularity, products are being commercially produced that allow the combined treatment of 
ice and compression for athletes in the field (110% Play Harder, Florida, USA). However, 
despite the common used of these methods for recovery, evidence for their proposed 
benefits is equivocal (Born et al., 2013; Mac Auley, 2001), and the physiological 
mechanisms by which they provide any benefits is also unclear (Bleakly et al., 2010, 
MacRae et al., 2011). 
2.5.1 CG’s Mechanisms of Action during Recovery 
2.5.1.1 Reduction of initial damage during exercise  
During endurance running it is suggested that the eccentric component of the SSC may 
cause structural damage to the muscle cells and consequently an inflammatory response as 
described above (Noakes, 2000). Paavolainen (1999) showed that both the braking and 
propulsion phases of the SSC were longer after completion of a 10 km run. Moreover, 
significant decreases were observed in peak vertical ground reaction forces and muscle 
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activation during 20 m sprints, post 10 km run (Paavolainen, 1999). These results suggest 
that repetitive stretch loading during the 10 km run, decreased the capacity of the 
neuromuscular system to generate force rapidly and to tolerate impact forces (Paavolainen, 
1999). This is interruption in contractile function was most likely caused by muscle damage 
and cellular disturbance as a result of the SSC (Duffield et al., 2008). It is suggested that the 
use of CGs may be able to attenuate the muscle damage caused during exercise by 
improving muscle mechanics on a molecular level (McComas, 1996) therefore improving 
muscle function (Duffield et al., 2008). It is possible that this improvement in muscle function 
and mechanics is due to reduced muscle oscillations during exercise (Kraemer et al., 1998). 
Kraemer et al. (1998) showed that CGs reduced the oscillations experienced in the thigh 
muscles during exercise; this reduction in oscillations was accompanied by increased 
maintenance of leg power in both trained and untrained individuals. This maintenance of 
muscle power was suggested to be the consequence of reduced muscle damage as a result 
of reduced muscle oscillations (Bringard et al., 2006a; Doan et al., 2003; Kraemer et al., 
1998). It is hypothesised that reduced initial muscle damage as a result of reduced muscle 
oscillations, may also reduce the subsequent post-exercise inflammatory response and 
therefore the secondary damage that would have been caused by immune cells and ROS 
(Creasy, 2008). These reductions in the magnitude of muscle damage and inflammation 
experienced could increase recovery time needed between sessions. However, Creasy 
(2008) warned that this mechanism was only hypothesised and that there was insufficient 
evidence to support it despite the wide proliferation of it as a suggested mechanism. Since 
then, further research has supported this mechanism showing reduced muscle oscillations 
during endurance running (Bakken, 2011); however, no measures of muscle damage or 
recovery were taken in this study, therefore the link between muscle oscillations and muscle 
damage remained speculative. However in that same year, a study using 3D cameras and 
muscle biopsies, showed reduced muscle oscillations and muscle damage in a compressed 
leg when compared to an uncompressed control leg (Borras et al., 2011). Borras et al. 
(2011) suggested that this results supported reductions in inflammatory response and 
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structural sarcomere damage as a result of reduced muscle oscillations during exercise. The 
current body of research is still insufficient to support the link between reduced muscle 
oscillations, muscle damage and recovery; therefore more research is required in this area. 
Additionally, all of the research in this area to date has examined muscle oscillations in the 
thigh muscle; therefore despite the prevalence of knee high compression use, it is still 
unclear if this mechanism is applicable to these garments. 
2.5.1.2 Reduced inflammation  
The use of compression garments during recovery is suggested to reduce the inflammatory 
response and subsequent muscle damage (MacRae et al., 2011). The external pressure 
created by compression garments may reduce inflammation in two ways; firstly, by reduction 
of the intramuscular space available for swelling (French, 2008), and secondly by increasing 
the hydrostatic pressure outside capillaries; therefore increasing lymphatic drainage (Born et 
al., 2013). The Starling equation, describes the roles of the hydrostatic and oncotic forces in 
the movement of fluid across capillary membranes through filtration. The filtration pressure is 
the hydrostatic pressure in the capillary minus the hydrostatic pressure of the interstitial fluid. 
This filtration pressure is opposed by the osmotic gradient caused by high concentration of 
proteins in the plasma in the capillaries compared to the interstitial fluid, which cause a 
greater oncotic pressure outside the capillary. The interstitial tissue’s hydrostatic pressure 
normally averages 1-2 mmHg and oncotic 25 mmHg (varying from tissue to tissue). This was 
thought to move fluid into the interstitial space at the arteriolar end of the capillary where 
filtration pressure exceeds oncotic and into the capillary at the venule end where oncotic 
exceeds filtration. However, more recent evidence suggests that filtration dominates the full 
length of the capillary (Levick, 2003). When external compression is applied, it is possible 
that the filtration pressure could be reduced and therefore net flow out of the capillaries could 
be reduced or net flow could be directed into the capillaries reducing oedema and 
inflammation (Born et al., 2013).  
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In a study on 118 healthy volunteers, using an optical leg volume meter, a mean daily 
volume increase of the leg of 2.3% in females and 1.6% in males was found. Compression 
(14 mmHg) reduced this daily increase by 31% and 18%, in males and females respectively. 
Higher compression (18 mmHg) reduced the daily increase by 37% and 32% in males and 
female respectively (p < 0.05). There was also a reduction in the perception of tiredness and 
perception of swelling in the legs, when compared to a control (6 mmHg) but there was no 
difference between the 14 and 18 mmHg conditions (Jonker, de Boer, Ader & Bezemer, 
2001). Hirai et al. (2002), found that elastic compression as low as 8 mmHg can prevent 
oedema in healthy and varicose vein patients. Reductions in post exercise inflammation 
have been shown, with CG use during recovery (Jonker et al., 2001). This result was 
supported by further research that reported a reduction in post exercise inflammation with 
the use of CGs (Borras et al., 2001; Driller et al., 2013). Attenuation of the inflammatory 
response with CGs has been linked with reduction in post exercise muscle damage (Creasy, 
2008), muscle soreness (Bochmann et al., 2005; Davies et al., 2009), recovery time and 
improved subsequent performance (Kraemer et al., 2001a). 
2.5.1.3 Decreased Muscle Soreness  
As discussed in the section above, the application of compression may attenuate changes in 
osmotic pressure post-exercise and reduce the space available for swelling (Ali et al., 2007); 
subsequently lessening the degree of inflammation, the circulation of inflammatory markers. 
This reduction in inflammatory markers and consequently the amount of ROS and RNS, is 
suggested to lower the magnitude of nerve fibre stimulate (Armstrong et al., 1984) and 
therefore the sensation of pain (Kraemer et al., 2004). Compression has been shown to 
decrease inflammation post exercise (Boras et al., 2011) and several studies have 
suggested that CGs can reduce PMS post exercise (Ali et al., 2007; Chatard & Atlaoui, 
2004: Connolly et al., 2003; Kraemer et al., 1998). Wearing CGs was found to reduce pain 
72-hours post-exercise and restored neuromuscular function at a faster rate than without the 
garments, after downhill walking (Perrey et al., 2008). More recently, Borras et al. (2011) 
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found CGs reduced PMS after a 40 minute run test at anaerobic threshold. This is supported 
by a meta-analysis, which also found that CGs reduced PMS (Hill et al., 2013). As muscle 
damage is suggested to be the major cause of muscle soreness post exercise (Connolly et 
al., 2003), muscle soreness can be used as an additional measure of muscle damage and 
inflammation. However, reductions in perceived muscle damage can increase repeat 
performance by positively affecting an athlete’s perception of recovery and motivation to 
perform (Hill et al., 2013). Ali et al. (2007) showed that decreases in perceived pain with CGs 
allowed better performance in subsequent bouts of exercise. Likewise, it has been shown 
that increased perceived vitality, as a result of decreased muscle soreness, can have a 
positive effect of an athlete’s performance. Therefore, it is likely that perceived muscle 
soreness as well as being a symptom of previous exercise, is also a determining factor in 
subsequent bouts (Hill et al., 2013). 
2.5.1.4 Increased blood flow  
As with performance, augmentations to blood flow are suggested as a mechanism by which 
CGs improve recovery. There is more evidence for blood flow increases with CGs in healthy 
people at rest than during exercise; however these results and their effect on recovery are 
still not conclusive. Bringard, Denis, Belluye and Perrey (2006a) found a significant reduction 
in blood pooling and an increase in gastrocnemius oxygenation during supine and standing 
recovery, in 12 trained sports men wearing compression tights, when compared to non-
compressive lycra tights and loose shorts at rest. Furthermore, Benko, Kalik and Chetty 
(1999), found significant increases in peak velocity in femoral vein with thigh length 
compression. This velocity increase was suggested to be indicative of increased venous 
return. Benko et al. (1999) also found a significant decrease in popleteal vein diameter. It 
was suggested that these findings show a decreased risk of venous stasis, intimal tears and 
venous thrombogenesis in healthy participants. Compression as low as 7.6 mmHg at the 
ankle to 5.2 at the thigh, was found to attenuate the venous diameter increase experienced 
during an 8 hour standing protocol (Kraemer et al., 2001). In contrast some studies have 
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shown that in healthy standing subjects CGs did not reduce vein diameter (Lord & Hamilton, 
2004; Mayberry et al., 1991) or increase venous return velocity (Mayberry et al., 1991). It 
has been suggested that increases in resting blood flow post exercise may aid recovery 
increasing the removal of metabolites, immune cells and reactive oxygen and nitrogen 
species; and by increasing the supply of nutrients needed for recovery, for example glucose 
and proteins (Hill et al., 2013). Additionally, the removal of immune cells, ROS and RNS 
could reduce the magnitude of muscle soreness experienced (Hill et al., 2013). 
2.5.2 Efficacy of CG during Recovery 
The results of research examining the effect of CGs on recovery are mixed; making 
conclusions about their usefulness more difficult. For example, some studies have found that 
CGs used post exercise can reduce Serum CK concentration (Connolly et al., 2003; Hill et 
al., 2013) found reductions in CK concentration with CGs post exercise. Likewise, Boras et 
al. (2011) found reduced muscle damage with CG use, in males after downhill walking. 
These results support CGs as a mechanism of reducing the muscle damage caused by 
exercise allowing great maintenance of muscle power and subsequent performance. French 
et al. (2008) measured post-exercise creatine kinase (CK), myoglobin, range of movement 
and lower body power as markers of recovery, in healthy males; no significant improvements 
to any marker of recovery were shown with full length compression tights compared to a 
control. However, this study used an average compression of 12 mmHg at the calf and 10 
mmHg at the thigh, less than the aforementioned suggested minimum pressures (Lawrence 
& Kakkar, 1980). Therefore, it is possible that this pressure was insufficient to reduce the 
post exercise inflammatory response. Despite this result, there are several studies that have 
shown CGs attenuate the loss of performance experienced during repeated jumps (Kraemer 
et al., 2001; Chatard & Atlaoui, 2004). Ali et al. (2011) also found those wearing CGs 
maintained leg power after a 10 km time trial. Doan et al. (2003) found no increase in 60 m 
sprint time in track athletes using compression shorts However, they did find a difference in 
vertical jump height performance after sprinting in those wearing compression shorts (0.461 
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m vs. 0.485 m, p = 0.015). Likewise Jakeman, Byrne and Eston (2010), found reduced 
decrement of jump performance, attenuated loss of strength and reduced muscle soreness 
with CG use; they therefore concluded that this attenuation of performance decrement 
supports the mechanism of reduced muscle damage with CGs. Additionally, the ability to 
maintain power output after a bout of maximal exercise could be very useful for athletes that 
need to train or compete multiple times per day or week and could lead to reductions in 
recovery time (Hill et al., 2013). This is supported by others who have shown reductions in 
recovery time with the use of CGs (Perrey, Bringard, Racinais, Puchaux & Belluye, 2008; 
Trenell et al., 2006). Gill, Beaven and Cook (2005) undertook a study comparing CGs to 
passive recovery using no CGs, after rugby matches and found reduced recovery time and 
decreased muscle damage with CGs. More recently Driller et al. (2013), showed a significant 
improvement (p < 0.05) in recovery with full length compression; this was evidenced by 
increased maintenance of power (-0.20% vs. -2.15%) and significant reductions in limb girths 
(Thigh: 53.2 cm vs. 52.9 cm; Calf: 37.6 cm vs. 37.1 cm) and blood lactate concentration (4 
mmol vs. 3 mmol) when compared to a control. There was also moderate, though not 
significant, effect on perceived soreness in the CG trial. Similarly, Chatard (1998) showed 
reduced muscle soreness after a 5km run with compression tights when compared to loose 
running shorts. In contrast to these studies, Pruscino, Halson and Hargreaves (2013) did not 
find an increase in physiological recovery markers after a hockey match simulation, but did 
find a decrease in perceived recovery with CGs, measured with a questionnaire; which could 
translate into an improved repeat performance through psychological benefits. Born et al. 
(2013) found a small positive effect of compression on recovery of strength and power tasks 
such as peak leg power, maximal throwing distance and vertical jump height. However, 
recovery of short sprints ability (10-60 m) was negatively affected by the use of compression 
clothing. Born et al., also found that compression had a negative effect on levels of creatine 
kinase. Born concluded that the results show a small improvement in recovery after muscle-
damaging exercise protocols; and suggested this was due to enhanced lymphatic outflow, 
thus reducing post exercise muscle swelling and pain. Furthermore, increased arterial inflow, 
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venous return, and increased clearance of waste products could potentially enhance the 
repair process (Hill et al., 2013).  
Limitations of CG recovery research 
The contrasting results for variables of recovery found in CG research make conclusions 
hard to reach; indeed two meta-analyses conducted in the same come to different 
conclusions about the effect of CGs on certain variables, for example CK (Born et al., 2013; 
Hill et al., 2013). It is likely that the conflicting results are due to limitations and 
inconsistencies in the methodologies of the current research.   
As with performance CG research, the type of CGs, training status of participants and 
exercise protocols used vary between studies; comparison of these results across conditions 
may add to the confusion. For example, the majority of studies examining recovery have 
used full length tights or full body compression (Hill et al., 2013); the research and benefits of 
which are then generalised and compared to other compression types. No research was 
identified that has shown reduction in Ck with knee high compression. As knee high CGs are 
the most commonly used for endurance events (Bakken, 2011), the current research aims to 
assess whether knee high CGs have the same benefits as other CG types, despite the lower 
muscle mass being covered. Likewise, the training status of participants greatly affects 
results. The majority of research into recovery has examined the effects on untrained 
participant, who may experience higher levels of muscle damage and fatigue (French et al., 
2008). Therefore these results may differ greatly from results obtained from an elite or highly 
trained population (Born et al., 2013); this should be considered when comparing results 
from such studies. The types of exercise used to induce fatigue, and to assess the effect of 
CGs on recovery also vary widely. As such the results vary depending on the type, length 
and intensity of the exercise protocol used (Barnet, 2006). Power exercise has shown more 
consistent results for attenuation of performance loss, however these types of exercise may 
benefit for mechanisms such as increased torque around joints due to the elasticity of the 
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garments (Doan et al., 2008); which other types of exercise such as endurance running may 
not benefit from. Likewise, it is widely accepted that eccentric contractions cause the highest 
levels of muscle damage (Cheung et al., 2003; Clarkson & Hubai, 2002; Clarkson & 
Tremblay, 1988; Friden, Sjostrom & Ekblom, 1983; Nosaka & Clarkson, 1996). Although, 
most exercise has an element of eccentric contraction involved, there are no sports or races 
that involve solely eccentric action. Therefore, eccentric muscle damage protocols may be 
less ecologically valid. Furthermore, Clarkson, Byrnes, McCormick, Turcotte & White (1986) 
found that muscle damage was caused by all types of muscle action. For chapter 5 of the 
current research, an ecologically valid protocol was desired to assess performance and 
recovery benefits for endurance athletes. Maximal 10 km running has been shown to induce 
significant losses in muscle function (Creasy, 2008) that can take even experienced 
endurance runners up to 48 hours to recover from. (Gomez et al., 2002). While longer 
protocols such as half or full marathons would induce greater fatigue, the use of these 
protocols is not possible in the current study; therefore 10 km time trials will be use in 
accordance with previous research in this area (Ali et al 2007; Ali et al., 2011). For Chapter 
6, fatigue of a specific muscle groups (lower leg) is required, therefore an eccentric muscle 
damage protocol will be used; as eccentric exercise has been shown to induce the greatest 
decrements to perceptual and physiological function (Clarkson & Hubai, 2002). As with the 
performance research, the greatest single limitation to CG research is the lack of blinding of 
interventions and consequently the placebo effect. None of the studies included in this 
review of recovery literature, have blinded the participants to the treatments they are 
receiving; as such the results of recovery measurement, especially perceptual 
measurements could be greatly affected by the participant’s belief and expectation of the 
outcome (Hill et al., 2013). Unfortunately it was not possible for the current study to blind 
participants or to include a robust placebo control; Therefore as with the results from 
previous research, it is important that any positive results be interpreted with the placebo 
effect in mind. 
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The time that CGs were applied during recovery also varies from study to study, and is often 
unreported (Hill et al., 2013). Born et al. (2013) suggests that the recovery benefits of 
compression clothing were most pronounced when applied for 12-48 hours. However this 
recommendation was made based on the timings used in studies that found positive results; 
not based on a comparison of the effects of different timings. No research has been 
identified that explores the effect of different timings of CG application on recovery. 
Additionally, the difference between 12 and 48 hours of intervention is very large and either 
an increase in intervention application time should induce an increase in benefit or this extra 
intervention is unnecessary. The most commonly used timing for CG application is 12 hours 
post exercise (French et al., 2008) and this level of intervention has been shown to induce 
significant recovery benefits (Gill et al., 2005; Jakeman et al 2010); therefore, the current 
research study used a 12 hour recovery intervention. 
2.5.3 Ice Therapy Mechanisms of Action during Recovery 
Ice therapy is one of the simplest and oldest therapeutic modality in the treatment of acute 
soft-tissue injuries, and has been used clinically since the 1940’s (Mac Auley, 2001). Ice 
therapy is now becoming one of the most commonly used recovery aids post exercise. 
Despite this, the underlying mechanisms by which ice is suggested to benefit recovery are 
still unclear (Bleakley et al., 2012).  
Reduced Inflammation 
The most commonly quoted benefit of ice application for recovery is a reduction in 
inflammation (Yamane et al., 2006). It is suggested that this reduction in inflammation is 
caused by a number of physiological responses to the reduction in tissue temperature. 
Firstly, application of ice causes vasoconstriction which limits blood flow to the area 
(Krityakiarana, Budworn, Khajohnanan, Suramas, & Puritasang, 2014); which reduces the 
magnitude of post exercise swelling (Lephart & Pincivero, 1999). Karunakara et al. (1999) 
showed that 20 minutes of ice application caused vasoconstriction and reduced blood flow 
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for the duration of the ice application; following that intervention, intermittent 10 minute on 10 
minute off applications of ice allowed this vasoconstriction to continue for up to an hour. 
They recommended this protocol as an aid, if reduced blood flow is desired. In addition to 
causing vasoconstriction and reduced blood flow, applications of ice that reduce skin 
temperature to below 15°C, are suggested to increased blood vessel permeability and fluid 
extraction (Mac Auley et al., 2001); which will cause a reduction in oedema and 
inflammation. This is suggested to reduce inflammation on a cellular level, which may bring 
about a faster return to functional activity (Sloan et al., 1989). However, increased 
permeability and fluid extraction has only been shown in animal models as a mechanism by 
which inflammation is reduced. In a similar way to CGs, the reduction of post exercise 
inflammation is hypothesised to reduce the concentration of inflammatory cells and ROS 
(Bleakley et al., 2012); this in turn reduces the amount of secondary muscle damage that 
occurs and is suggested to reduce the subsequent muscle pain (Ascensao, Leite, Rebelo, 
Malahaes & Magalhaes, 2014). 
Reduced metabolism 
In addition to changes in the vascular system, the application of ice is suggested to reduced 
the metabolic rate of the cells in the treated area (Krityakiarana et al., 2014). By reducing 
metabolic requirements of the affected area, inflammation and the resulting secondary 
muscle damage can be prevented or reduced (Karunakara et al., 1999). This reduction in 
metabolism has traditionally been the reason that ice has been used in the treatment of 
acute injuries, as a method of reducing inflammation and slowing the metabolism (Bleakley 
et al., 2012). A 50% reduction in enzyme activity and therefore metabolic demand of muscle 
tissue has been shown during treatments that reduce the skin temperature to between 10-
11°C (Chesterton, Foster & Ross, 2002). However, it is unclear whether this reduction in 
metabolism reduces the damage done to muscle cells or just delays it; it is also unclear 
whether or not this mechanism is beneficial to recovery from exercise induced muscle 
damage (Leader et al., 2012). 
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Reduced Muscle Soreness 
Ice therapy has been shown extensively to elicit an analgesic effect when applied after an 
acute injury or exercise induced muscle damage (Bleakley et al., 2012). In addition to 
reducing the amount of muscle damage cause through reduced inflammation, ice is 
suggested to reduce muscle soreness by slowing nerve impulse transmission (French et al., 
2008). This reduction in nerve transmission velocity is suggested to last up to 30 minutes 
post treatment (Mac Auley et al., 2001), and is suggested to increase pain threshold and 
consequently reduce perceived DOMS (Karunakara et al., 1999). Analgesic benefits have 
been shown in ice treatments inducing a skin temperature of 13.6°C, however, to achieve a 
10% reduction in nerve transmission a skin temperature below 12.5°C is required 
(Chesterton, Foster & Ross, 2002). 
2.5.4 Efficacy of Ice during Recovery 
Much research has examined the effect of icing on post-exercise recovery; during a 3-day 
basketball tournament, 29 players were assigned into three recovery groups: carbohydrate 
intake and stretching, cold-water immersion, and compression stockings (mean pressure 18 
mmHg). Pre and post-tournament tests (20 m sprints, agility test and vertical jump 
performance) suggested that cold-water immersion was the best recovery strategy 
(Montgomery et al., 2008b). Furthermore, Easton and Peters (1999) found reduced stiffness 
and post exercise damage with the use of ice. Similarly, other researchers have seen a 
reduced perception of leg soreness and fatigue with ice therapy (Ingram, Dawson, 
Goodman, Wallman & Beilby, 2009; Rowsell, Coutts, Reaburn & Hill-Haas, 2009). In addition 
to pain benefits, Gill et al. (2006) compared CK levels, up to 3 days post-match, in rugby 
players; passive rest showed a 39% recovery in CK levels at 84 hours post exercise when 
compared to an 85% recovery at 84 hours post exercise with ice therapy.  These finding 
where supported by several studies that have found ice to be a beneficial aid to recovery 
(French et al., 2008; Lane & Wenger, 2004).  
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However, Sloan et al. (1989), suggested that while the analgesic effect of Ice application are 
well documented, there is little scientific evidence for any other benefit. More recently the 
evidence for the use of ice has continued to be questioned; and together with CGs, there are 
doubts surrounding their efficacy for recovery. For example, Paddon-Jones & qugley (1997) 
showed that ice was not effective at reducing DOMS or reducing recovery time. Likewise, 
Krityakiarana et al. (2014) showed that 20 mins of ice application had no effect on ROM, 
perceived Pain or maximum voluntary contraction. In fact the control group showed better 
results. It was suggested that vasoconstriction immediately post exercise could stop the 
removal of waste products, immune cells and ROS, which may cause negative effects to 
recovery and DOMS (Krityakiarana et al. (2014). Oakley et al. (2013), used a continuous 20 
min post-exercise ice protocol during recovery; the cryotherapy group perceived significantly 
less pain, using a visual analogue scale, 48-hours after the exercise compared to a control 
group (3 cm vs. 5.4 cm, p = 0.048). However, there was no difference found in any other 
variable including: blood CK levels, maximum isometric torque or hamstring length. Guilhem 
et al. (2013) used four applications of localised air-pulsed cryotherapy (-30°C) for 3 days 
after strenuous eccentric exercise. They found that while some indicators of muscle damage, 
including oedema and decreased muscle activity, were delayed; cooling failed to improve 
long term recovery of muscular performance. This was supported by Tseng et al. (2013), 
who used cold pack application for 15 minutes at 0, 3, 24, 48 and 72 hours after exercise, 
they found an increase in blood CK and Myoglobin levels at 48 and 72 hours post exercise 
and greater perceived fatigue at 71 hours, when compared to a control. It was concluded 
that cooling of muscles delayed recovery post exercise and actually induced greater total 
muscle damage. Applying ice may increase short term recovery and reduce muscle 
soreness, by limiting secondary muscle damage caused by the inflammatory process. 
However, as suggested previously the effects of reduced inflammation on long term 
adaptations are still unknown. Reduced inflammation may negatively impact the natural 
adaptations experienced in response to exercise; by reducing the amount of insulin-like 
growth factor (IGF-1) released by macrophages during the acute inflammatory response 
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(Crystal, Townson, Cook & LaRoche, 2013). Leader et al. (2012) conducted a systematic 
review and meta-analysis (14 studies) on studies examining muscle cooling after exercise. 
Results showed that ice was effective at reducing DOMS; however the effects of ice on 
recovery of muscle function was inconclusive. They suggested that acute ice therapy 
appears to have no negative side effects; although the effect on long term adaptations after 
chronic use requires further investigation.  
The use of ice to reduce blood flow and inflammation is further brought into question by 
more recent studies that have shown benefits to recovery with interventions such as heat 
application and exercise; which cause vasodilation and increased blood flow. This is 
hypothesised to increase the removal of cellular debris and supply cells with the nutrients 
needed for recovery (Krityakiarana et al., 2014). Indeed, Bleakley et al. (2010) conducted a 
study that showed that an exercise protocol was more beneficial for recovery than a rest and 
ice intervention, they also stated that the rationale for cold water immersion and ice therapy 
in exercise recovery remains unclear. 
Limitations of Ice Therapy Research 
The confusion and contradictory results in ice therapy literature are at least in part due to a 
number of limitations. Firstly, there is no evidence based best protocol for recovery or to 
treat exercise induced muscle damage and inflammation (Chesterton et al., 2002); 
consequently the wide range of protocols used in the current research makes comparisons 
between studies difficult (Mac Auley et al., 2001). The current research into ice and recovery 
has used a number of different ice modalities, for example: wet ice, dry ice and cold water 
immersion; the type of ice used will affect the temperature induced in the underlying tissue 
(Chesterton et al., 2002); therefore comparison of results from different modalities may be 
difficult. Additionally, submersion in water during Cold water immersion and contrast bathing, 
will elicit a hydrostatic pressure which may act a form of compression (French et al.,2008); 
this confounding variable is rarely measured, reported or even acknowledged in the majority 
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of cold water immersion research. In addition to the type of ice used, the area that is affected 
is often different study to study. The body part that is treated (Karunakara et al., 1999), in 
combination with the amount of subcutaneous fat in that area (Bleakley et al., 2004) will 
greatly affect deep tissue temperature that is induced; further complicating the comparison of 
results. While differences body part and ice modality can be somewhat controlled, by 
achieving target skin or tissue temperatures; there is also no agreement on the optimal time 
that cooling should be administered (Chesterton et al., 2002). Chesterton et al. (2002), 
Suggested that the wide variance in ice application in the current research is due to an 
incomplete understanding of the physiological responses to cold treatment. It has also been 
suggested that many of the protocols used are not evidence based (Bleakley et al., 2004), 
are based on animal models (Bleakley et al., 2006) or the treatment of injuries (Chesterton et 
al., 2002). Many of the current studies have restricted ice intervention to a maximum of 20 
minutes; as application for longer than that can cause localised vasodilation (Karunakara et 
al., 1999). This is known as the hunting reflex, and is believed to protect tissue from cold 
damage (Mac Auley et al., 2001).  However, even the timing of this response is questioned; 
with some research suggested longer applications of ice are needed to induce benefits 
(Weston, Taber, Casagranda & Cornwall, 1994) and other suggesting that the 
vasoconstriction and dilation alternate between every 10 and 30 minute (Mac Auley et al., 
2001). An additional concern that affects the timing of ice application is concerns regarding 
nerve damage caused by excessive icing, as shown in some studies (KarunKara et al., 
1999). As a result of the hunting reflex and concerns of nerve damage intermittent protocols, 
such as 10 minutes on and 10 minutes off, have become popular. Bleakley et al., 2006, 
showed that intermittent applications of ice were more effective at reducing DOMS than a 
continuous protocol. However, despite this there is standardised protocol for intermittent ice 
application either, with differing timings and numbers of applications between studies. 
Additionally, there is insufficient evidence to show whether continuous or intermittent 
protocols are better for any other measure of recovery.  Finally, as with compression 
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research, one of the biggest confounding variables in ice therapy research is the lack of 
sufficient blinding and placebo controls (Bleakley et al., 2012; Mac Auley et al., 2001). As 
with compression, placebo trials are hard to design and carry out without the participant’s 
knowing which intervention is the inert treatment. As such, the results of ice research as 
subject to influence from the expectations of the participants and the placebo effect. It has 
been suggested that many of the results showing reduced pain more than 30 minutes after 
completion of the ice intervention, are likely due to the placebo effect (Bleakley et al., 2006). 
2.5.5 Combined Compression and Ice Therapy Mechanisms of Action 
Compression and ice have been used as part of the well established treatment for soft tissue 
injuries, RICE; meaning rest, ice, compress, elevate (Yamane et al., 2006). Rice has been 
widely accepted as a standard treatment for pain and oedema control after injuries and has 
been suggested to reduce recovery time (Wilkerson & Horn-Kingery, 1993). As such, 
compression and ice, both individually and combined, have become two of the most 
commonly used recovery therapies post exercise to increase recovery. Despite this, there is 
very limited research available to elucidate the benefits of combined ice and compression 
treatment or to inform of the best protocols to be used. 
Combined compression and ice therapy is suggested to work via the same mechanisms as 
ice therapy, namely: reduced inflammation, reduced muscle damage, reduced metabolic 
demand, and decreased DOMS due to reduced nerve transmission (Bleakley et al., 2012). 
The addition of compression is suggested to aid the reduction of inflammation and 
consequently the secondary muscle damage. Additionally, the pressure from compression 
has been shown to increase the speed and depth of tissue cooling (Krityakiarana, 2014); this 
is suggested to be due to increased skin contact with ice which may improve conductivity 
(Mac Auley et al., 2001), and reduction of the interstitial space allowing better heat transfer 
between cells (Krityakiarana, 2014). Mac Auley et al. (2001) also suggested that 
compression may reduce blood flow and limit re-warming of the treated tissue; however, this 
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hypothesised mechanism contradicts the suggested effects of CGs on blood flow in the 
current compression literature. Despite this, combined ice and compression therapy has 
been shown to be more effective at reducing tissue temperature, than ice therapy alone 
(Mac Auley et al., 2001). 
2.5.6 Efficacy of Combined Therapy during Recovery 
There is limited evidence for the effect of this combined treatment on recovery. In healthy 
rested participants, blood flow to the Achilles tendon was shown to decrease by 90% during 
combined ice and compression therapy (Knobloch et al., 2006). Baseline capillary blood flow 
was re-established within 20 seconds of cessation. This re-perfusion caused an increase in 
oxygen saturation of the tendon. While this result partially supports vasoconstriction and 
reduced blood flow during treatment, it is unknown what effect the re-perfusion and increase 
in oxygen supply will have on recovery post exercise. Increased lymph drainage and 
decreased oedema were measured during a 30 minute ice bag treatment combined with 
25mmHg pressure, when compared to a control leg (Meeusan et al., 1998). It was also 
shown in this study that the combined treatment was more effective at increasing lymph flow 
than either intervention applied on its own. The beneficial effects of the combined treatment 
to reduce swelling, has been confirmed in several studies (Leegwater, Willems, Brohet, & 
Nolte, 2012; Shelbourne, Klootwyk & DeCarlo, 1992). Leegwater et al. (2012) also showed 
the combined treatment to have an analgesic effect, when compared to a control. Sloan et 
al. (1989) examined the combination of ice therapy (15-20°C, for 20 minutes) and 
compression (30 mmHg) as a means of reducing inflammation and increasing recovery; it 
was concluded that the combination treatment may elicit a greater benefit to recovery than 
either intervention alone. However, this study only showed a trend towards improved 
recovery and no significant results were shown. Sloan et al. (1989) also highlighted the 
tendency for blood flow and swelling to return to baseline immediately after the treatment 
had finished; bringing into question the usefulness of this short term inflammation reduction. 
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Limitations of Combined Research 
Despite its wide use, there is currently a lack of research and evidence to support the use 
combined ice and compression therapy, and to elucidate the mechanisms by which recovery 
improvements may be gained (Leader et a, 2012). All the studies discussed about that have 
examined combined treatment on recovery used patients recovering from acute injury; there 
were no studies identified that have examined the use of combined treatment on recovery for 
exercise induced muscle damage. French et al., (2008), highlighted the presence of a 
hydrostatic pressure during cold water immersion therapy; that they suggested may act to 
force body fluids upward and inwards which may help to attenuate inflammation. However, 
this mechanism was only hypothesised and was not measured in that study. Additionally, the 
majority of cold water immersion and contrast bathing research do not identify this pressure 
as a confounding variable and as such do not indicate the depth of submersion or the 
magnitude of the hydrostatic force being applied during the intervention (French et al., 2008). 
Therefore, the use of cold water immersion therapy research to compliment the current 
research on combined therapy is not possible. The use of combined therapy also suffers 
from a lack of a standardised protocol, in the same way as ice therapy. In the few studies 
conducted the amount of compression, time of application and temperature of the ice differs 
from study to study; making conclusions about the best practice difficult.  Knobloch et al., 
(2006), suggested that evidence based data on the effects of cryotherapy and compression 
regarding physiological parameters such as tissue temperature decrease, vasoconstriction 
and metabolic effect are not currently available; therefore, further research is mandatory. 
Additionally, as with both treatments individually, research into the combined treatment is 
subject to influence from the placebo effect, due to difficulties in blinding and administering 
adequate placebo controls. Additionally, as with both individual treatments, the long term 
effects of chronic inflammation reduction are not understood and have not yet been 
investigated, meaning the usefulness of this intervention as a long term recovery aid is 
questionable for athletes.  
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2.6 Summary 
The sale and use of CGs is increasing in popularity in many different sports, with perceived 
potential benefits to both performance and recovery; however, the evidence to support the 
claimed benefits is equivocal. Therefore, this study aims to assess the effect of CGs on 
performance and recovery and the mechanisms linked to them. Studies have shown 
beneficial effects of CGs use for performance and recovery in running trials over 40 minutes, 
likely to be due to the increased time for muscle damage to occur. While a half marathon or 
marathon may induce more MD, the scale of this study could not support such a protocol.  
Furthermore, 10 km running is a popular distance for recreationally competitive runners and 
triathlon competitors; this supports the use of 10 km treadmill time trials as an ecologically 
valid test of the effects of CGs. There is limited compression research in recreationally 
competitive athletes; a population that commonly uses CGs as an ergogenic aid.  Likewise, 
there is limited research showing many of the suggested benefits of compression in knee 
high CGs; the most commonly used type of compression. Therefore, this study will assess 
the effect of knee high compression on performance and recovery post exercise, in 
recreationally competitive athletes. There are studies that support the use of CGs during 
exercise to attenuate the damaging effect on future performance and the use of CGs after 
exercise to aid recovery, with products on the market specifically design for use during or 
after exercise. Therefore, it would be useful to examine whether compression should be 
used during and/or after exercise for maximum benefit. Muscle damage and inflammation 
are possible causes of DOMS and the subsequent decline in repeat performance; however, 
CGs have been shown to attenuate these effects. Creatine Kinase as a marker of muscle 
damage and CRP as a marker of inflammation will be measured along with muscle girths to 
assess recovery. Furthermore, muscle oscillations are one of the possible causes of muscle 
damage; therefore, CGs effect on lower leg muscle oscillation will be explored.  
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Compression and Ice therapy, both individually and combined are two of the most commonly 
used ergogenic aids during recovery. Ice has been supported by many studies as a recovery 
strategy from soft tissue injury and exercise induced damage. However, the rationale for 
using ice and the mechanisms by which benefits may be elicited are still unclear. Despite 
this, it is believed that ice and compression combined could elicit increased benefits to 
recovery, based on the commonly used RICE procedure for soft tissue injuries. There is a 
need for ecologically valid recovery protocols that can be used by athletes and recreational 
sports people, at home and in the field. 110% Play harder have developed a means of 
applying compression and ice immediately following exercise. This research will examine the 
effects of this intervention on recovery post exercise. 
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2.7 General Aims and Research Questions 
Chapter 5  
Aims: To assess the effect of knee high compression on: i) acute 10 km running 
performance and ii) recovery post 10 km run; in competitive recreational endurance athletes. 
A secondary aim of this research is to test various mechanisms by which CGs are suggested 
to improve performance and recovery. 
To achieve these aims the following research questions will be answered: 
1. Does knee high compression use affect maximal 10 km running time trial time, in 
recreationally competitive endurance athletes? 
2. Is a maximal 10 km time trial sufficient to induce perceptual or physiological 
decrements post exercise, in recreationally trained athletes? 
3. Do any of the following CG applications help to attenuate these perceptual of 
physiological decrements; i) CGs worm during exercise, ii) CGs worm for 12 hours 
post exercise, or iii) CGs worn both during and for 12 hours post exercise? 
 
Chapter 6 
Aim: To assess the effect of compression garments and ice treatment on the perceptual and 
physiological recovery following a bout of eccentric exercise. As in chapter 5, a secondary 
aim of this research is to test various mechanisms by which CGs and ice are suggested to 
improve recovery and subsequent performance. 
To achieve these aims the following research questions will be answered: 
1. Will eccentric exercise affecting only the lower leg induce perceptual or physiological 
decrements sufficient to affect subsequent performance? 
2. Do CGs or combined CG and ice therapies applied to the lower leg effect perceptual 
or physiological markers of recovery post eccentric exercise?  
 56 
 
Chapter 3: General Methods 
3.1 Testing Conditions 
3.1.1 Testing and Measurements 
To ensure reliability of measurements and control of data; all testing, measurements and 
analysis was completed by the principle researcher (John Lea); the same equipment was 
also used throughout the testing and analysis for both chapters 5 and 6.  
3.1.2 Laboratory Environment 
All testing took place in the Human Performance Laboratory, H260, College Lane campus, 
University of Hertfordshire. This laboratory was air conditioned and temperature controlled. 
To ensure consistent testing conditions the temperature, pressure and humidity were 
recorded from an electrical barometer (Oregon Scientific, Oregon, USA) at the beginning of 
each testing day (Temperature: 22.1 ± 1.5°C, Pressure: 1004 ± 10 mbar, Humidity: 34.3 ± 
5.6%). Before the first trial the treadmill (HP Comos, Quasar, Gemany) was validated for 
weighted and un-weighted speed (Appendix 3). 
3.2 Ethical Approval 
Ethical approval was received from the University of Hertfordshire ethics committee, for all 
procedures used in both of these studies prior to testing commencing.  
3.3 Participant Recruitment 
A separate cohort was recruited for chapters 5 and 6, based on separate selection criteria 
(chapters 5.3.1 and 6.3.1). Participants for both phases were recruited using social media, 
email and word of mouth. Before the initial meeting participants were sent a participant 
information sheet (Appendix 4 and 12) which gave details of the study design, number of 
visits and what was expected of the participant. Written informed consent (Appendix 6 and 
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14) and health questionnaires (Appendix 4 and 12) were received from all participants, 
before any testing was completed. 
3.4 Pre-Testing Instructions 
Prior to completion of the first testing session, each participant’s was asked to refrain from 
exercise, alcohol, massages, stretching and supplements for 24-hours, and caffeine for 12 
hours prior to the start of each testing session. Participants were also told to keep their 
routine and preparation before each trial the same. 
3.5 Familiarisation Session 
All participants completed a preliminary session at least seven days before beginning the 
first trial. During this session the participants were shown around the laboratory, had the 
study protocols and tests explained to them, were familiarised with the perceptual scales 
(RPE and PMS) and were given an opportunity to ask any questions they may have had 
about the study. If the participant was happy to continue, they were given an opportunity to 
familiarise themselves with use of a treadmill at low speeds including dismounting the 
treadmill (HP Comos, Quasar, Germany). 
3.6 Anthropometric Measures 
3.6.1 Height 
Height was measured to the nearest 0.1 cm using a portable Stadiometer (Model 214, Seca, 
Hamburg, Germany). Height was measured while participants undertook a maximum 
inhalation, stood bare foot with heels together, with a straight back pushed against the rod, 
and with the head on the Frankfurt plane. 
3.6.2 Mass 
Mass was measured to the nearest 0.1 kg using electrical digital scales (Model 780, Seca, 
Hamburg). Participants wore minimal clothing and were barefoot during measurement. 
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3.6.3 Calf and Ankle Girth Measurement 
Girth measurements were conducted in accordance with the ACSM guidelines (2006). A 
tension regulated tape (Seca, Hamburg, Germany) was used on the right side of the body, 
pulled to proper tension without pinching skin to measure girth. Duplicate measurements 
were taken and the results given were the mean of the two measurements. Where the 
measurements differed by more than 2 mm a third measurement was taken and the median 
used. Calf girth measurement was taken at the level of maximum circumference between 
knee and ankle. Ankle girth measurement was taken at the level of the minimum 
circumference of the lower leg, superior to the malleoli of the ankle. 
3.6.4 Body Fat Percentage 
Body fat percentage was established using Tanita scales (Tanita, Illinios, USA) and was 
carried out in accordance with the manufacturer’s instructions. All participants were awake 
for at least three hours, had not conducted vigorous exercise for at least 12 hours, and had 
not consumed food or drink for three hours prior to measurement. Duplicate measurements 
were taken and the results presented were the mean of the two measurements. 
3.7 Physiological Measurement 
3.7.1 Blood Pressure 
Blood pressure (BP) measurements were taken (Omron, Milton Keynes, UK), from the left 
arm. The cuff was placed on the upper arm with the appropriate mark in line with the brachial 
artery. Blood pressure measurements were taken in duplicate; the results given are the 
average (mean) of the two results. If the two results differed by more than 5%, a third 
measurement was taken and the median result used.  
3.7.2 Heart Rate 
Resting heart rate (HR) was recorded using a wireless HR monitor (Polar, Finland). Two 
measurements were taken one minute apart; the mean of the two results was used for data 
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analysis. If the two results differed by more than 5%, a third measurement was taken and the 
median result used.  
3.7.3 Pain Algometry 
Perceived muscle soreness was measured using a pain algometer (Wagner Instruments, 
Greenwich, Canada) pressed at a force of 80N (Goddard, Karibe, and McNeill, 2004), the 
degree of muscle soreness was assessed using a 0-10 (0= no pain, 10=unbearable pain) 
visual analogue scale (Appendix 1). The sites used to assess muscle pain were taken from 
previous research (Creasy, 2008). The sites were located, and marked with a pen for 
consistency, using anatomical landmarks as follows: Tibialis anterior, middle of the muscle 
10 cm above the proximal aspect of lateral malleolus; Medial head of gastrocnemius, centre 
of the belly of the muscle; Lateral head of gastrocnemius, centre of the belly of the muscle; 
Biceps Femoris, 20 cm proximal to popliteal line; Vastus Lateralis, 20 cm above the distal 
end of lateral aspect of femur; Vastus Medialis, 10 cm above to the distal end of medial 
aspect of femur. Pain at each site was measured twice and the average taken, if there was a 
difference in pain rating of more than one unit, then a 3rd measurement was recorded and 
the median value used. 
3.8 Blood Analysis 
3.8.1 Blood Lactate and Glucose  
To assess blood lactate and glucose levels, whole capillary blood was collected from the 
finger tip. Prior to each sample, the finger was cleaned using an alcohol wipe. The finger tip 
was then punctured with a single-use lancet. The first drop of blood was discarded before 
the samples were collected into 10 ul glass capillary tubes (EKF Diagnostics, Cardiff, 
Wales). These tubes were placed in Micro-centrifuge tubes with Haemolysing solution (EKF 
Diagnostics, Cardiff, Wales). The samples were shaken and mixed before being placed in 
the analyser (EKF Diagnostics, Cardiff, Wales).  
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3.8.2 Serum Collection 
Whole capillary blood was collected, using the standard finger-prick technique, as above 
(Chapter 3.8.1), into 200ul microvettes, (Sarstedt, Nümbrecht, Germany) with clot activator 
(Silicate). Samples were placed in a centrifuge (Hyspin 16K, Anachem, Luton, UK) at 
10000xg for 5 mins to separate the serum. Serum was separated using a pipette (Gilsons, 
Middleton, UK) into a pre chilled micro-centrifuge tube and stored at -80°C for batch analysis 
once all trials were completed 
3.8.3 C-Reactive Protein 
After calibration according to the manufactures guidelines, samples were analysed using a 
semi automated spectrophotometer (RS Monza, Randox, Crumlin, Ireland). Serum (50 µL) 
was mixed with reagent R1 (CP7950, Randox, Crumlin, Ireland) and given 3 minutes to 
equilibrate. Saline (0.9%, 75 µL) or reagent R2 (75 µL) was then added and the sample was 
incubated for 15 minutes at 25°C. Following incubation, samples were analysed according to 
beer-Lambert’s law.  
3.8.4 Creatine Kinase 
After a calibration following the manufactures guidelines, samples were analysed using a 
semi-automated analyser (RS Monza, Randox, Crumlin, Ireland). Serum (10 µL) was 
reacted with 500 μL reagent R1 (CK110, Randox, Crumlin, Ireland), the sample was then 
inverted 10 times and aspirated into the flow cell for analysis. Absorptions were measured at 
one and four minute intervals, concentrations were calculated according to beer-Lambert’s 
law.  
3.9 Trial Garments 
3.9.1 Compression Sleeves 
The compression used in both chapters 5 and 6 were commercially available graduated 
ankle to knee sleeves (110% Play Harder, Florida, USA). The CGs were made of 70% 
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Polypropylene/ 30% Spandex. The sleeves were shaped to be unilateral and fit exclusively 
to the left or right leg. The compression was available in four sizes; extra small, small, 
medium and large. The pressure provided by the compression, as reported by the 
manufacturer, was 45 mmHg at the ankle to 35 mmHg at the base of the knee. The CGs 
have a double layered construction (mean combined un-stretched thickness 1.69 ± 0.02 
mm), to accommodate an ice insert for combined use. The reusable ice inserts (110% Play 
Harder, Florider, USA; Figure 2) were supplied with the compression garments. The ice 
inserts were first hydrated by soaking in water until all compartments had expanded to full 
size. Inserts were frozen at -18 to -20°C, for a minimum of 12 hours prior to use. 
3.9.2 Fitting Compression 
Once calf girth was determined, the appropriate sized garment for each participant was 
chosen using the manufactures sizing guide (Appendix 2). Compression was fitted on the 
lower leg, superior to the malleoli of the ankle and inferior to the Head of fibula and was 
adjusted to the comfort of the athlete.  
3.10 General Statistics 
All data was analysed for significance in SPSS (version 18, SPSS, Chicago, USA). Prior to 
analysis data was checked for normality; due to the sample sizes (n<50) Shapiro-Wilk’s tests 
(p > 0.05) and visual inspections of their histograms were used.  
Normally distributed data was analysed to determine any significant difference between 
groups using: Paired samples T-Tests and one way repeated measures analysis of variance 
(ANOVA). Mauchly’s test for sphericity was conducted with the ANOVAs; where sphericity 
was breached a Greenhouse-Geisser adjustment was used. Post-hoc tests for pair-wise 
comparison were conducted to determine the areas of statistical significant. Bonferroni 
adjustments were performed to reduce the probability of type 1 errors. Parametric data were 
presented as mean values ± standard deviation (±SD). The coefficient of variation for certain 
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variables was calculated using the following equation: (SD÷Mean) x 100. Results are 
presented as a percentage.  
The Creatine Kinase data for both chapters 5 and 6 had positively skewed frequency 
distribution. This data underwent logarithmic transformation, followed by further Shapiro-
wilk’s testing to confirm normality. As the logarithmically transformed data was normally 
distributed (p > 0.05), repeated measures ANOVAs were conducted as described above.  
Data that were found to deviate from normality were assessed using Wilcoxon signed-rank 
tests (two groups) and Friedman tests (3 or more groups). Post hoc comparisons were 
carried out using Wilcoxon signed-rank tests, following the Friedman tests, to assess where 
significance was present. Non-parametric data were reported as median (range). 
An α-level of < 0.05 was accepted for statistical significance in all parametric and non-
parametric statistical testing. 
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Chapter 4: Pilot Testing: Ice Therapy Protocol 
4.1 Introduction 
Ice therapy has been commonly used for recovery in clinical practice since the 1940’s (Mac 
Auley, 2001), and is now established as a key component of treatment for soft tissue injuries 
(Kowal et al., 1983) and post exercise muscle damage (French et al., 2008). A systematic 
literature review by Mac Auley (2001) suggests that the optimum temperature range to slow 
cell metabolism while reducing risks such as cell and nerve damage, is 10-15°C. While the 
evidence was sufficient to recommend an optimum temperature range, Mac Auley stated 
that there was insufficient evidence to recommend the optimum timing and frequency of ice 
application. However it was suggested that an effective technique favoured by some 
research was an intermittent protocol of: 10 minutes ice, 10 minutes rest at room 
temperature, followed by a further of 10 minutes ice therapy. This 10 on 10 off intermittent 
application was confirmed to be more effective at reducing pain, when using ice packs, 
compared to a 20 minute continuous protocol (Bleakley et al., 2006). Despite this, the 
confusion in this area continues due to conflicting research demonstrating that continuous 
icing protocols can also be effective for post exercise recovery (Bailey et al., 2007; Vaile, 
Halson, Gill & Dawson, 2008). 
The research in this thesis (chapter 6) used a commercially available portable ice insert 
system (110% Play Harder, Florida, USA), designed to allow the combined use of ice and 
compression in the field. This system could allow easy and convenient treatment for athletes 
immediately post exercise. However, as this system is designed for field based use, it has 
certain characteristics that differentiate it from the methods used in previous studies: Firstly, 
the ice pack had two different sides (Figure 2); one side was a white porous side through 
which the ice pack was hydrated before use, the second side was a plastic black non porous 
side. These two surfaces were very different and it was unclear which side of the ice insert 
should be used inwards (towards the leg), to achieve the desired temperature range. 
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Additionally, as this system was designed for use in the field, the same ice insert would be 
used for the entire treatment; consequently using the intermittent protocol may be less 
effective as it is not possible to re-cool the ice pack between applications. Therefore the 
purpose of this pilot test was to assess the most effective icing protocol to be used to reach 
the target skin temperature of 10-15°C, when using this portable ice insert system. The 
independent variables in this test were: i) ice therapy timing (intermittent vs continuous) and 
ii) Ice pack orientation (Black side or White Side facing the leg) 
 
Figure 2: 110% Play Harder Ice Inserts (White and Black sides) 
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4.2 Method 
4.2.1 Participants 
Six healthy male volunteers (Age (Median): 22 years (20-27 years), Height: 176.7 ± 5.3 cm, 
Mass: 70.1 ± 3.2 kg, Body fat: 13.7 ± 5.3%) completed this study. All participants completed 
a minimum of two exercise sessions per week, for 30 mins or more. 
4.2.2 Experimental procedures 
All testing was completed in the Human Performance Laboratory (Temperature: 21.7 ± 
0.3°C, Pressure: 1005 ± 12 mbar, Humidity: 32.3 ± 4.6%), on the University of Hertfordshire 
campus. Each participant completed four trials, separated by a minimum of 24 hours, in a 
randomised cross over design. Prior to testing, participants rested for a minimum of 5 
minutes in a seated position, during which time written informed consent was collected. The 
four conditions undertaken were: Continuous 20 minutes ice application with; i) the white 
side of the ice pack towards the leg (Cont-W) and ii) the black side of the ice pack towards 
the leg (Cont-B). And intermittent trials consisted of 10 minutes of ice application followed by 
10 minutes of rest at room temperature and finally a further 10 minutes of ice application. 
The intermediate protocol was conducted with: i)  the white side of the ice pack towards the 
leg (Inter-W) and ii) the black side of the ice pack towards the leg (Inter-B). During the 
breaks in the intermittent protocols the ice pack was placed inside an insulated bag as would 
be done in the field. The same ice pack was used for the entire intervention. For all trials the 
participant wore a compression garment (110% Play Harder, Florida, USA) on the right leg, 
into which the ice pack was inserted. The ice pack sat between the two layers of the 
garment, therefore the ice insert was not in direct contact with the skin. Skin temperature 
was recorded every two minutes using an electronic thermometer (1320 Type K, Tes, 
Taiwan). The thermometer was placed with the sensor located over the belly of the calf 
musculature, in direct contact with the skin; this was secured using hypo-allergenic tape and 
the pressure of the compression garment to ensure there was no movement during the 
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measurement. Participants remained in the seated position throughout the test, with legs 
uncrossed and feet flat on the floor. Shoes were worn throughout the procedure. 
4.2.3 Data analysis 
Mean skin temperature, at each time point during the intervention, was calculated for all 
groups. Likewise, the average skin temperature (Median and Range) during the 20 minutes 
of ice application was calculated for each group. Statistical analysis was conducted (as 
described in chapter 3.10), to assess any differences present between groups in; final 
(minimum) skin temperature achieved and average skin temperature during the entire 
intervention. 
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4.3 Results 
The lowest skin temperatures were reached in the trials with the black side of the ice inserts 
facing the leg. The lowest temperature reached was 11.2°C in the Inter-B trial; the minimum 
temperature was 0.3°C higher in Cont-B. A statistical analysis of variance (ANOVA) revealed 
that there was a statistical difference between groups for minimum skin temperature reached 
(F2, 11 = 622, p = 0.001). Bonferroni pairwise comparison showed that both the Inter-B and 
Cont-B trials reached statistically lower final temperatures than the Inter-w and Cont-W 
conditions (p < 0.05). However, the difference in final temperature between the Inter-B and 
Cont-B conditions was not significant (p = 1.00).  
The Cont-B trial reached the target temperature range (10-15°C) at 12 minutes; however it 
took until 14 minutes for the Inter-B trial to reach the target range. From 14 minutes onward 
the Inter-B group had the lowest temperature of any trial, at every time point until the end of 
the test (Table 3). The average temperature during the 20 minute ice intervention was 
calculated for each group. The median temperatures during the interventions were: Cont-W; 
17.7°C (30 - 15.5°C), Inter-W; 16.7°C (29.3 - 13.7°C), Cont-B; 15.7°C (29.5 - 11.7°C), and 
Inter-B; 15.5°C (29.2 – 11.2°C). A Friedman test revealed significance between groups for 
average skin temperature (X23 = 29.3, p = 0.001). Wilcoxon signed-rank tests showed that, 
as with minimum temperature, Inter-B and Cont-B had lower average skin temperatures than 
the Cont-W and Inter-W conditions (p < 0.05): additionally the difference between the Inter-B 
and Cont-B groups was again not significant (p = 0.58).  
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Table 3: Skin temperature (°C) during ice therapies (mean ± SD, n = 6) 
Time  
(Mins) 
Pre 2 4 6 8 10 
Break 
Temp 
12 14 16 18 20 
Cont-W 
Temp (°C)   
30 ± 0.9 22.3 ± 0.5 19.5 ± 0.5 18.7 ± 0.5 17.7 ± 0.5 17.7 ± 0.8 - 17.3 ± 1 16.8 ± 1 16.3 ± 1.4 15.7 ± 1.2 15.5 ± 1 
Cont-B 
Temp (°C) 
29.5 ± 1 20.3 ± 1.9 18.2 ± 1.2 16.5 ± 1 16.2 ± 1 15.7 ± 0.5 - 14.5 ± 0.8 14.2 ± 1.2 12.8 ± 1 12 ± 0.6 11.5 ± 0.5 
Inter-W 
Temp (°C) 
29.3 ± 0.5 20.9 ± 1.7 19 ± 1.8 17.7 ± 1.6 16.7 ± 1.9 16 ± 2 24.2 ± 0.4 17.5 ± 1.2 16.3 ± 1 15.5 ± 0.8 14.7 ± 1.2 13.7 ± 1.2 
Inter-B 
Temp (°C) 
29.2 ± 1 19.8 ± 1.3 18 ± 0.9 16.5 ± 1 15.7 ± 0.8 15.2 ± 1.1 21.7 ± 2 15.5 ± 1.9 13.5 ± 1 11.7 ± 0.5 11.5 ± 0.8 11.2 ± 0.8 
Pre= skin temperature (°C) under CGs before ice was inserted. Break Temp= skin temperature after 10 minute break at room temperature in intermittent trials 
only.  
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4.4 Discussion 
The results of this study showed that in both timing conditions the black side of the ice pack 
was more efficient at cooling the skin to within the target temperature. This increased 
thermo-conductivity of the black side compared to the white side, was caused by the type of 
materials used on each side, and a difference in material thickness. The results of this study 
also demonstrated that the intermittent protocol with the black surface of the ice insert facing 
the leg (Inter-B) induced the lowest skin temperatures, when compared to all other trials. The 
Inter-B trial also maintained the lowest average skin temperature throughout the ice 
intervention when compared to the other trials. However, these results were not statistically 
significant when compared to Cont-B. Cont-B also reached the target temperature of 10-
15°C faster than the Inter-B trial, and was within 0.3°C of its minimum temperature and 
0.2°C of the average temperature achieved.  While there was no significant difference 
between these continuous and intermittent trials, previous research has suggested that 
intermittent protocols are frequently favoured in current ice therapy research (Mac Auley, 
2001), and that intermittent protocols are more effective at reducing perceived muscle 
soreness and DOMS (Bleakley et al., 2006).  As a result of this research and the lower 
average temperatures reached in the Inter-B trial, the intermittent protocol with the black side 
of the ice insert facing the participant’s leg was used in the main study.  
A limitation to this study was the small sample size, for more reliable results a greater 
number of participants would be required, however this information was sufficient to inform a 
decision in this instance. 
4.5 Conclusion 
There was statistical difference in surface temperature achieved between the Cont-B and 
Inter-B trials. As intermittent trials have been shown to be more effective than continuous 
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trials at reducing DOMS and the Inter-B trial achieved the lowest temperatures; the Inter-B 
protocol was used in the main study (chapter 6). 
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Chapter 5- The effect of knee high compression garments on 
10 km run performance, and recovery in competitive 
recreational endurance athletes 
5.1 Introduction 
Compression garments are used extensively during and after exercise for the proposed 
benefits to performance (Bringard et al., 2006b) and recovery (Gill et al., 2006; Jakeman et 
al., 2010). These proposed benefits make the use of CGs attractive to recreationally 
competitive athletes who are looking to increase performance, with limited time to train and 
recover. The use of knee high CGs is a fast growing trend at events such as triathlons and 
running events, where 10 km is a common run distance (Bakken et al., 2011). However, the 
recreational athletes taking part in such events are training regularly, three or more times per 
week; and it is currently still unclear whether CGs will be beneficial to an athlete who is 
familiar with the exercise (Hill et al., 2014) and has adaptations from training, such as 
reduced susceptibility to muscle damage (French et al., 2008).  
For recreational athletes looking to CGs for improved performance and recovery, it is also 
unclear what the optimal timings of application are to achieve maximal benefits.  It is 
suggested that the use of compression during exercise as well as improving performance 
(Ali et al., 2007) may reduce muscle oscillations (Doan et al., 2003) and consequently 
reduce the muscle damage caused during that exercise (Creasy, 2008); while the use of 
compression post exercise may reduce inflammation (Davies et al., 2009) and secondary 
muscle damage caused by immune cells and reactive oxygen species (Bochmann et al., 
2005). As a result of this some CG companies market different compression garments to be 
worn during and after exercise (2XU, Melbourne). Born et al. (2013) suggested that the 
greatest benefits of CGs seem most pronounced when applied for the recovery process 12 
to 48 hours after significant muscle damage inducing exercise. However as the majority of 
the studies looking into the effects of CGs on recovery administered the compression during 
 72 
 
recovery only (Hill et al., 2013) and there are no studies comparing compression use during, 
after or combined during and after, it is impossible to know the most effective application of 
compression for recovery. It is possible that the use of CGs both during and after exercise 
could have an additive effect or even a synergistic effect, although the effect of combined 
use during and after exercise has not yet been confirmed.   
This study compared the effects of compression use: during, after and combined (during and 
after); on 10 km running performance and post exercise recovery, in competitive recreational 
endurance athletes. 
5.2 Aims and Hypotheses 
Aims:  1. To assess the effect of wearing knee high compression garments on muscle 
oscillations 
2.To assess the effect of wearing knee high compression garments on 10 km 
treadmill time trial performance 
3. To assess whether a maximal 10km time trial is sufficient to elicit physiological or 
perceptual decrements during recovery. 
4. To examine the effects of wearing knee high compression garments: i) During 
exercise, ii) Post exercise for 12 hours, and iii)  During exercise and post exercise for 
12 hours; on physiological and perceptual recovery 
 
Hypotheses 
Hypothesis 1: Muscle oscillations, during running at 12 km.h-1, will be significantly reduced when 
wearing CGs when compared to a control. 
Null hypothesis 1: There will be no statistically significant difference in muscle oscillations 
between trials. Any differences will be due to chance alone. 
Hypothesis 2: The wearing of CGs will significantly decrease 10 km time trial performance time  
Null Hypothesis 2: There will be no statistically significant difference in run time when wearing 
CGs. Any differences will be due to chance alone. 
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Hypothesis 3: During a maximal 10 km running time trial, the use of CGs will significantly 
reduce: i) Average heart rate, ii) average blood lactate levels and iii) average RPE scores; when 
compared to a control. 
Null Hypothesis 3: There will be no statistically significant difference between trials in: i) 
Average heart rate, ii) average blood lactate levels or iii) average RPE scores. Any differences 
will be due to chance alone. 
Hypothesis 4: 24 hours post 10 km running time trial, blood CK levels will be significantly lower 
when CGs are worn: i) during the exercise, ii) for 12 hours immediately post-exercise and iii) 
during and for 12 hours post-exercise; when compared to a control. 
Null Hypothesis 4: There will be no statistically significant difference in blood CK levels between 
any trials. Any differences will be due to chance alone. 
Hypothesis 5: 24 hours post 10 km running time trial, PMS will be significantly lower when CGs 
are worn: i) during the exercise, ii) for 12 hours immediately post-exercise and iii) during and for 
12 hours post-exercise; when compared to a control. 
Null Hypothesis 5: There will be no statistically significant difference in PMS between any trials. 
Any differences will be due to chance alone. 
Hypothesis 6: 24 hours post 10 km running time trial, blood CRP levels will be significantly lower 
when CGs are worn: i) during the exercise, ii) for 12 hours immediately post-exercise and iii) 
during and for 12 hours post-exercise; when compared to a control. 
Null Hypothesis 6: There will be no statistically significant difference in blood CRP levels 
between any trials. Any differences will be due to chance alone. 
Hypothesis 7: 24 hours post 10 km running time trial, average calf girth will be significantly lower 
when CGs are worn: i) during the exercise, ii) for 12 hours immediately post-exercise and iii) 
during and for 12 hours post-exercise; when compared to a control. 
Null Hypothesis 7: There will be no statistically significant difference in average calf girth 
between any trials. Any differences will be due to chance alone. 
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5.3 Study Methods 
5.3.1 Participants 
Eighteen healthy male volunteers agreed to participate in this study, with 13 completing all 
four trials (Age (median): 26 years (19-48 years), Height: 178 ± 5 cm, Mass: 76.2 ± 6.5 kg, 
Body Fat: 18.6 ± 4.1%, V̇O2Max: 50 ± 5 ml.kg-1). Figure 3 shows participant recruitment and 
attrition for this Chapter. 
 
 
 
 
 
 
 
Figure 3: A schematic of participant recruitment and attrition 
 
5.3.1.1 Inclusion Criteria  
The participants used in this study were: Healthy males, aged 18-50, able to run 10 km in ≤ 
50 mins, trained a minimum of three times per week and had competed in five or more races 
(≥5 km) in the two years prior to commencing the study. 
5.3.1.2 Exclusion Criteria  
The excluded criteria for this study were: Participants below 18 or above 50 years of age, 
any illness, medical issues or injuries preventing completion of a 10 km run, any medication 
use that makes exercise inadvisable, any issues relating to blood taking or an unwillingness 
to complete the require protocols.  
Preliminary Testing/ Familiarisation  
(n=18) 
Excluded (n=3)  
Time commitments (n=2)  
Did not meet criteria (n=1) 
Withdrawn (n=1)  
Time commitments 
Trial 1 
(n=15) 
Withdrawn (n=1)  
Injury 
Trial 2 
(n=14) 
Completed Study  
(n=13) 
 75 
 
5.3.2 Study Design 
This study was a randomised cross-over design, in which each participant completed four 
exercise trials: 1. 10 km run wearing loose running shorts providing no compression (CON), 
2. 10 km run wearing graduated compression (EX), 3. 10 km run wearing loose running 
shorts followed by 12 hours wearing graduated compression (REC) and 4. 10 km run 
wearing graduated compression followed by 12 hours recovery wearing graduated 
compression (EXREC).  
5.3.3 Preliminary Testing 
Baseline measurements of height, weight, calf and ankle girth and body fat percentage were 
recorded (see chapter 4). Perceived muscle soreness (calves, hamstrings and quadriceps) 
was recorded in two ways; firstly, they were shown a visual analogue scale and asked how 
much muscle pain they felt at that time; secondly by means of the pain-algometer (see 
chapter 4).  
5.3.3.1 V̇O2Max and Lactate Testing 
Participants completed an incremental lactate profile into V̇O2Max test to voluntary 
exhaustion. The Lactate- V̇O2Max test protocol (Tanner, Nielsen & Allgrove, 2014) consisted 
of participant running on a 1% gradient treadmill, starting at 2 km.h-1 below their 10 mile run 
pace (or estimated). Each stage was two minutes long. At the end of each stage the 
participant dismounted the treadmill for a 45 second break. During this break a capillary 
blood sample was taken for blood lactate and glucose and the treadmill speed was 
increased 1 km.h-1. Once the participant reached 80% of predicted maximum HR no more 
blood samples were necessary therefore the 45 second breaks between stages were 
stopped and the protocol became continuous. After a two minutes stage at 16 km.h-1, the 
treadmill gradient was increased by 1%. The test then continued in one minute stages with 
the gradient increasing by 1% at the end of each stage until volitional exhaustion. During this 
test oxygen consumption (ml.min-1), carbon dioxide excretion (ml.min-1) and respiratory 
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exchange ratio (RER) were recorded using a human respiratory analyser (Metalyser 3B, 
Cortex, Leipzig, Germany). Heart rate was recorded (Polar, Kempele, Finland) 15 seconds 
and RPE (Borg, 1973) 10 seconds before the end of each stage. An encouragement 
schedule (Appendix 7) was followed during the test, so that encouragement was consistent 
between participants. To ensure a true V̇O2max score was achieved the results must conform 
to a minimum of three of the following criteria for V̇O2max (BASES, 1997): 
1. V̇O2 Plateau –defined as an increase in oxygen uptake of less than 2 ml.kg-1.min-1 or 
3% with an increase in exercise intensity.  
2. A respiratory exchange ratio of 1.15 or above 
3. Final heart rate within 10 bpm of maximum. A predicted maximum can be used if true 
maximum is unknown (220-age) 
4. Rating of perceived exhaustion on the Borg scale (6-20) of 19 or above 
5.3.4 Muscle Oscillation Procedure  
Before completing the main study, each participant underwent a separate muscle oscillation 
measurement via video analysis. This test was completed at least 24 hours before the main 
study was started. Seven retro-reflective markers were fitted on the right leg and foot of each 
participant as follows: A. lateral femoral epicondyle; B. Medial femoral epicondyle; C. Belly of 
the calf muscle on the posterior midline of the leg; D. Shin bone at the same height as the 
calf marker; E. Lateral malleolus of the ankle; F. Medial malleolus of the ankle; G. Head of 
the first metatarsal (Figure 4).  
 77 
 
 
Figure 4: Muscle oscillation marker positions (left & Middle) and computer image (Right) 
Following a self-paced five minute warm up, two 1 minute treadmill trials were completed at 
12 km.h-1. From a standing start participants increased the speed of the treadmill, at a self 
selected rate, until the treadmill reached 12 km.h-1. Once at the correct speed and running 
comfortably the participant gave a verbal signal; following which data was collected for 1 
minute. This procedure was completed twice. During one of the trials, knee high 
compression stocking were worn (COMP), during the other no compression was worn 
(CON). These trials were completed in a randomised order. The legs were filmed throughout 
these trials using a 3D infrared motion capture system (Motion analysis, Santa Rosa, USA). 
The distances between markers were recorded against time. Using the distances between 
markers C, E and F the longitudinal: displacement, peak velocity and peak acceleration of 
marker C (calf muscle) was calculated. Displacement against time was plotted; showing one 
cycle of the running gait, from the point of maximum knee flexion, through heal strike, back 
to point of maximum knee flexion.  The calf muscle movement was in all participants 
approximately sinusoidal; with two periods of positive net displacement and two periods of 
negative net displacement per cycle.  The two periods of negative displacement were used 
to calculate average negative velocities of the calf muscle; this allowed comparisons of 
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velocities associated with heel strike (1st displacement) and velocities of the muscle during 
normal running gait (2nd displacement) (Figure 5). 
 
Figure 5: Calf muscle movement (relative to malleoli of the ankle) during running. Blue line indicates 
peak muscle oscillation 
5.3.5 Main Trial Procedure 
Participants were required to complete four trials (CON, EX, REC & EXREC); each trial 
consisted of two consecutive days of testing. Where possible, to control for natural variance 
in physiological markers and performance (Drust, Waterhouse, Atkinson, Edwards & Reilly, 
2005), participants were booked in at the same time and on the same days for each trial. On 
day one of each trial, participants arrived at the laboratory (H260, College Lane, University of 
Hertfordshire) and completed a 48 hours exercise log (Appendix 8), 24 hour food diary 
(Appendix 9) and health screen. Participant height, weight and calf girth was recorded and a 
wireless HR monitor fitted (Polar, Kempele, Finland) to provide an accurate measurement of 
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HR during exercise (Goodie, Larkin & Schauss, 2000).  After the participant had rested for 
ten minutes, HR and blood pressure measurements were taken. A baseline capillary blood 
sample was then collected for CK, CRP, lactate and glucose analysis. Participants 
completing the EX or EXREC trial were fitted with CGs (110% Play Harder, Florida, USA). 
The participant then complete a self-paced warm up on the treadmill (HP Comos, Quasar, 
Germany) for five minutes, followed by a maximal 10 km time trial. Rating of perceived 
exertion (RPE) and HR were recorded at 3 minute intervals during the run and performance 
time recorded using a stop watch (Fasttime 0, Leicestershire, UK). Blood lactate and glucose 
were measured during the run at 2.5, 5, 7.5 and 10 km.  
An encouragement schedule was used to ensure motivation was consistent between trials 
and participants (Appendix 10). Participants were allowed to drink water ad-libatum during 
the run; however, no other drinks or supplements were permitted. During the run, 
participants were able to see the distance covered, but not speed or performance time. The 
participants were free to adjust speed their as they wished, but were not informed of their 
performance times until all trials were completed. After the run, participants were offered a 
shower and allowed to leave the laboratory, if they were completing the REC or EXREC 
trials they were fitted with CGs before leaving and instructed to wear them for 12-hours 
before removing (Gill et al., 2005; French et al., 2008). Following completion of each 
compression treatment, participants were asked to record, using a visual analogue scale (0-
10): Perceived comfort of the garment (0 “very uncomfortable” to 10 “very comfortable”), 
Perceived tightness (0 “very loose” to 10 “very tight”) and perceived pain caused by the 
garment (0 “no pain” to 10 “very painful”). 
On visit two, participants arrived at the laboratory 24 hours after the start of day 1. They 
were told to refrain from exercise, massages, stretching, and supplementation until after day 
two testing was completed. Participants completed a 24 hours food diary and were asked to 
rate their PMS and compression garment perceived comfort, using a questionnaire 
(Appendix 11). After a 10 minute rest, HR and BP were recorded. Following this, PMS was 
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measured using the pain algometer and a capillary blood sample was taken for later 
measurement of CK and CRP. Finally, calf girth was measured and the participant was 
permitted to leave the laboratory. Recovery measurements were collected at 24 hours post 
exercise as it has been suggested that physiological responses, such as CK, peak within 24 
hours after exercise modalities such as running (Jones et al., 1985). 
Before each subsequent trial participants were emailed the food diaries they completed for 
trial 1 (24 hours pre and post run), and were asked to consume the same foods and drinks if 
possible. 
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5.4 Results 
5.4.1 Muscle Oscillation Results 
The data from one participant (participant 4) was removed from analysis for muscle 
oscillations due to gaps in the data; therefore the muscle oscillation cohort was n=12. 
5.4.1.1 Peak Velocity and Peak Acceleration 
Peak Velocity 
In all cases peak calf muscle velocity was experienced during the first muscle oscillation 
after heal strike. Median (Range) peak velocity was 0.386 m.s-1 (0.203 – 0.865 m.s-1) and 
0.334 m.s-1 (0.212 – 0.627 m.s-1), in the CON and COMP trials respectively (Table 4). 
Wilcoxon signed-rank testing revealed that there was no significant difference in peak 
velocity between conditions (Z = -0.94, p = 0.18).  
Peak Acceleration 
The median (range) peak accelerations were 28.658 m.s-2 (14.000 – 120.520 m.s-2) and 
30.043 m.s-2 (12.200 – 89.640 m.s-2) in the CON and COMP trials respectively (Table 4). 
Peak acceleration was also experienced during the first oscillation post heal strike.  There 
was no significant difference in calf muscle acceleration between trials, as shown by the 
wilcoxon signed-rank test results (Z = -0.46, p = 0.33). 
Table 4: Peak calf muscle velocity and acceleration during running at 12 km.h-1 (Median (Range), n = 
12) (p > 0.05). 
  
Peak Velocity 
m.s-1 
Peak Acceleration  
m.s-2 
CON 0.386 (0.203-0.865) 28.66 (14.00-120.52) 
COMP 0.364 (0.212-0.627) 30.04 (12.20-89.64) 
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5.4.1.2 Average Negative Velocity 
The average velocity of the calf muscle during each period of negative displacement was 
calculated. A repeated measures ANOVA showed significant differences in average velocity 
between groups (F1, 43 = 17.74, p = 0.001). Post hoc analysis revealed no significant 
difference in average velocity during the first (1.03 ± 0.46 m.s-1) and second (1.10 ± 0.25 
m.s-1) displacement in the CON trial (p = 0.45). There was also no significant difference in 
average velocity for the first period of negative displacement between the CON and COMP 
trials (p = 1.00). In the COMP trial the average velocity of the second period (0.51 ± 0.20 
m.s-1) of negative displacement was significantly lower than the first period (0.79 ± 0.31 m.s-
1, p = 0.001). The second displacement in the COMP trial was also significantly lower that 
the CON trial (p = 0.002, Figure 6). 
 
Figure 6: Average calf muscle velocity during negative displacement phases of muscle movement; 
when running at 12 km.h-1 (mean ± SD, n = 12)    Significant difference when compared to first 
average velocity in COMP trial (p < 0.05). # Significant difference when compared to second average 
velocity in CON trial (p < 0.05). 
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5.4.1.3 Muscle Displacement  
Displacement was calculated for each cycle of calf muscle movement, relative to the malleoli 
of the ankle. A paired samples T-test revealed a significant decrease (t23 = 4.06, p = 0.001) 
in displacement with the use of CGs (13.28 ± 3.27 mm) compared to the CON trial (17.57 ± 
4.36 mm; Figure 7). 
 
Figure 7: Maximum displacement of calf muscle across a cycle of muscle movement; when running at 
12 km.h-1 (mean ± SD, n = 12).    Significant difference when compared to CON, p < 0.05). 
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5.4.2 Ten Kilometer Performance Results 
Each participant completed two 10 km runs with no compression (CON & REC) and two runs 
wearing knee high CGs (EX & EXREC). Therefore for 10 km performance time and 
physiological response during exercise data, there were two conditions: COMP (wearing 
compression) and CON (no compression), with two trials in each condition. 
5.4.2.1 Performance Time 
Ten kilometre run time with the use of CGs (COMP) and without CGs (CON) was compared 
as a measure of performance. Mean performance time was 46.88 ± 1.76 mins and 47.07 ± 
1.94 mins for the CON and COMP conditions respectively (Figure 8). A paired samples t-test 
showed no significant difference in run time between these conditions (t25 = 0.55, p = 0.59).  
 
 
Figure 8: 10 km run time with CG use (COMP) and no compression (CON) (mean ± SD, n = 26). 
 
5.4.2.2 Physiological Responses during Exercise 
Paired samples t-tests revealed no significant differences between the CON and COMP 
trials for: Average HR (t25 = 0.92, p = 0.37), RPE (t25 = 0.47, p = 0.64), blood lactate (t25 = 
0.84, p = 0.41), or blood glucose (t25 = 1.32, p = 0.13) during the 10 km time trials. The mean 
results for each variable are shown in Table 5. 
Table 5: Heart rate, RPE, lactate and glucose during 10 km run (mean ± SD, n = 26) (p > 0.05).  
 
Trial 
Average HR RPE Lactate  Glucose 
(BPM)   (mmol.L-1) (mmol.L-1) 
CON 172 ± 6 14 ± 1.4 6.09 ± 1.93 4.34 ± 0.66 
COMP 173 ± 8 13 ± 0.1 6.43 ± 0.67 4.47 ± 0.72 
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5.4.3 Recovery Results 
5.4.3.1 Resting and Post Exercise Cardiac Variables 
A repeated measures ANOVA showed no significant difference between or within conditions 
for resting or 24-hours post-exercise HR (F7, 84 = 1.97, p = 0.07). Similarly, there was no 
difference between or within conditions for pre and 24 hours post Systolic BP (F7, 84. = 0.49, 
p = 0.84). Friedman’s tests revealed that there was also no significant difference between 
condition for pre or 24 hours post: diastolic BP (X27 = 4.8, p = 0.68), or mean arterial 
pressure (X27 = 3.97, p = 0.783).  Average pre and post results are presented in Table 6. 
Table 6: Heart rate, systolic BP (mean ± SD), diastolic BP and mean arterial pressure (median 
(range)) at rest and 24 hours post 10 km run (n=26, p > 0.05).  
  CON EX REC EXREC 
Pre-HR (BPM) 58.5 ± 8.5 62.5 ± 7.1 63.6 ± 6.6 60.4 ± 6.2 
Post-HR (BPM) 60.2 ± 6.7 64.2 ± 9.1 63.6 ± 8.7 61.3 ± 7.7 
Pre-Systol (mmHg) 128 ± 11 126 ± 11 127 ± 14 127 ± 12 
Post-Systol (mmHg) 128 ± 13 125 ± 11 127 ± 11 128 ± 11 
Pre-Diastol (mmHg) 72 (62-102) 70 (60-101) 67 (59-103) 70 (60-102) 
Post-Diastol (mmHg) 68 (55-102) 69 (58-103) 68 (55-99) 69 (50-96) 
Pre-MAP (mmHg) 90 (83-118) 89 (81-117) 88 (74-121) 88 (82-118) 
Post-MAP (mmHg) 90 (75-120) 86 (77-119) 87 (77-115) 90 (73-115) 
Systol = Systolic blood pressure, Diast = Diastolic blood pressure, MAP = Mean arterial pressure. 
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5.4.3.2 Muscle Damage 
Creatine Kinase was measured immediately pre and 24 hours after completion of the 10 km 
run. The increase in CK 24 hours after exercise relative to baseline in each condition were: 
CON: 168.93 U/L, EX: 146.17 U/L, REC: 20.77 U/L, and EXREC: 104.75 U/L. Creatine 
kinase increased by 75.6% in CON compared to a 5% increase in REC; despite this, 
repeated measures ANOVA testing revealed no significant differences between any trial (F3, 
41 = 1.14, p = 0.34). Average pre and post CK results for each condition are presented below 
(Table 7). 
Table 7: Baseline and 24 hours post run CK (Median (Range), n = 13)  
Trial 
Pre-CK 
(U/L) 
Post-CK 
(U/L) 
CON 160 (75-752) 262 (110-1011) 
EX 195 (57-1588) 399 (144-1592) 
REC 228 (68-2034) 216 (138-1621) 
EXREC 187 (46-1356) 282 (137-1551) 
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5.4.3.3 Inflammation  
C-Reactive Protein 
Serum CRP levels were recorded at baseline, before each 10 km time trial, and 24 hours 
post exercise. The mean CRP levels measured during each trial were: CON; 2.88 ± 1.68 
mg.L-1 & 3.51 ± 1.43 mg.L-1, EX 2.87 ± 1.38 mg.L-1 & 3.00 ± 1.55 mg.L-1, REC 3.03 ± 0.91 
mg.L-1 & 3.01 ± 1.34 mg.L-1, and EXREC 2.66 ± 1.17 mg.L-1 & 3.39 ± 0.57 mg.L-1; baseline 
and 24 hours post exercise respectively (Figure 9). A repeated measures ANOVA showed 
that there were no statistically significant differences in CRP levels pre or post exercise 
within or between any trial (F7, 84 = 0.81, p = 0.58).  
 
Figure 9: Pre and 24 hours post run serum C-Reactive Protein levels (mean ± SD, n = 13) (p  > 0.05).   
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Calf Girth 
As with CRP, repeated measures ANOVA testing revealed no significant differences in calf 
girth pre or post exercise within or between any trial (F3, 43 = 0.65, p = 0.61). The mean (SD) 
results for calf girth pre and 24 hours post exercise respectively were: CON 36.8 ± 2.2 cm & 
36.9 ± 2.2 cm, Ex 36.9 ± 2.3 cm & 36.9 ± 2.2 cm, REC 36.8 ± 2.2 cm & 36.8 ± 2.2 cm, 
EXREC 37.0 ± 2.4 cm & 36.8 ± 2.3 cm (Figure 10). 
 
Figure 10: Pre and 24 hours post run calf girth (mean ± SD, n = 13) (p > 0.05).   
 
  
30
31
32
33
34
35
36
37
38
39
40
CON EX REC EXREC
C
a
lf
 G
ir
th
 (
c
m
)
Trial
Pre
24h Post
 89 
 
5.4.3.4 Muscle Soreness 
Perceived Muscle Soreness Questionnaire  
Friedman’s testing revealed that there were significant time effect on perceived muscle pain 
for all muscle groups; Calf (X24 = 15.1, p = 0.005), Quadriceps (X24 = 19.75, p = 0.001), 
Hamstrings (X24 = 15.92, p = 0.003). Post Hoc Wilcoxon signed rank testing showed that 
perceived muscle pain for all muscle groups was significantly increased 24 hours post 
exercise compared to baseline, in all trials (p < 0.05) However, there was no significant 
difference between trials, for any of the three muscle groups (p > 0.05). Median (Range) 
pain rating for each muscle group are presented in Table 8. 
Algometry Muscle Soreness 
Statistical analysis (ANOVA) of algometry measurements revealed significant differences in 
muscle pain between time points in the quadriceps and hamstrings (F4, 48 = 8.62, p = 0.001 & 
F4, 48 = 4.23, p = 0.005; respectively). Similarly Friedman’s testing revealed significant 
difference in muscle pain in the calf (X24 = 12.96, p = 0.011). Post hoc testing showed that 
24 hours post exercise pain increased in all trials and all muscle groups (p < 0.05); however 
there was no significant differences between any trials, for any of three muscle groups. (p > 
0.05). Median (Range) calf muscle pain data and Mean (SD) quadriceps and hamstrings 
data are presented in Table 8. 
Table 8: Baseline and 24 hours post exercise perceived muscle pain from visual analogue scales 
(median (range)) and algometry (mean ± SD, n = 13).  
Quads = Quadriceps, Hams = Hamstrings. 
a. Significant increase compared to baseline (p < 0.05) 
  Base CON EX REC EXREC 
Perceived Pain Questionnaire (/10) 
Calf 0 (0) 1 (0-4)a 1 (0-4)a 1 (0-6)a 1 (0-3)a 
Quads 0 (0) 1 (0-4)a 1 (0-4)a 2 (0-6)a 1 (0-2)a 
Hams 0 (0) 2 (0-5)a 1 (0-3)a 1 (0-5)a 1 (0-4)a 
Algometer Pain Rating (/10) 
Calf 0 (0-3) 2 (0-5)a 2 (0-4)a 2 (0-4)a 2 (0-4)a 
Quads 2.0 ± 1.2 3.9 ± 1.6a 3.2 ± 1.5a 3.8 ± 1.6a 3.4 ± 1.5a 
Hams 1.6 ± 1.4 3.2 ± 1.6a 2.0 ± 1.4a 2.5 ± 1.7a 2.2 ± 1.6a 
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5.4.4 Perceived Comfort of Garments 
Following each CG treatment participants rated the comfort, tightness and any pain caused 
by the garment during use. ANOVA testing revealed statistically significant differences 
between trials in perceived comfort (F2, 24 = 5.71, p = 0.009); while no differences were found 
for perception of tightness (F2, 24 = 1.84, p = 0.181). The mean (SD) results for perceived 
tightness for each trial were: EX 6.9 ± 1.1, REC 6.7 ± 1.3, and EXREC 7.1 ± 1.3 (Figure 11). 
A Friedman’s test showed no significant differences between conditions for induced pain (X22 
= 0.667, p = 0.717); the median (range) results for all trials was 0 (0-2). Post hoc analysis 
revealed a significant reduction in perceived comfort in the EXREC trial (6.8 ± 2.9) compared 
to EX (7.7 ± 2.3, p = 0.016) and REC (7.3 ± 2.5, p = 0.031) (Figure 11).  
 
Figure 11: Perceived comfort and tightness induced by compression garments (mean ± SD, n = 13).         
      * Significant difference when compared to EX and REC trials (p < 0.05). 
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5.5 Discussion 
The aims of this study were to: i) Assess the effect of knee high CGs on muscle oscillations, 
ii) assess the effect of wearing knee high compression garments on 10 km running 
performance, iii) determine whether a maximal 10 km time trial was sufficient to elicit 
physiological or perceptual decrement during recovery, and iv) examine the effects of 
different application times of knee high CGs on perceptual and physiological recovery. 
Overall, there was no effect of wearing CGs on performance when compared to a control. 
Similarly, there was no effect of CGs on muscle pain, muscle damage or inflammation 24 
hours post exercise. However, maximum displacement and average velocity of the calf 
muscle were reduced with CGs when running at 12km.h-1. 
5.5.1 Muscle Oscillation 
The aim of this test was to assess the effect of wearing knee high compression garments on 
the movement of the calf muscles. Studies to date have measured the velocity, displacement 
and frequency of muscle movements and refer to all of these as measurement of muscle 
oscillations. Therefore, it is unclear from the current literature what the key component, or 
components, of a muscle oscillation are in relation to exercise performance or recovery.  
This study measured the peak velocity, peak acceleration, average velocity and total 
displacement of the calf muscle during running at 12 km.h-1. The results showed no effect of 
wearing CGs on peak velocity or peak acceleration experienced by the calf muscle, when 
compared to a non-CG control. However, there was a decrease in total displacement and 
average downward velocity of the calf muscle with CG use compared to the control.  
5.5.1.1 Peak Velocity 
The peak velocity of the calf muscle in all observed cases was immediately after foot contact 
with the ground. The present study showed no significant difference in peak calf muscle 
velocity with CGs compared to control. This was refuted by Kraemer et al. (1998), who 
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examined the movement of the thigh musculature upon landing from repeated maximal 
jumps. They reported a decrease in muscle velocity with the use of CGs and it was 
suggested that the CGs reduced the velocity to almost zero. This study also showed greater 
power maintenance between jumps with the use of CGs; it was hypothesised that this was 
due to a reduction in sarcomere damage, caused by the reduction in muscle oscillations, or 
in this case a decrease in velocity (Kraemer et al., 1998). The contradictory results found 
between the current study and Kraemer et al. (1998) are most likely due to the differences in 
exercise modality and compression type. As the forces during landing from a jump are 
greater than those experienced during endurance running, it is possible that peak velocities 
were produced that were able to be attenuated using compression. It is also possible that 
the muscle groups of the thigh are more susceptible to velocity change, whether due to the 
size and mass of the muscle, the position on the skeleton or the phase of contraction upon 
landing. The current study cannot support the findings of Kraemer et al. (1998), as a 
mechanism by which knee high compression can benefit the calf muscles. There is a lack of 
research in this area and as such the role of muscle velocity during exercise remains 
unclear.  
5.5.1.2 Peak Acceleration 
The peak acceleration of the muscles measured in this study was always experienced during 
the first muscle oscillation after the foot made contact with the ground. There was no 
significant difference in acceleration of the calf muscle with or without compression. Only 
one previous study has measured the acceleration of muscles during oscillation; Bakken 
(2011) used accelerometers placed under compression shorts, to examine muscle 
oscillations during 90 minute running. However, they did not report the peak acceleration 
forces experienced, but instead reported the number of muscle movements in a set period. It 
was shown in that study that the number of muscle movements was decreased with the use 
of CGs. Bakken showed a trend towards reduced muscle damage in their study, however 
this result was non-significant. It is currently unknown whether the magnitude or frequency of 
 93 
 
the acceleration forces experience by the muscles during exercise is a cause, or even a key 
factor in muscle damage, performance or recovery. The current study did not support 
changes in acceleration as a mechanism of action for calf compression.  
5.5.1.4 Average Negative Velocity 
During each gait cycle two periods of negative net calf muscle displacement (towards the 
ankle) were observed; the average velocity during these two periods was calculated and 
compared. With the use of compression both periods of average negative velocity were 
decreased, although only the second period was decreased significantly. No previous 
research has assessed average muscle velocity during exercise. However, as the number of 
muscle movements per time period remained unchanged; it is concluded that the reductions 
in average muscle velocity were as a result of reduced muscle displacement. As such any 
benefits to exercise or recovery would be as a result of the reduced muscle displacement.  
5.5.1.4 Total Displacement  
There was a significant decrease in total displacement of the calf muscle during each gait 
cycle with the use of compression garments, compared to the control. This result was 
supported by all research to date that has measured muscle displacement (Bakken, 2011; 
Borras et al., 2011; Doan et al., 2003). However, the maximum displacement of the thigh 
muscles measured in these studies were caused by the force transferred through the 
muscles upon contact with the floor; in contrast the maximum displacement of the calf 
muscles found in the current study, was part of the natural movement of the muscle during 
the running gait, and was unaffected my ground contact. As a result the role of reduced calf 
muscle displacement during performance and recovery is still unclear. However, research 
suggests that a reduction in muscle displacement could both increase performance (Born et 
al., 2013) and decrease recovery time (Hill et al., 2013); the current evidence to support 
these mechanisms is discussed further in the relevant sections below. 
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5.5.2 Exercise Performance 
This study found no significant difference in 10 km run time with the use of CGs compared to 
control; therefore, the null hypothesis is accepted. This result supports the findings of several 
studies that found no difference in running performance with knee high CGs (Ali et al., 2011; 
Creasy, 2008; Varela–Sanz et al., 2011); and a review of the published literature, which 
concluded that CGs have little or no effect on performance (MacRae et al., 2011). However, 
a more recent literature review and meta-analysis showed a positive effect size (ES = 0.15) 
for performance during endurance exercise (Born et al., 2013). It is likely that these 
conflicting results are caused by a number of variables: Firstly, the current research 
examining endurance performance have used a range of different exercise protocols. For 
example, many studies that have shown benefits to endurance performance have used time 
to exhaustion protocols (Born et al., 2013; Goh at al., 2011; Higgins et al., 2009; Kemmler et 
al., 2009; Sear et al., 2010). It could be argued that TTE is not an ecologically valid 
measurement of performance, as there are no real sports or events that continue indefinitely 
until exhaustion; it is instead a measure of efficiency, economy and motivation of the athlete, 
and as such can be heavily influenced by the placebo effect. It has also been shown that 
TTE results are not as reliable as time trials with a fixed distance (Born et al., 2013). A 
second confounding variable is the type of compression garment used; many of the positive 
benefits to endurance exercise have been shown with full length tights or full body 
compression (Born et al., 2013; Goh at al., 2011; Higgins et al., 2009; Sear et al., 2010). It is 
likely that mechanisms such as reduced muscle oscillations, that are hypothesised to give 
more optimum muscle mechanics McComas et al., 1996) that could lead to increased 
movement economy (Born et al., 2013) and increased performance (Kraemer et al., 1997), 
would be more effective when applied to a larger muscle mass. While these variables make 
comparison between studies more difficult, there have been contradictory findings in studies 
with similar protocols using the same types of compression. Therefore, if is probable that the 
biggest influencing factor in performance results is the placebo effect (MacRae et al 2011). 
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This is supported by Born et al. (2013), who showed no differences in maximum oxygen 
uptake, blood lactate, HR, cardiac output or stroke volume; and therefore concluded that in 
the absence of physiological benefit the changes in performance were due to the placebo 
effect, caused by a lack of blinding of interventions. 
5.5.2.1 Heart Rate 
There was no significant difference in heart rate during exercise with the use of compression 
compared to the control; consequently the null hypothesis is accepted. These results support 
the findings of several studies that have found no difference in HR when using CGs (Ali et 
al., 2011; Creasy, 2008; Duffield et al., 2010; Goh et al., 2010). However, there is conflicting 
research that has shown a decreased HR with compression use (Ali et al., 2007; Dascombe 
et al., 2011; Varela–Sanz et al., 2011). The contradictory results found in Ali et al. (2007) can 
be explained by the use of untrained participants; however, the findings of Dascombe et al., 
and Varela-sanz et al. were shown in trained athletes. Varela-Sanz et al., showed reduced 
HR, but no differences in TTE or VO2 peak. This could imply a placebo effect was 
responsible for the HR reductions; However, RPE was not different between trails indicating 
the participants believed they were working equally hard in each trial. Dascombe et al (2011) 
showed benefits to blood flow, oxygen consumption and HR with CGs, but also showed no 
differences in maximal performance or TTE. It is clear from these results that any 
augmentation of the blood flow and reduction in HR were, not sufficient to affect 
performance; however, these results prompt further investigation to explain the mechanism 
behind the contradictory findings. Some clarity was achieved when MacRae et al. (2011) 
concluded that the literature up to that point (July, 2010) showed submaximal and maximal 
HR was unaffected by compression use; Likewise, Born et al. (2013) showed that CGs had 
no effect on any cardiac parameter during exercise including: heart rate, cardiac output, 
cardiac index or stroke volume.   
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Heart rate was recorded as a measure of exercise intensity and the efficiency of the athlete’s 
performance. The current study also recorded RPE as a measure of perceived intensity; as 
with HR, no significant difference was found in RPE during the 10 km running, with or 
without compression. These findings would suggest that knee high compression had no 
effect on physical effort (Laukkanen & Virtanen, 1998), efficiency, energy expenditure (Strath 
et al., 2000) or the perceived intensity of effort. These results support the findings from the 
previous section (Chapter 5.5.2) that increases found in performance in some studies were 
due to perceptual benefits caused by the placebo effect, and were not due to a physiological 
benefit.   
5.5.2.2 Blood Lactate 
This study found no difference in blood lactate during the 10 km run with CGs compared to 
the control, therefore the null hypothesis was accepted. This result is supported by other 
research that has shown the same blood lactate response exercise (Ali et al., 2010; Duffield 
et al., 2010; Scanlan et al., 2008; Sperlich et al., 2010). Despite some conflicting results in 
elderly athletes (Chatard et al., 2004) and during the first 60 minutes of recovery (Driller et 
al., 2013);  it has been concluded in recent reviews that CGs have no effect blood lactate 
levels during exercise (Born et al., 2013; MacRae et al., 2011). The current research 
supports these finding for recreationally trained athletes during maximal 10 km running.  
Blood lactate levels are caused by and are proportional to muscle hypoxia and acidosis 
(Lindinger et al., 2004; Robergs et al., 2004); as such lactate levels are affected by the level 
of exertion, economy of exercise, localised blood flow and oxygen supply to the muscle cells. 
Therefore, as with HR, the results from the current study do not support any mechanism of 
increased exercise efficiency, for example blood flow or muscle oscillations as a benefit of 
knee high CGs for trained individuals during exercise.  
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5.5.3 Recovery 
5.5.3.1 Muscle Soreness 
Perceived muscle pain was recorded with a visual analogue scale both with and without use 
of a pain algometer. Pain increased in the calf, hamstrings or quadriceps in all conditions 24 
hours post exercise; however there was no significant difference in 24 hours post-exercise 
pain in between trials. These results demonstrated that no application of compression 
(during, after or combined during and after exercise) had any effect on perceived muscle 
pain when compared to a control (no compression); therefore, the null hypothesis was 
accepted. While these results are supported by some research (French et al., 2008; 
Pruscino et al., 2013), the majority of studies examining post exercise muscle soreness have 
shown CGs to have an effect (Born et al., 2013; Hill et al., 2013; Jakeman et al., 2010; 
Kraemer et al., 2001; Perry et al., 2008). It has been suggested that CGs are able to reduce 
exercise induced muscle damage and consequently muscle pain (Kraemer et al., 1997); by 
reducing muscle oscillations and optimising the of muscle mechanics, for example increased 
cross bridge overlap (McComas et al., 1996). However, there is insufficient evidence to 
support these mechanisms and therefore they remain speculation. Additionally, as this study 
found no difference in muscle damage, there was no physiological reason why CGs would 
have lowered muscle pain. As discussed in Chapter 2, a limitation to the current research 
into CGs is that participants are not blinded to the intervention and may have preconceived 
expectations of what CGs will do; therefore, this study supports suggestions that the findings 
of reduced perception of pain in the current research may predominately be due to the 
placebo effect (MacRae et al., 2011).  
5.5.3.2 Exercise Induced Muscle Damage and Inflammation 
There were no significant differences in CK, CRP or Calf girth measurements post exercise 
in any trials. These results would suggest that the maximal 10km run used in this study was 
insufficient to elicit significant muscle damage or inflammation, in a recreationally competitive 
 98 
 
population. These results are supported by previous research that has shown CGs to have 
no effect on creatine kinase, in trained individuals (Ali et al., 2010; Bakken, 2011; Duffield et 
al., 2010; Pruscino et al., 2013). It is suggested that trained individuals gain adaptations to 
training that protect the muscles from repeat damage; therefore physiological responses to 
exercise, such as muscle damage and inflammation, would be expected to be reduced when 
compared to untrained individuals (French et al., 2008). However, as was shown in previous 
research (chapter 2), the CK and CRP data collected during this study suffered from high 
inter test variance (Brancaccio et al., 2007). This variance in the data could cause a result to 
be not statistically different, despite the presence of localised muscle damage (Creasy, 
2008). The significant increase in perceived muscle soreness demonstrated in this study 
could support this idea, as the major cause of muscle soreness post exercise is believed to 
be muscle damage and the associated inflammatory response (Clarkson & Hubal, 2002). 
However, in the absence of muscle damage or inflammation marker increases, this result is 
inconclusive. 
 Some research, in contrast to the findings of the current study, has shown a reduction in CK 
and CRP, with CGs. However, these studies use eccentric loading protocols (Borras et al., 
2011; Davies et al, 2009; Kraemer et al., 2001), unfamiliar exercise (Duffield et al., 2007) or 
heavy contact sport (Gill et al, 2005). Indeed, a recent meta-analysis found that wearing CGs 
reduced CK levels (Hill et al., 2013). Of the seven studies analysed, three suggested that 
CGs had a positive effect; all three of those studies used eccentric exercise protocols. It is 
probably that unfamiliar and eccentric protocols will elicit greater muscle damage (French 
2008); consequently, these results are irrelevant to endurance exercise and generalisation of 
results from one exercise modality to another is not valid. Additionally, all research 
demonstrating positive results for CK or muscle damage have used full length tight or full 
body compression (Davies et al, 2009; Duffield et al., 2007;  Gill et al, 2005; Hill et al., 2013); 
no studies were identified that have demonstrated reduced CK or muscle damage with knee 
high CG use.  
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A suggested mechanism by which CGs may reduce muscle damage, inflammation and 
consequently recovery time after endurance exercise, is by reduced muscle oscillations 
(Bakken, 2011; Borras et al., 2011; Doan et al., 2003). Findings from the current study 
support reductions in muscle displacement during running; however, as the 10 km protocol 
used was insufficient to induce a significant increase in muscle damage or inflammatory 
markers, the current findings cannot support this mechanism in trained individuals using 
knee high compression. 
To further assess whether knee high CGs are able to attenuate muscle damage and 
inflammation in trained athletes during ecologically valid exercise protocols, longer duration 
races for example marathons or ultra-marathons (Benigni et al., 2001) could be used. 
Additionally, more specific and sensitive methods of muscle damage and inflammation 
measurement could be used for example muscle biopsies (Borras et al., 2011) or MRI 
(Clarkson & Hubal, 2002).  
5.6 Conclusion 
The peak velocity and peak acceleration of the calf muscle when running at 12 km.h-1 were 
unchanged with the use of compression, whereas total displacement of the calf muscle was 
reduced. This increased stabilisation of the muscle has been hypothesised to increase 
running economy, decrease muscle damage and increase recovery. However, these 
mechanisms are speculative as there is insufficient evidence to support them. The current 
study found that compression use had no effect on 10 km performance, heart rate, RPE or 
blood lactate concentration during exercise. When considered together with other research 
findings, these results suggest that any performance improvements in trained individuals 
undertaking familiar exercise, wearing knee high compression are likely to be due to a 
placebo effect. The 10 km protocol was sufficient to induce significant increases in perceived 
muscle pain in all trials; however, there were no differences between the trials; proving that 
CGs were ineffective. Therefore, reductions in perceived muscle pain in previous studies are 
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also likely due to the placebo effect. There was no difference in muscle damage or 
inflammation after the 10 km time trials; participant familiarisation with the exercise and high 
variation in the data likely contributed to the lack of significant change. No studies were 
identified that showed reductions in CK or CRP with the use of knee high compression. It is 
likely that CGs compressing a larger muscle mass could have a greater effect to some 
variables of performance and recovery; therefore, results from such garments should not be 
generalised to knee high CGs. 
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Chapter 6- The effect of combined knee high compression 
and ice therapy on recovery after eccentric exercise 
6.1 Introduction 
There are many different recovery strategies used after exercise to allow the participant to 
perform again in the minimum time possible. These strategies include fluid and carbohydrate 
replacement (Burke, Kiens & Ivy, 2004), stretching (Cheung et al., 2003), contrast bathing 
(Gill et al., 2006), cold water therapy (Bleakley et al., 2006) and compression garments 
(Montgomery et al., 2008b). Recently ice therapy and compression garments have become 
increasing popular (Montgomery et al., 2008b). Compression garments have been shown to 
improve the recovery of strength and power (Hill et al., 2013), reduce muscle pain (Chatard 
& Atlaoui, 2004) and reduce muscle damage post exercise (Davies et al., 2009). Likewise it 
has been shown that ice can increase recovery, decrease muscle pain (Swenson, sward, 
Karlson, 1996) and decrease muscle damage (Bailey et al., 2007). Both Ice and CGs have 
also been shown to provide improvements in perceptual markers of recovery (French et al., 
2008). These perceptual benefits have in certain cases been sufficient to improve repeat 
performance independent of any physiological changes (Hill et al., 2013; Pruscino et al., 
2013).  However despite these findings and the wide use of these strategies, there are many 
conflicting results that make the evidence for their use equivocal (Bleakley et al., 2010; 
MacRae et al., 2011).  
Rest, ice, compression and elevation (RICE) are routinely used as a combined treatment for 
sports injuries such as strains and sprains (Clanton and Coupe, 1998). Sloan et al. (1989), 
examined the combination of ice therapy and compression as a means of increasing 
recovery post exercise. They used 30 mmHg of compression and a temperature of 15-20°C, 
for 20 minutes, and suggested this combination may elicit a greater benefit to recovery than 
either intervention alone. Despite this, there is a lack of understanding about the collective 
effects of these treatments on muscle damage and recovery post exercise (Trenell 2007). 
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This is possibly due to a lack of available methods by which an athlete could administer 
combined therapies without improvising such as completing an ice bath treatment while 
wearing CGs.  Furthermore there are logistical limitations to combining treatments in the 
field; while compression treatments are easily transported and used immediately following 
training and competitions, ice therapies are often limited to use at home or at a training 
centre; due to the difficulties with storing and transporting ice to an event. In response to 
these limitations,110% Play Harder have developed a portable system for applying 
combined compression and ice therapy immediately post exercise in the field or at any other 
time as required by the athlete. This study examined the use of this portable compression 
and ice therapy system after exercise. 
6.1.1 Exercise Protocol 
In the previous study (chapter 5), the maximal 10 km time trial did not cause significant 
increases in blood CK levels. Eccentric exercise has been shown to cause more muscle 
damage and perceived muscle soreness than exercises using concentric or isometric 
movements (Cheung et al., 2003; Clarkson & Hubai, 2002); therefore an eccentric protocol 
was utilised in this study. However, as discussed previously (Chapter 2.8.1) a limitation of 
serum CK, as a means of measuring muscle damage, is that it is impossible to distinguish 
which muscle groups are damaged and contributing to the CK levels, or to ascertain the 
magnitude to which a specific muscle group is damaged (Jones et al., 1985). As the CGs 
used in this study were knee high and therefore would only apply compression to the 
musculature of the lower leg, it was important to ensure that any muscle damage, or 
reductions in muscle damage, were measured in the treated muscle groups. Consequently, 
previously used protocols such as downhill walking (Boras et al., 2011) and squatting 
(French et al., 2008) could not be used, as the larger muscles of the upper leg would also be 
targeted (French et al., 2008); instead an eccentric exercise protocol was employed to target 
the musculature of the lower leg only. While such an eccentric protocol may not be 
considered ecologically valid for athletes participating in the majority of sports; it was used to 
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test the mechanisms by which perceptual and physiological recovery of the lower leg 
musculature could be improved. If benefits were found with this type of exercise it could 
indicate mechanism by which ecologically valid modes of exercise could be affected. 
 6.2 Aims and Hypotheses 
Aims:   
1. To assess the effect of compression garments and ice treatment on physiological 
and perceptual recovery after eccentric exercise  
2. To test various mechanisms by which CGs and ice are suggested to improve 
recovery and subsequent performance. 
Hypotheses: 
Hypothesis 1: Within 72 hours post-exercise, perceived recovery will be significantly 
increased when: i) CGs are worn for 12 hours post exercise and ii) CGs are worn for 12 
hours and ice therapy is administered immediately post-exercise; when compared to a 
control. 
Null Hypothesis 1: There will be no statistically significant difference in perceived recovery 
between any trials. Any differences will be due to chance alone. 
Hypothesis 2: Within 72 hours post-exercise, PMS  will be significantly increased when: i) 
CGs are worn for 12 hours post exercise and ii) CGs are worn for 12 hours and ice therapy 
is administered immediately post-exercise; when compared to a control. 
Null Hypothesis 2: There will be no statistically significant difference in PMS between any 
trials. Any differences will be due to chance alone. 
Hypothesis 3: 48 hours post-exercise, blood CK levels will be significantly increased when: 
i) CGs are worn for 12 hours post exercise and ii) CGs are worn for 12 hours and ice therapy 
is administered immediately post-exercise; when compared to a control. 
Null Hypothesis 3: There will be no statistically significant difference in blood CK levels 
between any trials. Any differences will be due to chance alone. 
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Hypothesis 4: 48 hours post-exercise, 1 km time trial performance will be significantly 
increased when: i) CGs are worn for 12 hours post exercise and ii) CGs are worn for 12 
hours and ice therapy is administered immediately post-exercise; when compared to a 
control. 
Null Hypothesis 4: There will be no statistically significant difference in 1 km time trial 
performance between any trials. Any differences will be due to chance alone.  
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6.3 Study Methods 
6.3.1 Participants 
Eleven healthy male volunteers agreed to participate in this study, with 9 completing all three 
trials (Age (median): 23 years (20-27 years), Height: 178.7 ± 5.3 cm, Mass: 78.2 ± 14.4 kg, 
Body Fat: 16.2 ± 8.4%). Figure 12 shows participant recruitment and attrition for this chapter. 
 
 
 
 
 
Figure 12: A schematic of participant recruitment and attrition  
6.3.1.1 Inclusion Criteria  
The participants used in this study were: Healthy males, aged 18-50, undertook a minimum 
of two exercise sessions per week, for 30 mins or more and were able to complete a 
maximal 1 km run. 
6.3.1.2 Exclusion Criteria  
The excluded criteria for this study were: Participants below 18 or above 50 years of age, 
any illness, medical issues or injuries preventing completion of the exercise protocols, any 
medication use that makes exercise inadvisable, any issues relating to blood taking or an 
unwillingness to complete the require protocols.  
6.3.2 Study Design 
This study was a randomised cross-over design, in which each participant completed three 
exercise trials: 1) eccentric muscle damage followed by recovery with no intervention (CON), 
Completed Study  
(n=9) 
Preliminary Testing/ Familiarisation  
(n=11) 
Withdrawn (n=1)  
Time commitments 
Withdrawn (n=1)  
Illness 
Trial 1 
(n=10) 
 106 
 
2) eccentric muscle damage followed by 12 hours wearing graded compression (COMP), 3) 
eccentric muscle damage followed by 12 hours wearing graded compression and surface 
icing for 20 minutes post exercise (ICE)  . 
6.3.3 Preliminary Testing 
Baseline measurements were recorded including height, mass and body fat percentage 
(chapter 4). Following a self-paced five minute warm up, participants then completed a 1km 
time trial on a treadmill, starting from stationary. During the run, participants were able to see 
distance covered, but they were not able to see speed or performance time. The participants 
were free to adjust speed according to how they felt. An encouragement schedule was used 
to ensure motivation was consistent between trials and participants (Appendix 15). 
6.3.4 Main Trial Proceedure  
Each trial consisted of four consecutive days; the first day was the eccentric exercise day 
followed by three days (up to 72 hours post exercise) of recovery measurements. Recovery 
was monitored for 72 hours post exercise, as this has been shown to be the time period 
during which peak muscle soreness (Nosaka et al., 2008) and CK Levels (Peterson et al., 
2001) occur. Where possible the start of day 1 of each trial was at the same time, on the 
same day of the week. The procedure during each trial was as follows:  
On day one participants arrived at the laboratory (H260, College Lane, University of 
Hertfordshire) and completed a 24 hour exercise log (Appendix 16), 24 hour food diary 
(Appendix 17) and health screen (Appendix 13). Participant height and weight were 
recorded. The participant was then asked to rest for a minimum of five minutes, during which 
time they were asked to fill out the first section of the recovery questionnaire (Appendix 18); 
including, perceived muscle pain, perceived maximum ability, feeling scale rating and felt 
arousal level (Creasy, 2008; Pruscino et al., 2013). Baseline calf circumference, PMS 
(algometry) and CK samples were then collected. The pain algometer was applied to the 
Tibialis anterior, lateral and medial heads of the gastrocnemius as in chapter 4, this ensured 
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that both heads of the gastrocnemius and the soleus were targeted with the algometer. The 
participant then completed a lower body eccentric exercise protocol, focusing on the 
gastrocnemius and soleus muscles.  
The protocol consisted of a five minute warm up of skipping, participants unable to skip with 
a rope were asked to complete the movement without one. Participants then completed two 
minutes of walking on the treadmill at 5.5 km.h-1. A 1 km time trial was then completed 
following the same protocol as the baseline run. After a break of three minutes the 
participants then completed the eccentric exercise protocol. This started with straight leg calf 
raises. Fifteen repetitions were completed on the right leg immediately followed by fifteen 
repetitions on the left leg, this constituted one set. This exercise was continued for 3 sets 
after which the participant was allowed a 2 minute break. Following the break the same 
protocol was completed with bent leg calf raises. The bent leg raises aimed to target the 
soleus muscle. Participants were show an image (Appendix 19) of the degree of leg bend 
required to ensure consistency. The straight and bent leg calf raises were conducted in time 
with a metronome (Qwik Time, Quartz Metronome, Camarillo, USA) to ensure all repetitions 
had a 2 second concentric phase, a 3 second eccentric phase with a 1 second pause at the 
end of the eccentric phase. During the final repetition of the final set RPE was recorded. The 
eccentric portion of this exercise protocol took approximately 30 minutes to complete; this 
was designed to produce a similar workload to previous protocols that: used 30 minutes of 
downhill walking to induce significant muscle soreness (Trenell at al., 2007; Perry et al., 
2008) and reductions in maximal voluntary contraction (Perry et al., 2008), and 100 eccentric 
bicep contractions used to induce significant CK increases (Kraemer et al., 2001). Drinking 
water was allowed during the session; however, no energy drinks or supplements were 
allowed.  
After the exercise participants completing the CON trial were allowed to leave, participants 
completing the COMP trial were fitted with CGs and then allowed to leave and participants in 
the ICE trial were fitted with CGs and undertook an icing protocol before leaving. The ice 
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protocol consisted of inserting ice packs (110% Play Harder, Florider, USA) into the 
compression garments on both legs, with the black side facing the participant. The icing 
protocol was 30 minutes long in total; ice was applied for 10 minutes then removed and 
placed in an insulating bag for 10 minutes, then re-applied for a further 10 minutes. Skin 
temperature was monitored (1320 Type K, Tes, Taiwan) throughout the protocol. The 
thermometer was placed with the sensor located over the belly of the calf musculature, in 
direct contact with the skin; this was secured using hypo-allergenic tape and the pressure of 
the compression garment to ensure there was no movement during the measurement. 
Participants remained in the seated position, with legs uncrossed and feet flat on the floor, 
throughout the ice protocol. Shoes were worn throughout the procedure. Temperature was 
recorded every 5 minutes; the protocol was discontinued if the surface temperature dropped 
below 10°C. During both COMP and ICE participants wore the CGs for 12-hours before 
removing (Gill et al., 2005; French et al., 2008). 
On day two, 24 hours post exercise participants filled out section two of the recovery 
questionnaire. On day three, 48 hours post eccentric exercise participants returned to the 
laboratory and filled out section three of the recovery questionnaire. Calf girth, PMS 
(Algometer) and CK were measured and they completed a maximal 1 km time trial under the 
same conditions as the previous runs. Participants were not informed of their performance 
times until all trials were completed. On day four, 72 hours post exercise participants filled in 
section four of the recovery questionnaire.  
Before each subsequent trial participants were emailed the food diaries that they completed 
for trial 1 (24 hours pre and 72 hours post exercise), and were asked to consume the same 
foods and drinks if possible.   
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6.4 Results 
6.4.1 Interventions 
Participants rated the perceived exertion of the last repetition of the calf exercise for each 
trial. Friedman’s testing showed there was no significant difference (X22 = 2.00, p = 0.368) in 
RPE between trials (Median (Range); CON: 19 (18-20), COMP: 19 (18-20), ICE: 19 (18-20)). 
During the ice intervention skin temperature was measured; the mean skin temperature after 
the 30 minute intervention was 11.9 ± 1.2°C. In all 9 cases skin temperature reduced to 
within the target 10-15°C range (Figure 13). 
 
 
Figure 13: Skin temperature measurement during icing protocol (mean ± SD, n = 9).  
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6.4.2 Repeat Performance 
One Kilometre run times were compared to a baseline run recorded when no strenuous 
exercise had been conducted. The means ± SD for each condition were: Baseline 3.82 ± 
0.49 mins, CON 3.94 ± 0.44 mins, COMP 4.05 ± 0.51, and ICE 3.89 ± 0.38 (Figure 14). A 
repeated measures ANOVA showed no significant difference between any trial for 1 km run 
time (F3, 24 = 1.75, p = 0.184).  
 
Figure 14: 1 km run time at baseline and 48 hours post calf exercise (CON, COMP & ICE). (mean ± 
SD, n = 9) (p > 0.05). 
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6.4.3 Muscle Damage and Inflammation 
Creatine Kinase was measure pre and 48 hours post eccentric exercise as a marker of 
muscle damage. Repeated measures ANOVAs showed no significant differences between 
any groups for CK (F2, 18 = 1.15, p = 0.34). Median (Range) pre and post exercise CK results 
for each condition are presented in Table 9. 
Table 9: Serum CK levels at baseline and 24 hours post calf exercise (Median (range), n = 9) (p > 
0.05).   
Trial 
Pre-CK Post-CK 
(U/L) (U/L) 
CON 151 (77-364) 232 (103-822) 
COMP 169 (63-394) 136 (83-1269) 
ICE 127 (61-181) 182 (83-1163) 
 
Calf girths were measured pre and 48 hours post eccentric exercise as a measure of local 
inflammation. The mean ± SD results for each condition were: CON 37.4 ± 2.9 cm & 37.6 ± 
2.9 cm, COMP 37.4 ± 2.9 & 37.6 ± 2.8, and ICE 27.2 ± 2.8 & 37.3 ± 2.6; pre and 48 hours 
post respectively (Figure 15). A repeated measure ANOVA revealed no significant 
differences in calf girth between any condition (F5, 40 = 2.32, p = 0.61). 
 
Figure 15: Pre and 48 hours post exercise calf girth (mean ± SD, n = 9) (p > 0.05).   
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6.4.4 Perceived Muscle Pain; Algometry 
Friedman’s testing revealed significant differences between conditions for perceived Tibialis 
anterior pain (X25 = 15.22, p = 0.009). Wilcoxon signed rank tests showed: Tibialis anterior 
pain was significantly increased after the eccentric muscle damage protocol when compared 
to the pre measure (p = 0.016), in the CON trial. Post ICE pain was significantly lower (p = 
0.031) when compared to post CON pain. There were no other significant differences, in 
Tibialis anterior pain, between groups (p > 0.05, Table 10). A repeated measures ANOVA 
also revealed significant differences in perceived calf pain between conditions (F5, 40 = 12.71, 
p = 0.001). Post hoc testing showed an increase (p = 0.012) in post exercise calf muscle 
soreness in CON when compared to baseline. There were no other significant differences 
between groups (p > 0.05, Table 10). 
Table 10: Pre and 48 hours post exercise algometry pain of the Tibialis anterior (Median (Range)) 
and Calf muscles (mean ± SD, n = 9). 
  CON COMP ICE 
Tibialis Anterior 
Pre 0 (0-5) 0 (0-2) 0 (0-4) 
Post 1 (0-6)a 1 (0-4) 0 (0-3)b 
Calf 
Pre 2.7 ± 1.7 2.4 ± 0.8 2.4 ± 1.5 
Post 5.4 ± 1.4c 4.9 ± 2.2 3.8 ± 1.8 
a. Significant difference when compared to Tibialis Anterior pre CON trial (p < 0.05)  
b. Significant difference when compared to post CON (p < 0.05) 
c. Significant difference when compared to Calf pre CON trial (p < 0.05) 
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6.4.5 Perceived Muscle Pain; Questionnaire 
Perceived muscle pain in the Tibialis anterior, Calf, Hamstrings and Quadriceps was 
measured using a questionnaire with visual analogue scales (0-10); at baseline, 24, 48 and 
72 hours post eccentric exercise. 
Tibialis Anterior 
Twenty four hours perceived pain of the Tibialis anterior, increased in all trials (CON: 1.3, 
COMP: 1.2, ICE: 0.5) compared to baseline (Table 11). Friedman’s testing revealed 
significance between groups (X211 = 30.2, p = 0.001). Wilcoxon post hoc testing showed that 
the increase in COMP was significant (p = 0.031) but not in CON (p > 0.05). However the 
coefficient of variation for these pain data were COMP: 106% compared to CON: 121% 
(Table 11). The increase in Tibialis anterior pain experience in ICE was also non-significant 
(p = 0.063). Perceived pain was significantly lower at 72 hours compared to 24 hours in both 
ICE and COMP (p = 0.031). In contrast the 72 hours CON pain rating was not significantly 
different to 24 hours (p = 0.188). 
Calf 
Friedman’s tests also showed significance between groups for perceived calf muscle pain 
(X211 = 58.5, p = 0.001). Wilcoxon signed rank tests revealed that: Pain was significantly 
increased in CON at 24 (p = 0.002), 48 (p = 0.002) and 72 hours (p = 0.004), compared to 
baseline (Table 11); however the 72 hours pain was significantly lower (p = 0.023) than the 
48 hours rating. Similarly for COMP, 24 (p = 0.004), 48 (p = 0.008) and 72 hours (p = 0.016) 
pain ratings were significantly increased. For ICE, 24 (p = 0.016) and 48 hours (p = 0.008) 
pain was significantly increased compared to baseline; however 72 hours pain was not 
significantly increased (p = 0.125), and was significantly lower than both the 24 (p = 0.016) 
and 48 hours (p = 0.008) ratings. ICE pain ratings were significantly lower than CON at all 
time points (24: p = 0.016, 48: p = 0.023, 72 hours: p = 0.016). There was also a trend at all 
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time points for lower pain in COMP compared to CON, however this was not significant (24: 
p = 0.068, 48: p = 0.076, 72 hours: p = 0.156) (Table 6). 
Hamstrings and Quadriceps 
Friedman’s analysis was carried out on the perceived pain data for the Hamstrings and 
Quadriceps; There were no significant differences in perceived muscle pain for either muscle 
group, between any trials or time points (Hamstrings: X211 = 11.92, p = 0.37; Quadriceps X211 
= 15.2, p = 0.27) (Table 11). 
Table 11: Perceived muscle pain from visual analogue scale (median (range), n = 9) 
Trial Baseline 24 Hours 48 Hours 72 Hours 
Tibialis Anterior 
CON 0 (0-1) 1 (0-5) 1 (0-6) 0 (0-5) 
COMP 0 (0-1) 1 (0-4)a 0 (0-4) 0 (0-1)b 
ICE 0 (0-1) 1 (0-1) 0 (0-1) 0 (0)b 
Calf 
CON 0 (0-0) 5 (1-7)a 6 (1-9)a 3 (0-7)a,c 
COMP 0 (0-0) 2 (0-6)a 2 (0-6)a 3 (0-4)a 
ICE 0 (0-1) 2 (0-6)a,d 1 (1-7)a,d 1 (0-5)b,c,d 
Hamstrings 
CON 0 (0-2) 0 (0-3) 0 (0-4) 0 (0-2) 
COMP 0 (0-4) 0 (0-5) 0 (0-5) 0 (0-2) 
ICE 0 (0-3) 0 (0-6) 0 (0-5) 0 (0-2) 
Quadriceps 
CON 0 (0) 1 (0-4) 1 (0-5) 0 (0-3) 
COMP 0 (0) 0 (0-3) 0 (0-4) 0 (0-2) 
ICE 0 (0-1) 1 (0-4) 0 (0-1) 0 (0-1) 
a. Significant increase compared to baseline (p < 0.05) 
b. Significant reduction compared to 24 hours result (p < 0.05) 
c. Significantly reduction compared to 48 hours result (p < 0.05) 
d. Significantly lower compared CON trial at same time point (p < 0.05) 
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6.4.6 Perceptual Measures of Recovery 
Perceptual measures of recovery were taken at baseline, 24, 48 and 72 hours, using a 
recovery questionnaire with visual analogue scales (0-10).  
Perceived Maximum Ability 
A Friedman’s test showed significant differences between conditions for perceived maximum 
ability (X211 = 37.74, p = 0.001). Post hoc testing revealed that: In all trials perceived 
maximum ability was reduced at 24 hours (CON: p = 0.008, COMP: p = 0.047, ICE: p = 
0.047; Table 12). In CON 48 hours perceived ability was also significantly reduced (p = 
0.016) compared to baseline; however, 72 hours ability was significantly increased when 
compared to 24 (p = 0.037) and 48 hours (p = 0.039). Likewise in ICE, 72 hours ability was 
significantly increased compared to 24 (p = 0.016) and 48 hours (p = 0.016). In the COMP 
trial perceived ability increased significantly at 48 (p = 0.016) and 72 hours (p = 0.047) 
compared to 24 hours. The 48 hours rating was also significantly higher in COMP compared 
to CON (p = 0.012); there were also non-significant trends at 24 (p = 0.055) and 72 hours (p 
= 0.09) for COMP ability to be higher than CON. Likewise, there were non-significant trends 
at 24 (p = 0.055) and 48 hours (p = 0.063) for ICE ability to be higher than CON (Table 12).  
Perceived Recovery 
Significant differences were revealed between groups for perceived recovery during 
Friedman testing (X211 = 42.98, p = 0.001). Wilcoxon signed rank tests showed perceived 
recovery in CON was significantly lower at all time points (24, 48 & 72 hours: p = 0.008) 
compared to baseline; however, the 72 hours rating of recovery was significantly increased 
(p = 0.016) compared to 48 hours.  COMP recovery at 24 hours was significantly lower than 
baseline (p = 0.004); but then significantly improved by 72 hours (p = 0.008). There was a 
non significant trend at 48 hours for COMP to be more recovered than CON (p = 0.068). 
Both 24 (p = 0.004) and 48 hours (p = 0.008) ICE ratings were significantly lower than 
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baseline. 72 hours ICE perceived recovery was significantly improved compared to 24 (p = 
0.027) and 48 hours (p = 0.043); and there was also a trend for 72 hours ICE to be greater 
than 72 hours CON (p = 0.078), however this trend was non-significant. Conversely, 48 
hours ICE was significantly increased (p = 0.016) when compared to CON (Table 12). 
Sleep and Feeling scale  
Friedman’s tests revealed no statistical differences between any trials or time points for 
sleep (X211 = 5.75, p = 0.89) or feeling scale ratings (X211 = 14.12, p = 0.227) (Table 12). 
Felt arousal 
Friedman’s testing showed significant differences between groups for felt arousal (X211 = 
20.17, p = 0.43). Wilcoxon signed rank testing revealed that: Felt arousal in ICE was 
significantly increased at 72 hours compared to baseline (p = 0.031); there was also a non 
significant trend for increased arousal at 72 hours in COMP compared to baseline (p = 
0.063). 72 hours arousal in COMP was significantly higher (p = 0.047) than CON; there was 
a trend for 72 hours arousal to also be higher in ICE than CON (p = 0.063), however this 
was not significant (Table 12). 
Perceptions of Interventions 
Compression garment comfort was rated by each participant after use (COMP, 7.1 ± 2.4; 
ICE, 7.2 ± 2.0). A paired t-test revealed there was no significant difference in CG comfort 
between trials (t8 = 0.263, p = 0.799).  Participants also rated how effective they felt the ice 
protocol had been in aiding recovery and reducing muscle pain, at 24 hours post exercise; 
the mean rating out of 10 was 8.3 ± 1.2. 
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Table 12: Perceived maximum performance, sleep, recovery, feeling scale and felt arousal (median 
(range), n = 9)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a. Significantly lower than at baseline (p < 0.05). 
b. Significantly higher than 24 hours (p < 0.05). 
c. Significantly higher than 48 hours (p < 0.05). 
d. Significantly higher than 48 hours CON (p < 0.05). 
e. Significantly higher than at 72 hours CON (p < 0.05). 
 
 
 
 
 
  
Trial Baseline 24 Hours 48 Hours 72 Hours 
Perceived Maximum Performance Ability 
CON 90 (80-100) 70 (50-90)a 60 (30-100)a 80 (40-100)b,c 
COMP 90 (70-100) 80(60-90)a 90 (70-100)b,d 100 (70-100)b 
ICE 90 (80-100) 80 (60-90)a 80 (60-90)  90 (70-100)b,c 
Sleep 
CON 8 (4-10) 8 (4-10) 9 (3-10) 8 (6-10) 
COMP 9 (4-10) 9 (4-10) 9 (5-10) 8 (6-10) 
ICE 8 (5-10) 8 (4-10) 8 (5-10) 9 (6-10) 
Perceived Recovery 
CON 10 (7-10) 5 (1-9)a 5 (1-10)a 7 (2-10)a,c 
COMP 10 (7-10) 7 (0-10)a 9 (0-10) 8 (6-10)b 
ICE 10 (7-10) 7 (2-10)a 7 (4-10)a,d 8 (6-10)b,c 
Feeling Scale 
CON 3 (-1-5) 3 (-2-5) 3 (-3-4) 3 (1-5) 
COMP 3 (0-5) 3 (2-4) 4 (2-4) 4 (2-5) 
ICE 2 (1-5) 3 (1-4) 3 (1-4) 4 (2-5) 
Felt Arousal 
CON 4 (2-5) 4 (3-5) 4 (1-6) 4 (3-5) 
COMP 4 (2-6) 4 (3-6) 5 (2-6) 5 (4-6)e 
ICE 4 (2-6) 4 (3-5) 4 (3-5) 4 (4-6)a 
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6.5 Discussion 
The aims of this study were: to assess the effect of compression garments and ice treatment 
on perceptual and physiological measures of recovery, and to test various mechanisms by 
which CGs and ice are suggested to improve recovery and subsequent performance. This 
study found significant reductions in perceived pain in the ICE trial compared to the control. 
There were also increases in perceived recovery and perceived maximum performance 
ability at certain time points in the COMP and ICE trials. However, there were no significant 
differences in running performance, muscle damage or calf girths 48-hours after eccentric 
exercise compared to baseline. 
6.5.1 Perceptual Measures of Recovery 
Perceived maximum ability was significantly lower in all trials 24-hours post exercise 
compared to baseline. The COMP trial recovered by 48 hours; while after both CON and ICE 
it took 72 hours for perceived maximum ability to increase significantly from the 24 hours 
result. After 48 hours perceived ability was significantly higher in the COMP trial compared to 
CON. Furthermore, perceived maximum ability 72 hours post exercise in CON was still 
significantly lower than baseline, but this was not the case after COMP or ICE.  
Perceived recovery was significantly less in all trials 24 hours after the eccentric exercise 
when compared to baseline. At 48 hours post exercise the ICE trial participants perceived 
themselves to be significantly more recovered than after the CON trial; the COMP trial 
showed a trend towards this result. Felt arousal was also significantly lower at 72 hours in 
the CON trial when compared to the COMP trial.  
These results suggest that CGs and ice treatments during recovery can give an increased 
perception of recovery and maximum ability. However, these results are limited to certain 
time points within certain trials and the results for perceived recovery and perceived 
maximum ability do not seem to support one another. MacRae et al. (2011) suggested that 
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the subjective nature of perceived variables and high inter-subject variance make reliable 
findings difficult to achieve; despite this, they concluded that the overall effect of CGs on 
perceptual ratings of recovery tended to be better or at least no worse. Kraemer et al. (2010) 
showed increases in some psychological measures of recovery with the use of full body 
compression. However these benefits were accompanied by improvements to some 
physiological variables and performance measures; the results of the current study showed 
improvements in perceptual measures and not in any physiological or biological variables. 
Similarly, Pruscino et al. (2013), found psychological benefits of CG use to recovery with no 
physiological effects. It has been proposed that reduced voluntary muscle activation may 
contribute to the reduced muscle strength seen after eccentric exercise even when muscle 
damage is not present (Hill et al., 2013). Hill et al., (2013) went on to suggest that 
interventions such as CGs may increase recovery in two ways: Firstly, they may attenuate 
the physiological effect of the exercise; secondly, they may increase restoration of central 
factors that may result in increased voluntary activation, irrespective of physical changes. 
This is supported by the findings of Duffield et al. (2007), who found that an increased 
feeling of vitality was concurrent with increases in repeat performance, in the intervention 
trials. Likewise the current study observed increases in felt arousal in the treatment 
conditions but not in the control; which correspond to other increases in perceptual variables. 
Results from previous studies and reviews suggest that perceived variables of recovery are 
affected by the lack of blinding of interventions and participant expectations of results; 
causing perceptual results to be affected by the placebo effect. Kraemer et al. (1998) 
compared the use of two compression garments to a loose fitting gym short; they asked 
participants to rate the perceived benefit of each intervention, and found that increases in 
repeated jump performance, matched the expected benefit as rated by the participant. Any 
benefit to recovery or repeat performance, whether caused by a placebo effect or otherwise, 
is nonetheless a benefit (MacRae et al., 2011). However, if the only benefits of CGs are due 
to the placebo effect, then there is no need for graduated compression, zoning, development 
of new weave types and materials, or the production of garments that can cost in excess of 
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£150; as these benefits could be delivered by any tight fitting garments. Furthermore if, as 
was shown in this study, the improvements to perceptual variables do not cause improved 
repeat performance, then this is of no benefit to the athlete. 
6.5.2 Muscle Soreness 
The algometry pain rating for the Tibialis anterior was significantly higher 48 hours after the 
eccentric exercise when compared to baseline, in the control group; however, there was no 
significant increase in pain in the COMP or ICE trials. The 48-hours post exercise pain rating 
was also significantly lower in the ICE trial than in CON. Perceived soreness in the Tibialis 
anterior, as rated in the questionnaire, significantly decreased by 72 hours in both the COMP 
and ICE trials. However, at 72 hours pain remained elevated in the control group. In the calf, 
algometry pain at 48 hours was significantly increased in the control trial but not in the 
COMP and ICE trials. In the questionnaire calf pain was significantly increased at all-time 
points when compared to baseline, except the 72 hours ICE result; the ICE trials pain ratings 
were also significantly lower than the control at all-time points except baseline. The COMP 
group showed a non-significant trend towards reduced perceived pain at all-time points 
except baseline when compared to the control.  
These results show that the use of CGs and compression plus ice gave reductions in pain 
perception compared to the control (no intervention). This result is supported by many of the 
previous studies that have examined CGs effect on pain (Born et al., 2013; Hill et al., 2013; 
Jakeman et al., 2010; Kraemer et al., 2001; Perry et al., 2008). Many studies that have 
examined the effect of ice on post exercise muscle pain have also found beneficial results 
(Easton and Peters, 1999; Lane and Wenger, 2004; Rowsell et al., 2009). The use of ice has 
been shown to reduce nerve conduction which is suggested to explain the reduced muscle 
soreness found in many studies (MacAuley, 2001). However, in the current study reductions 
in muscle soreness were present for up to 72 hours when compared to the control. As the 
ice therapy was only administered on day 1, immediately post exercise, it is unlikely that 
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nerve conduction could be the mechanism by which pain was affected over such a long time 
period, without repeat ice treatments. Additionally pain reductions were experienced in the 
COMP group who would not have benefitted from a reduction in nerve conduction. Therefore 
it is unlikely that nerve conduction is the mechanism by which these pain reductions were 
achieved.  
The current study found no difference in muscle damage or inflammation 48-hours post 
exercise, which would suggest there was no physiological cause for the reduced muscle 
pain. Previous research has suggested that there is a psychological effect of CGs on 
recovery and performance often independent of blood or other physiological markers that 
indicated any effect (Pruscino et al., 2013). MacRae et al. (2011), suggested that reduced 
perception of pain seen after wearing CGs is likely to be due to the placebo effect. Likewise, 
in a study looking at ice therapy; a group that received 20 minutes of cryotherapy perceived 
significantly less pain 48 hours after the exercise, when compared to a control. However 
there was no difference found in any other variable including: blood CK levels, maximum 
isometric torque or hamstring length (Oakley et al., 2013). Furthermore, Leader et al. (2012) 
conducted a meta-analysis that showed ice was effective at reducing DOMS; however, the 
effects of ice on recovery of muscle function were inconclusive. It has been suggested in 
recent research that ice may delay markers of post exercise fatigue; for example muscle 
damage, inflammation and  decreased muscle activity, rather than reducing them (Tseng et 
al., 2013). It is unlikely that this is the case in the current study, with combined CGs and ice, 
as the data showed that muscle soreness peaked in all groups at 48 hours irrespective of 
the intervention received; with reductions in the peak muscle pain in the COMP and ICE 
trials when compared to CON.  This would suggest that the reductions in perceived pain 
were caused by a dampening of physiological or perceptual responses to exercise rather 
than a delay in those responses. 
Both CGs and ice have been shown to have beneficial effects on pain perception; however 
as these effects are often shown independent of a physiological benefit, it is most likely that 
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these perceptual benefits are the result of the placebo effect. It currently remains unclear 
whether the perceptual benefits of knee high compression and ice are sufficient to cause an 
improvement in recovery. Further research is required to explore the effect of CGs and ice 
on long term adaptations, as presently the positive psychological effects of these treatments 
are not sufficient to justify their use, especially if they may have negative effects on training 
adaptations and future performance. 
6.5.3 Repeat Performance  
No significant difference was found in any trial for 1 km run time 24 hours after the eccentric 
exercise, when compared to baseline. These results may indicate that the exercise was not 
sufficient to induce enough fatigue to hinder performance. However, the average RPE for the 
eccentric calf exercise was over 19, which implies it was close to maximal and eccentric 
exercise has been shown to be the most effective form of exercise to decrease muscle 
function (Carling et al., 1995; Kraemer et al., 2001) and increase muscle soreness (Davies et 
al., 2009). The participants in the current study also reported increases in muscle soreness 
and reductions in perceived ability, which would imply the exercise was fatiguing, however 
this was not sufficient to impact the subsequent running performance.  It is possibly that as 
the calf musculature is not greatly involved in the major movements of the legs during 
running, for example flexion and extension of the hips and knee, athletes are able to ignore 
any discomfort in the calf caused by the eccentric exercise. Therefore, it may be concluded 
that fatigue of the calf muscles alone is not sufficient to significantly affect performance of 
dynamic movements involving the whole body or lower body. If this study had employed 
performance testing specific to the calf musculature at 48 hours post eccentric exercise, for 
example maximal voluntary contractions (Perry et al., 2008), there may have been a 
significant reduction in performance, caused either by reduced motivation (Hill et al., 2013) 
or structural damage to the muscle fibres (Clarkson and Hubal, 2002). 
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Previous studies that have observed significant differences in repeat performance have used 
protocols that have fatigued the larger muscle groups in the legs, for example: two 30 minute 
maximal cycling bouts (Driller et al., 2013), maximum repeated jump performance (Jakeman 
et al., 2010), rugby match simulation including sprints and jumps (Gill et al., 2005) and 
repeated sprints and jumps (French et al., 2008). All of these studies also used full length 
compression tights, which compress the larger muscle groups of the lower body. However, 
despite this treatment affecting a larger muscle mass, some studies were still unable to show 
a statically difference to recovery compared to a control (French et al., 2008). Born et al. 
(2013) found a small positive effect of compression on recovery of strength and power tasks 
(ES = 0.10); such as peak leg power, maximal distance throwing and vertical jump height. 
Born and colleagues concluded that CGs provide a small improvement in recovery after 
muscle-damaging exercise protocols; and suggested this was due to enhanced lymphatic 
outflow, thus reducing post exercise muscle swelling and pain. Hill et al. (2013), found 
moderate reductions in decrement to strength and power and a reduction in CK, when 
compression was worn during or during and after intense exercise. However, there were no 
studies identified that have used exercise protocols or compression that only affect the calf 
musculature. Therefore, it is still unclear whether knee high compression garments are able 
to have a major effect on repeat exercise performance in most sports.  
6.5.4 Muscle Damage 
Creatine kinase was measured pre and 48-hours post eccentric exercise. There was no 
significantly difference in any trial after 48 hours compared to baseline, and there was no 
difference between groups at either time point. A significant rise in serum CK post exercise 
would be an indication that the exercise had caused an increase in muscle damage 
(Brancaccio et al., 2007). As a significant increase in CK was not found either; i) the 
eccentric exercise protocol did not induce muscle damage in the calf or ii) CK was not a 
sensitive enough measure to pick up the muscle damage that was present.  
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As suggested above, it may be that the eccentric protocol was not sufficient to induce 
significant muscle damage, this would be supported by the results that there was no 
decrement to run performance 48-hours post exercise. It is possible that the calf muscles are 
resilient to muscle damage due to the higher frequency of eccentric loading in normal 
movements, when compared to the muscles of the upper leg.  However, the average RPE 
was greater than 19 during the calf exercise, indicating that the exercise was near maximal 
and eccentric exercise has been shown to be the most effective form of exercise at causing 
muscle damage (Cheung et al., 2003; Clarkson & Hubal, 2002; Clarkson & Tremblay, 1988; 
Friden et al., 1983; Nosaka & Clarkson, 1996). Furthermore as shown in the previous 
section there were significant increase in muscle pain, this suggest that some muscle 
damage was present. Therefore it may be that there was some localised muscle damage 
but, that damage was not able to be measured using CK. The CK data from the current 
study showed high inter and intra subject variance similar to the results shown in previous 
studies (Creasy, 2008). This high variance together with the small size of the muscle area 
affected by the exercise may have made a significant serum CK result impossible, even if 
muscle damage was present. The current research that have shown CGs to have an effect 
on CK have used protocols that engage all major muscle groups of the legs; for example, 
maximal repeated jump performance (Jakeman et al., 2010), drop jumps (Davies et al., 
2009), sprints and jumps (Duffield et al., 2007; French et al., 2008; Gill et al., 2005) and 
whole body resistance training (Kraemer et al., 2010). No studies were found that have 
shown CK increases with calf exercise alone or that identified reduced CK with knee high 
CG use.  
It is possible that if a more muscle specific method of measuring muscle damage or muscle 
function was used, that any localised muscle damage to the calf could be measured. For 
example previous research has used maximal voluntary contraction (MVC) to measure 
muscle damage. Perry et al. (2008) conducted a study during which participants had one leg 
treated with CGs and the other acted as a control. Serum CK measurements were not used 
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as it would have been impossible to distinguish between legs.  Instead MVCs were used in 
each leg to compare muscle function to baseline. A more specific method of measuring 
localised muscle damage may have yielded more valid results; however, as repeat 
performance was unaffected, any muscle damage present was insufficient to affect recovery. 
Therefore it remains unclear whether reduced muscle damage is a mechanism by which 
knee CGs and ice therapy may improve recovery; although the results from this study may 
suggest it is unlikely.  
6.5.5 Inflammatory Response to Exercise 
There was no significant difference in calf girth 48-hours post-exercise in any group 
compared to baseline. As there was not a significant amount of muscle damage caused by 
the eccentric exercise, it would follow that there would not be a large inflammatory response. 
However, it is a possibility that the method used to measure inflammation was not sensitive 
enough. As discussed in chapter 2.8.2, although muscle girths are used in many studies 
(Driller et al., 2013: French et al., 2008) as a convenient measure of localised swelling, this 
measurement is not sensitive enough to identify inflammation on a cellular level. 
Furthermore, perhaps there was localised inflammation that this method was unable to 
measure. This was supported by the increase in post exercise muscle soreness seen in all 
trials suggested to be caused by ROS released by immune cells during the inflammatory 
response (Armstrong et al., 1984). However as CK was not significantly increased and 
repeat performance was unaffected, it would suggested that any localised inflammation that 
may have been present was not enough to affect recovery. 
It is also possible that the eccentric protocol was not sufficient to elicit a significant amount of 
inflammation in the calf muscles, because these muscles are more accustomed to eccentric 
movements, than the muscle of the upper leg, and therefore have adapted to make them 
more resilient to subsequent muscle damage and inflammation (French et al., 2008). The 
majority of studies looking at post exercise inflammation have used exercise protocols 
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affecting the thigh muscles; for example, downhill walking (Borras et al., 2011; Trenell et al., 
2006).  Only one study was identified that measured inflammation directly in the calves 
(Driller et al., 2013). This study measured thigh and calf muscle girths immediately post 
maximal cycling exercise and then again after a 60 minute recovery protocol. While the 
effect in the thigh musculature was far greater than in calf, both showed a decrease in girth 
after the 60 minute recovery with CGs. However, inflammation as a result of exercise 
induced muscle damage has been shown to peak between 24 and 48 hours post-exercise 
(Strachan et al., 1984). Therefore, it is likely that the differences in muscle girths measured 
in this study were due to a decrease in superficial blood pooling rather than inflammation 
caused by exercise induced muscle damage.  
It has also been suggested that CGs have no effect on muscle circumferences and that girth 
measurement does not correlate to muscle pain (MacRae et al., 2011). Therefore, the role of 
knee high compression and ice therapies in the reduction of inflammation remains unclear. 
To allow further exploration into this mechanism, a more sensitive method of inflammation 
measurement is required, to assess local cellular inflammation in the affected muscle, for 
example muscle biopsies (Clarkson and Hubal, 2002). 
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6.6 Conclusion 
The maximal eccentric exercise caused significant increases in perceived pain and 
reductions in perceived ability and recovery. However the exercise did not cause a 
significant increase in serum CK or inflammation markers; and despite increases in post 
exercise calf muscle pain, repeat performance was unaffected. Both CGs and compression 
with ice had positive effects on the perception of: pain, recovery and maximum ability post 
eccentric exercise. However, as these perceptual benefits were not accompanied by any 
physiological improvements, the placebo effect was most likely the cause. Furthermore, as 
the benefits to the perceptual responses to exercise did not affect repeat performance in the 
current study; it is still unclear whether these perceptual differences are of benefit to an 
athlete’s performance. Further research is required to examine the role of muscle damage 
and inflammation as mechanisms for increased recovery when using knee high CGs and ice 
as the current literature is equivocal regarding treatments affecting the lower leg.  
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Chapter 7: Discussion 
7.1 General Discussion 
The aims of these studies were: to explore the effect of different applications of knee high 
CGs on physiological, biomechanical and perceptual measures of athletic performance and 
recovery (chapter 5); and to examine the effect of knee high CG and ice therapy on recovery 
after eccentric damage of the calf (chapter 6). Chapter 5 showed a reduction in muscle 
displacement with CG use however no differences were found in performance. However, it 
was concluded that the 10 km time trial used was not sufficient to induce a measurable 
amount of muscle damage or inflammation, in the recreationally trained athletes used. 
Chapter 6 showed improvements in perceptual responses following eccentric exercise, with 
CGs and combined CG and ice treatment. However, the eccentric exercise did not elicit a 
physiological response and no differences were measured in repeat 1 km running 
performance. Therefore, the perceptual responses measured in chapter 6 were most likely 
elicited by the placebo effect. Therefore, the current studies were unable to support the use 
of CGs and ice for performance or recovery. 
7.1.1 Exercise Performance 
This study found no differences in 10 km performance time, heart rate, RPE or blood lactate 
concentration with CGs. It has been suggested that increased venous return and blood flow 
with CG use can reduce HR and increase metabolite removal (Creasy 2008); although 
because neither HR or blood lactate concentration were affected and performance time 
remained the same, the results of this study do not support increased blood flow as a benefit 
of knee high CGs during exercise, in trained individuals. This is possibly because the 
skeletal muscle pump surpasses any possible effect on blood flow provided by CGs 
(Bringard et al., 2006a). It has also been suggested that CGs can increase muscle 
oxygenation (Driller et al., 2013) or increase economy of oxygen use (Bringard et al., 2006b) 
during exercise. If CGs have an effect on oxygen usage, then hypoxia should be reduced 
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when compared to exercise of the same intensity without CGs. This study has shown that 
both exercise intensity (run time, HR and RPE) and hypoxia (lactate) remained constant with 
and without CGs. Therefore, this study found no evidence to support the mechanism of 
increased oxygen uptake; and this mechanism has now been largely discounted in recent 
research in trained individuals (Ali et al., 2010; Bernhardt et al., 2005; Born et al., 2013).  
Despite there being no performance improvement found in this study (chapter 5), results of 
the muscle oscillation test showed reduced muscular displacement. Perhaps it is possible 
that over a longer event for example a marathon or ultra-marathon this stabilisation of the 
muscle could increase running economy and potentially improve performance or reduce 
effort. Further research is necessary to explore the role of reduced muscle oscillations, with 
knee high CGs, on running economy over longer events. 
7.1.2 Exercise Recovery 
In Chapter 6, markers of perceived recovery, including pain, showed some improvements. 
However, there were also contradictions; for example, perceived maximum ability showed 
benefits with compression but not with ice, while perceived recovery showed improvements 
with ice but not with compression. This is common as subjective measurements have been 
shown to have a potential for high variance, which may affect reliability of results (Burnett et 
al., 2010). The ability of CGs to affect perceived recovery was further questioned by the 
results of chapter 5; which showed increases in muscle pain in all groups 24 hours post 
exercise, and application of compression did not affect post exercise pain levels. 
Furthermore, while improvements in perceived recovery were measured (chapter 6), no 
corresponding improvements in repeat performance were experienced in any trial. 
Measurement of recovery through physiological variables (muscle damage and 
inflammation) was complicated in the current studies, by high variance and low reliability of 
the data.  Chapter 5 used a form of ecologically valid exercise (10 km run), that was familiar 
to the recreationally trained athletes. This combined with adaptations to training within those 
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athletes (Clarkson & Hubal, 2002), likely made any increases in muscle damage or 
inflammation too small to be measure with the markers used. Chapter 6 also showed no 
increases muscle damage or inflammation post exercise. Unlike the exercise in chapter 5, 
the eccentric exercise used was not familiar to the participants; however, due to the 
indiscriminate nature of the makers used, a focused exercise protocol was necessary to 
avoid muscle damage of the larger muscles of the legs. This meant that established 
methods of inducing eccentric muscle damage and inflammation, such as downhill walking 
could not be used. A more sensitive and specific measurement tool, for example muscle 
biopsies (Borras et al., 2011), may be needed to show differences in these variables with 
knee high compression, especially when in a trained population. Despite this, the consensus 
of the previous research is that CGs and ice have a positive effect on perceived pain and 
recovery (Leader et al., 2012; Hill et al., 2013). However, research is subject to a lack of 
placebo controls and due to the lack of placebo controls and the absence of physiological 
benefits with the use of knee high CGs and ice; it is concluded that the psychological 
benefits of CGs and ice were caused by the placebo effect.  Additionally, any recovery 
interventions that are shown to reduce muscle damage or inflammation require further 
research to examine the effects on long term adaptations to exercise, to ensure there are no 
deleterious effects.   
7.2 Limitations 
There were a number of limitations that affected these studies: As with all previous studies 
examining CGs, the participants were not blinded to the trial they were participating in or the 
intervention they were receiving. There was also no placebo interventions as placebo trials 
for this type of study are very hard to design and conduct. In previous studies, non-
compressive garments have been used; However, compression as low as 7.6 mmHg has 
been shown to elicit a physiological response in healthy participants when standing 
(Kraemer et al., 2001) and participants can consistently identify low compressive and non-
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compressive garment (Ali et al., 2011; Creasy, 2008). The use of a deception placebo, for 
example mock ultrasound, could be useful in future studies to overcome this problem.  
High variance in CK and CRP results made it difficult to find statistically significant 
differences between groups; this effect could have been reduced if larger cohorts were 
tested, if untrained participants were used or if more specific and sensitive measurements 
were used, for example muscle biopsies. Furthermore, measures of maximal voluntary 
contractions and maximum countermovement jump heights could have been used to show 
any reduction in force production post exercise. Reduced force is considered to be one of 
the most valid and reliable indirect measures of exercise induced muscle damage in humans 
(Clarkson & Hubal, 2002). 
When measuring muscle oscillations with CG use, the retro-reflective marker on the belly of 
the calf muscle was stuck on top of the compression garment. It is unknown the effect that 
that might have on the results collected, although it is possible that movement of the muscle 
could be missed through the compression. Previous research that has examined muscle 
oscillation using high speed cameras has also suffered from this limitation (Borras et al., 
2011; Doan et al., 2003; Kraemer et al., 1997). Unfortunately, due to time constraints, it was 
not possible to do a validation or reliability test on the camera system before data collection, 
although calibration was performed. Future research could work to address some of these 
issues concerning validation. 
In chapter 6, participants were required to complete a second 1 km run 48 hours after the 
eccentric muscle damage. This second run was undertaken at this time to limit the number 
of visits the participants made to laboratory and reduce dropout. While this run may have 
influenced the 72 hours measures of perceived recovery and pain, this was conducted by all 
participants in all trials therefore the comparison of the 72 hours data was still valid. 
Furthermore,  the recovery questionnaire was not validated, however many of the questions 
used were taken from previous studies on the effect of compression garments on recovery 
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and the cross over design of the study allowed the variance in each participant’s perceptions 
to be assessed.  
Finally, the pressure elicited by the compression used in these studies was 45 mmHg at the 
ankle and 35 mmHg at the base of the knee, as measured on a static body form by the 
manufacturer. This level of compression is above that recommended by Lawrence and 
Kakkar (1980) for augmenting blood flow; however, no research has been conducted to 
show the effect of different levels of compression on any other variable during exercise. In 
chapter 6, the compression delivered by the garment was also likely to be increased when 
the ice insert was placed between the two layers of the garment; due to greater stretching of 
the outer layer, this increased pressure could be a confounding variable and may affect the 
results of such an intervention. In future research, it would be useful to measure the 
pressure of the garments on each individual, during each intervention, in an attempt to keep 
within the recommended range and more accurately report the pressure provided by the 
garments for comparison with other research. 
7.3 Conclusion 
Knee high CGs had no effect on 10 km running performance, HR, RPE, lactate, muscle 
damage, inflammation or perceived pain. It is possible that reduced muscular displacement, 
as found in chapter 5, could increase running efficiency and decrease muscle damage over 
longer events; however, the current study was unable to present results to support this 
hypothesis. The use of CGs and CGs with ice elicited decreases in perceived muscle pain 
and increases in perceived recovery; however, these benefits were mixed and contradictory 
and were not accompanied by any physiological benefits or benefits to repeat performance. 
Therefore, it was concluded that the psychological benefits of ice and compression found in 
this study and others was most likely caused by the placebo effect. Further research is 
necessary to explore whether knee high compression is able to exert an effect on any 
markers of performance or recovery beyond the placebo effect; in both trained and untrained 
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individuals. This will require testing procedures that incorporate placebo trials and sufficient 
blinding of the participant, possibly utilising a deception placebo. 
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Chapter 9: Appendices  
Appendix 1: Visual Analogue Scale Pain 
 
Please rate your current pain: 
 
    
Mild                  Moderate                  Severe . 
         No Pain                                                                                                 Unbearable pain 
0       1       2       3       4       5       6       7       8       9      10  . 
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Appendix 2: 110% Play Harder Size Guide 
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Appendix 3: Treadmill Speed Validation 
 
 
Displayed Belt Length 
Actual Speed Un-
Weighted 
Actual Speed 
Weighted 
Speed (km.h-1)  (mm) (km.h-1) (km.h-1) 
8 3750 8 8 
9 3750 9.01 8.91 
10 3750 9.92 9.9 
11 3750 10.97 10.91 
12 3750 11.9 11.9 
13 3750 12.99 12.97 
14 3750 13.96 13.85 
15 3750 14.98 14.85 
16 3750 15.9 15.88 
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Appendix 4: Participant Information Sheet – Chapter 5 
FORM EC6: PARTICIPANT INFORMATION SHEET 
Title of Research 
The effect of compression garments on 10 km run performance, muscle damage and post 
exercise recovery in competitive endurance athletes 
Introduction 
You are being invited to take part in a research study. Before you decide whether to do so, it 
is important that you understand the research that is being done and what your involvement 
will include. Please take the time to read the following information carefully and discuss it 
with others if you wish. Do not hesitate to ask us anything that is not clear or for any further 
information you would like to help you make your decision. Please do take your time to 
decide whether or not you wish to take part. Thank you for reading this. 
What is the purpose of this study? 
There is a need for fast recovery in athletes who compete or train multiple times per week, 
often required to perform consistently without a rest day (Wallace et al., 2008). The use of 
compression garments (CGs) in sport is becoming more popular, as they are believed to aid 
performance and recovery (French et al., 2008). There are many claims made and many 
mechanisms suggested for how CGs increase performance and recovery. This study aims to 
investigate whether Compression garments have an effect on 10 km running performance, 
muscle damage and recovery. 
Project Aims: 1. To assess the effect of compression garments on performance 
                      2. To compare the effects of administering compression on muscle damage 
                           and recovery: 
                                        i. During exercise 
                                       ii. Post exercise for 12 hours 
                                      iii. During exercise and post exercise for 12 hours 
                      3. To assess the effect of compression on Inflammation 
                      4. To assess the effect of compression on muscle oscillations 
Do I have to take part? 
It is completely up to you whether or not you decide to take part in this study. If you do 
decide to take part you will be given this information sheet to keep and be asked to sign a 
consent form. Agreeing to join the study does not mean that you have to complete it. You 
are free to withdraw at any stage without giving a reason. A decision to withdraw at any time, 
or a decision not to take part at all, will not affect the rest of the treatment/care that you 
receive. 
What will happen to me if I take part? 
If you decide to take part in this study, you will be involved in it for approximately 5 weeks. 
The first thing to happen will be a familiarisation session and V̇O2Max testing. This will involve 
you coming to the laboratory where you will be shown around, have the study explained to 
you and will fill out a health screen and consent form. You will be given an opportunity to 
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familiarize yourself with running on a treadmill at low speeds including dismounting the 
treadmill. You will then complete two 1 minute runs at 12 km.h-1, with a break in-between. 
During one of the runs you will wear compression and during the other no compression, the 
order in which you will do this will be random. While you run a 3D camera system will film 3 
small dots attached to one of your legs. You will then complete a lactate threshold into 
V̇O2Max test, that will give us a measurement of your aerobic fitness. This test will involve you 
starting at 2 km.h-1 less than your 16 km.h-1 pace (or estimated if unknown), every two 
minutes the speed will increase by 1 km.h-1. After two minutes at 16 km.h-1 the gradient will 
increase by 1 degree every minute. You will be asked to run until exhaustion. 
Following the familiarisation session, you will be asked to return to the laboratory to 
complete four trials, preferable over 4 consecutive weeks. During these visits you will 
complete four 10 km running trials in a randomised order. The four trials will be: no 
compression used (Con), compression used during the run (Ex), compression used for 12 
hours after the run (Rec) and compression during the run and for 12 hours post run (Exrec). 
Each trial will consist of two days: On day one you will complete a self-paced maximal 10 km 
run on a treadmill. During the run; heart rate, lactate, RPE and performance time will be 
measured. On day two, 24 hours post run, muscle damage (Creatine kinase) and 
inflammation (C-reactive protein) will be measured, using a small finger prick blood test, calf 
muscle girths, measured using a tape measure, and muscle soreness will be measured 
using a verbal feedback based on a pain scale. Below is a guide for each day 
Day 1 
Meet at the laboratory  
Fill out health screen, food diary and training diary 
Change into appropriate clothing for assigned trial and apply heart rate monitor  
Complete warm up (5 mins)  
Complete a self paced maximal 10 km time trial  
Return home (estimated time 1.5 hours) 
Day 2 
Return to laboratory (24 hours post run)  
Complete remainder of food and training diary 
Have heart rate and Blood pressure measured 
Have a finger prick blood test  
Muscle girths measured  
Give a perceived muscle soreness rating  
Return home (estimated time 30 mins) 
Participants should come to each visit prepared with comfortable running shorts, T shirt and 
running shoes. 
What are the possible disadvantages, risks or side effects of taking part? 
All the tests and exercises used in this study are safe and have been used and researched 
in previous studies. Participants will have all test procedures explained before starting to 
ensure all procedures are performed correctly. All tests will be conducted following the 
university guidelines. 
Maximal/race pace 10 km running may cause muscle soreness and stiffness. Maximal 
exercise can cause energy depletion, light headedness and in extreme circumstances 
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fainting. All participants should be accustomed to these affect as they have participated in a 
minimum of five races in the past two years and train a minimum of three times per week. 
Any feelings of light headedness should be reported to the researcher immediately. 
What are the possible benefits of taking part? 
You will receive a free running V̇O2Max test and results. You could experience benefits from 
completing the 10 km runs, as with any exercise programme. You will get a free trial of knee 
high compression stockings. You will also receive experience of participating in a research 
study and will be allowed to view the results after the study is finished. 
How will my taking part in this study be kept confidential? 
The information that is obtained during the study will follow ethical and legal practice and 
handled in strict confidence. The information obtained, however, will be used for statistical 
analysis with your right to privacy retained. All information will be anonymised; that is, all 
figures and numbers will not be traceable to you and personal details will be removed. All 
data you provide will be stored on a password protected computer. 
What will happen to the results of the research study? 
If you agree to take part, your results will be stored on a password protected computer and 
disk drive, with your name and other details removed. All paper data will be locked in a filing 
cabinet in a room which will be locked when it is not being occupied by a member of the 
research team at University of Hertfordshire. The data may be published in a scientific 
journal. In publication of results it will not be possible to identify individual participants. All 
personal data will be destroyed upon completion of the study. 
Who has reviewed this study? 
This research study has been reviewed by an independent Research Ethics Committee, to 
protect your interests. This study has been reviewed and given a favourable opinion by the 
Hertfordshire University Ethics Committee. The study design and suitability has been 
discussed with Dr. Amy Tanner and Ms. Lindsy Kass 
Who can I contact if I have any questions? 
If you would like further information or would like to discuss any details personally, please 
get in touch with me, in writing, by phone or by email: 
John Lea 
G104a, CP Snow building 
College Lane Campus 
University of Hertfordshire 
AL10 9AB 
John_lea87@hotmail.com 
Although we hope it is not the case, if you have any complaints or concerns about any 
aspect of the way you have been approached or treated during the course of this study, 
please write to the University Secretary and Registrar. 
Thank you very much for reading this information and giving consideration to taking part in 
this study. 
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Appendix 5: Health Screen – Chapter 5 
UNIVERSITY OF HERTFORDSHIRE                     Researcher: John Lea 
SCHOOL OF LIFE SCIENCE  
HEALTH SCREEN 2  
Title of Project: The Affects of Compression Clothing on Performance, Muscle Damage, Power and 
Fatigue in Male 10 km Runners 
Subject Name:  
It is important when having volunteered as subject for this study, and having read the briefing sheet 
for subjects that you answer the following questions. Please do not answer any questions if you 
consider them intrusive. 
1) Do you suffer from high blood pressure, or any heart problems? 
Yes No 
2) Do you often get dizzy, or do you know that you have low blood pressure? 
Yes No 
3) When and what did you last eat? 
 
4) Are you under the influence of alcohol or any other psycho-active substance?  
Yes No 
5) Have you had a cold or flu in the last two weeks? 
Yes No 
6) Are you suffering from any musculo-skeletal injury? 
Yes No 
7) Are you currently taking any medication (over the counter, or prescription)? 
Yes No 
(you do not need to answer “Yes” if you are only taking oral contraceptives, or if you are an 
asthmatic with an inhaler available) 
8) Do you, or have you suffered from any blood related disorders, or have you any issues 
related to blood taking? 
Yes No 
9) Have you ever been told that you should not exercise? 
Yes No 
10) Do you feel fully fit, and eager to act as subject? 
Yes No 
11) Is there any reason, not stated above, why you cannot take part as a subject in this practical? 
Yes No 
 
Signature…………………………………………………..   Date: 
Checked by (Name):       Date: 
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Appendix 6: Consent Form – Chapter 5 
 FORM EC3 
 (Rev. June 11) 
                                             University of Hertfordshire 
 CONSENT FORM FOR STUDIES INVOLVING HUMAN PARTICIPANTS 
I, the undersigned [please give your name here, in BLOCK CAPITALS] 
…………………………………………………………………………………………………………………………. 
of  [please give contact details here, sufficient to enable the investigator to get in touch with you, such as a postal  
or email address] 
…..…………………………………………………………………………………………………………………… .. 
hereby freely agree to take part in the study entitled: 
The effect of compression garments on 10 km run performance, muscle damage and 
post exercise recovery in competitive endurance athletes 
1  I confirm that I have been given a Participant Information Sheet (a copy of which is attached to this form) giving 
particulars of the study, including its aim(s), methods and design, the names and contact details of key people 
and, as appropriate, the risks and potential benefits, and any plans for follow-up studies that might involve further 
approaches to participants.   I have been given  details of my involvement in the study.  I have been told that in 
the event of any significant change to the aim(s) or design of the study I will be informed, and asked to renew my 
consent to participate in it.  
2  I have been assured that I may withdraw from the study at any time without disadvantage or having to give a 
reason. 
3  I have been given information about the risks of my suffering harm or adverse effects.   I have been told about 
the aftercare and support that will be offered to me in the event of this happening, and  I have been assured that 
all such aftercare or support  would be provided at no cost to myself.  
4  I have been told how information relating to me (data obtained in the course of  the study, and data provided 
by me about myself) will be handled: how it will be kept secure, who will have access to it, and how it will or may 
be used.   
5  I have been told what will be done if the study reveals that I have a medical condition which may have existed 
prior to the study, which I may or may not have been aware of, and which could affect the present or future health 
of myself or others. If this happens, I will be told about the condition in an appropriate manner and advised on 
follow-up action I should take.   Information about the condition will be passed to my GP, and I may no longer be 
allowed to take part in the study. 
6  I have been told that I may at some time in the future be contacted again in connection with this or another 
study. 
Signature of 
participant……………………………………………………………………………………Date…………………………. 
Signature of (principal) investigator……………………………………………………… Date………………………… 
Name of (principal) investigator [in BLOCK CAPITALS please] 
………………………………………………………………………………………………………………………………... 
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Appendix 7: V̇O2Max Verbal Encouragement Schedule  
 
Start of test:           Do you feel ok “name”?  
                                 Are you ready to start? 
                                 Starting at “speed”  
                                 We will start in 3, 2, 1, go. 
End of first stage:  Dismount the treadmill in 3, 2, 1, Now. 
 
Lactate Threshold Stages (repeated for each stage) 
Start of stage:  Going up to “speed” 
  Back on the treadmill in 3, 2, 1, Go 
  2 minutes at this speed “name” 
 
1min into stage:  That’s half way through this stage, one minute left 
End of stage: Dismount the treadmill in 3, 2, 1, Now. 
 
V̇O2Max Stages  
 Before 1st stage:  This will be the last blood test. No more stops now, so you can 
focus on the max test. Give everything you’ve got. Let’s get the best result we can. 
 
Stages ≤16 km.h-1 on 1% gradient (repeated for each stage) 
Start of stage:  Speed going up to “new speed” in 3, 2, 1 
  2 minutes at this speed “name” 
  keep going, you’re doing really well 
 
1min into stage:  That’s half way through this stage, one minute left 
1.5min into stage: 30 seconds left of this stage, keep pushing. 
 
Stages 16 km.h-1 on >1% gradient (repeated for each stage) 
Start of stage:  Gradient is going up by 1% in 3, 2, 1 
  1 minute at this gradient “name” 
  keep going, you’re doing really well 
 
30secs into stage:  That’s half way through this stage, 30 seconds left 
Keep Pushing 
Give everything you’ve got  
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Appendix 8: Exercise Log – Chapter 5 
 
Please list all physical activity performed. 
Day -2  
(48-24 hours before run) 
Day -1 
(24 hours before 10 km run) 
10 km Run day 
(24 hours after 10 km run) 
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Appendix 9: Food diary – Chapter 5 
 
Please list all the food and drink you have consumed for the 24 hours prior to this 
testing session. Quantity or weight of the food should be included where possible. 
 
  
24 Hours Before10 km Run 24 Hours After 10 km Run 
Breakfast Breakfast 
Snacks Snacks 
Lunch Lunch 
Snacks Snacks 
Dinner Dinner 
Snacks Snacks 
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Appendix 10: 10 km Verbal Encouragement Schedule  
 
Start of test 
Do you feel ok “name”?  
Are you ready to start? 
We will start in 3, 2, 1, go. (Simulate race start) 
1 km That’s the first kilometre done you’re doing well. Find your rhythm now.  
2.5 km You’re a quarter of the way now “name”, keep it up you’re doing great 
3 km You’re doing good “name” 
4 km You’re doing great, find your pace. 
5 km That’s half way, let’s keep up this pace. 
6 km You’re doing great “name” keep going. 
7.5 km That’s 7.5 k, “name”, three quarters done. Let’s win this race 
8 km Only 2 km left “name” 
9 km Last kilometre now “name” let’s finish strong. Let’s win this race  
9.5 km Come on “name” 500m left. Strong finish. Win this race. 
9.7 km Last 300m “name”, nearly there, finish strong. You can win this. 
9.8 km 200m left “name”, keep going. Win the race.  
9.9 km Last 100m “name”, go to the finish. Keep going. Finish strong 
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Appendix 11: Perceived Comfort of Compression Garments 
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Appendix 12: Participant Information Sheet – Chapter 6 
 
UNIVERSITY OF HERTFORDSHIRE 
ETHICS COMMITTEE FOR STUDIES INVOLVING THE USE OF HUMAN PARTICIPANTS 
(‘ETHICS COMMITTEE’) 
FORM EC6: PARTICIPANT INFORMATION SHEET 
Title of Research 
The effect of combined compression and ice therapy on recovery after 
eccentric exercise 
Introduction 
You are being invited to take part in a research study.  Before you decide whether to 
do so, it is important that you understand the research that is being done and what 
your involvement will include.  Please take the time to read the following information 
carefully and discuss it with others if you wish.  Do not hesitate to ask us anything 
that is not clear or for any further information you would like to help you make your 
decision.  Please do take your time to decide whether or not you wish to take part.  
Thank you for reading this. 
What is the purpose of this study? 
There is a need for fast recovery in athletes who compete or train multiple times per 
week, often required to perform consistently without a rest day (Wallace et al., 2008). 
The use of compression garments (CGs) in sport is becoming more popular, as they 
are believed to aid recovery (French et al., 2008). Ice is also used extensively to aid 
recovery after exercise. For most athletes the application of pressure and ice 
together is difficult and requires expensive equipment or homemade solution, such 
as ice bathing whilst wearing compression garments. Likewise, the application of 
effective reliable combined ice compression treatment in the field is, for most, not 
possible. There are now CGs available, with pockets for the application of ice built in 
to them (110% Harder, Canada). These pockets allow the combined treatment at 
home and in the field, with consistent graduated compression and safe ice 
application. 
This study aims to investigate whether compression alone or compression and ice 
treatment combined, have an effect on the rate of recovery experienced after 
exercise. 
Study Aims:         1. To assess the effect of compression on recovery 
                   2.To assess the effect of combined compression and ice                   
                       treatment on recovery 
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Do I have to take part? 
It is completely up to you whether or not you decide to take part in this study.  If you 
do decide to take part you will be given this information sheet to keep and be asked 
to sign a consent form.  Agreeing to join the study does not mean that you have to 
complete it.  You are free to withdraw at any stage without giving a reason.  A 
decision to withdraw at any time, or a decision not to take part at all, will not affect 
the rest of the treatment/care that you receive. 
 
What will happen to me if I take part? 
If you decide to take part you will first come in for a familiarisation and baseline 
session. This session will be at least seven days before you begin the first trial. 
During this session you will be shown around the laboratory, will have the study 
protocols and tests explained to you, will be familiarised with the perceptual scales 
(Perceived effort and Muscle soreness) and will be given an opportunity to ask any 
questions you may have about the study. You will then fill out a health screen and 
consent form. Baseline measurements will then be recorded including height, weight 
and body fat percentage. You will then be given an opportunity to familiarise yourself 
with the use of a treadmill at low speeds including dismounting the treadmill. 
Following a self paced five minute warm up, you will then complete a 1 km time trial. 
During the run, you will be able to see distance covered, but not speed or 
performance time.  
Each trial will consist of four consecutive days, where possible you will be booked in 
to start day 1 of each trial at the same time on the same day of the week. You will be 
asked to keep your routine and preparation the same before each trial and will be 
asked to refrain from exercise, caffeine and supplements for 24 hours before each 
trial. On day one you will arrive at the laboratory (G111 or H260, College Lane, 
University of Hertfordshire) and will fill out an exercise log, food diary and a health 
screen. After a rest of a minimum of five minutes, a baseline finger prick blood 
sample will be collected. This sample involves a small prick on the finger no needles 
are used; the sample will be used to measure Creatine Kinase (CK), a marker of 
muscle damage. You will then complete a lower body eccentric exercise protocol 
focusing on the lower leg including: skipping (without rope if you cannot skip), 
hopping, calf raises and small bench jumps. You will be allowed to drink water during 
the session however no energy drinks or supplements will be allowed. After the 
exercise participants completing the control trial (CON) trial will be allowed to leave. 
If you are completing the compression trial (COMP) you will have CGs fitted then will 
leave and if you are in the ice trial (ICE), you will be fitted with CGs, will undertake a 
20 minute icing protocol then you will leave. On the COMP and ICE trials you will be 
asked to wear the CGs for 12-hours before removing. 
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On day two, 24 hours post exercise; you will fill out a questionnaire about recovery 
and muscle soreness, in your own home. You will not be required to return to the 
laboratory on day two. 
On day three, 48 hours post exercise you will return to the laboratory, fill out the 
recovery and muscle soreness questionnaire, will have a finger prick blood sample 
for muscle damage and will complete a maximal 1 km time trial. You will not be 
informed of your performance times until all trials are completed. After the run you 
will be allowed to leave the laboratory. 
On day four, 72 hours post exercise you will fill out the last of the recovery 
questionnaire, at home. You will not be required to attend the laboratory on day four. 
You should come to each visit with comfortable running shorts, T shirt and Trainers. 
 
What are the possible disadvantages, risks or side effects of taking part? 
All the tests and exercises used in this study are safe and have been used and 
researched in previous studies. Participants will have all test procedures explained 
before starting to ensure all procedures are performed correctly. All tests will be 
conducted following the university guidelines. 
Exercise can cause energy depletion, light headedness and in extreme 
circumstances fainting. The exercise in this study is short and therefore is unlikely to 
elicit any of these responses. Also all participants should be accustomed to these 
affect as they train a minimum of two times per week. Any feelings of light 
headedness should be reported to the researcher immediately. It is likely that the leg 
exercises with cause some muscle soreness of the calves; this is normal and should 
not cause alarm. If you think any pain or discomfort believed to be more than muscle 
soreness should be reported to the researcher. 
Finger prick blood sampling can cause a slight bruised feeling on the side of the 
finger; the sample will not be taken from the part of the finger used to type or text 
message. When the finger is pricked a small sharp pinch sensation can be felt, but 
often it is painless.  
What are the possible benefits of taking part? 
You will get a free trial of a new brand of knee high compression stockings, and the 
ability to use ice with those stockings. You will receive experience of participating in 
a research study and will be allowed to view the results after the study is finished, 
which may give you an idea of your fitness level. 
You may receive benefits to fitness and leg strength, from the exercise undertaken. 
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How will my taking part in this study be kept confidential? 
The information that is obtained during the study will follow ethical and legal practice 
and handled in strict confidence. The information obtained, however, will be used for 
statistical analysis with your right to privacy retained. All information will be 
anonymised; that is, all figures and numbers will not be traceable to you and 
personal details will be removed. All data you provide will be stored on a password 
protected computer. 
What will happen to the results of the research study? 
If you agree to take part, your results will be stored on a password protected 
computer and disk drive, with your name and other details removed. All paper data 
will be locked in a filing cabinet in a room which will be locked when it is not being 
occupied by a member of the research team at University of Hertfordshire. The data 
may be published in a scientific journal. In publication of results it will not be possible 
to identify individual participants. All personal data will be destroyed upon completion 
of the study. 
Who has reviewed this study? 
This research study has been reviewed by an independent Research Ethics 
Committee, to protect your interests. This study has been reviewed and given a 
favorable opinion by the Hertfordshire University Ethics Committee. The study 
design and suitability has been discussed with Dr. Amy Tanner and Ms. Lindsy Kass 
Who can I contact if I have any questions? 
If you would like further information or would like to discuss any details personally, 
please get in touch with me, in writing, or by email:  
John Lea 
G104a  
CP Snow building 
College Lane Campus 
University of Hertfordshire 
AL10 9AB 
 
John_lea87@hotmail.com 
Although we hope it is not the case, if you have any complaints or concerns 
about any aspect of the way you have been approached or treated during the 
course of this study, please write to the University Secretary and Registrar. 
Thank you very much for reading this information and giving consideration to 
taking part in this study. 
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Appendix 13: Health Screen – Chapter 6 
UNIVERSITY OF HERTFORDSHIRE                     Researcher: John Lea 
SCHOOL OF LIFE SCIENCE  
HEALTH SCREEN 2  
Title of Project: The Affects of Compression Clothing on Performance, Muscle Damage, Power and 
Fatigue in Male 10 km Runners 
Subject Name:  
It is important when having volunteered as subject for this study, and having read the briefing sheet 
for subjects that you answer the following questions. Please do not answer any questions if you 
consider them intrusive. 
12) Do you suffer from high blood pressure, or any heart problems? 
Yes No 
13) Do you often get dizzy, or do you know that you have low blood pressure? 
Yes No 
14) When and what did you last eat? 
 
15) Are you under the influence of alcohol or any other psycho-active substance?  
Yes No 
16) Have you had a cold or flu in the last two weeks? 
Yes No 
17) Are you suffering from any musculo-skeletal injury? 
Yes No 
18) Are you currently taking any medication (over the counter, or prescription)? 
Yes No 
(you do not need to answer “Yes” if you are only taking oral contraceptives, or if you are an 
asthmatic with an inhaler available) 
19) Do you, or have you suffered from any blood related disorders, or have you any issues 
related to blood taking? 
Yes No 
20) Have you ever been told that you should not exercise? 
Yes No 
21) Do you feel fully fit, and eager to act as subject? 
Yes No 
22) Is there any reason, not stated above, why you cannot take part as a subject in this practical? 
Yes No 
 
Signature…………………………………………………..   Date: 
Checked by (Name):       Date: 
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Appendix 14: Consent Form – Chapter 6 
 FORM EC3 
(Rev. June 11) 
                                             University of Hertfordshire 
 CONSENT FORM FOR STUDIES INVOLVING HUMAN PARTICIPANTS 
I, the undersigned [please give your name here, in BLOCK CAPITALS] 
…………………………………………………………………………………………………………………………. 
of  [please give contact details here, sufficient to enable the investigator to get in touch with you, such as a postal  
or email address] 
…..…………………………………………………………………………………………………………………… .. 
hereby freely agree to take part in the study entitled: 
The effect of combined knee high compression and ice therapy on recovery after 
eccentric exercise  
1  I confirm that I have been given a Participant Information Sheet (a copy of which is attached to this form) giving 
particulars of the study, including its aim(s), methods and design, the names and contact details of key people 
and, as appropriate, the risks and potential benefits, and any plans for follow-up studies that might involve further 
approaches to participants.   I have been given details of my involvement in the study.  I have been told that in 
the event of any significant change to the aim(s) or design of the study I will be informed, and asked to renew my 
consent to participate in it.  
2  I have been assured that I may withdraw from the study at any time without disadvantage or having to give a 
reason. 
3  I have been given information about the risks of my suffering harm or adverse effects.   I have been told about 
the aftercare and support that will be offered to me in the event of this happening, and I have been assured that 
all such aftercare or support  would be provided at no cost to myself.  
4  I have been told how information relating to me (data obtained in the course of  the study, and data provided 
by me about myself) will be handled: how it will be kept secure, who will have access to it, and how it will or may 
be used.   
5  I have been told what will be done if the study reveals that I have a medical condition which may have existed 
prior to the study, which I may or may not have been aware of, and which could affect the present or future health 
of myself or others. If this happens, I will be told about the condition in an appropriate manner and advised on 
follow-up action I should take.   Information about the condition will be passed to my GP, and I may no longer be 
allowed to take part in the study. 
6  I have been told that I may at some time in the future be contacted again in connection with this or another 
study. 
Signature of 
participant……………………………………………………………………………………Date…………………………. 
Signature of (principal) investigator……………………………………………………… Date………………………… 
Name of (principal) investigator [in BLOCK CAPITALS please] 
………………………………………………………………………………………………………………………………... 
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Appendix 15: 1 km Time Trial Verbal Encouragement Schedule  
 
Start of test 
Do you feel ok “name”?  
Are you ready to start? 
So this is 1 km as fast as you can. 
We will start in 3, 2, 1, go. (Simulate race start) 
 
250m Good “name”, Keep going as quick as you can. 
  
500m That’s half way, you’re doing great. Keep pushing. 
 
600m 400 m to go. Last lap of the track. Give it everything you’ve got. 
 
800m Last 200 m. Come on “name” Let’s go, as fast as you can now. 
 
900m Last 100 m “name”. Everything you’ve got now. 
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Appendix 16: Exercise Log – Chapter 6 
 
Please list all physical activity performed. 
24 Hours Pre Eccentric 
Exercise 
0-24 Hours Post Eccentric 
Exercise 
24-48 Hours Post Eccentric 
Exercise 
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Appendix 17: Food diary – Chapter 6 
 
Please list all the food and drink you have consumed for the 24 hours prior to this 
testing session. Quantity or weight of the food should be included where possible. 
 
  
24 Hours Pre Eccentric Exercise 24-48 Hours Post Eccentric Exercise 
Breakfast Breakfast 
Snacks Snacks 
Lunch Lunch 
Snacks Snacks 
Dinner Dinner 
Snacks Snacks 
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Appendix 18: Chapter 6- Recovery Questionnaire 
 
Day -1: Please fill out this page for the last 24 hours 
 
Pain 
Please rate the pain in your Tib Ant, calf, Hamstrings and Quadriceps 
Tib Ant 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Calf 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Hamstrings 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Quadriceps 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Max performance 
Please rate at what percentage of you maximum you think you could perform now 
 
Unable       0      10      20     30     40     50     60     70     80     90    100% maximum  
Sleep 
Please rate your last night sleep out of 10 
 
No Sleep       0       1       2       3       4       5       6       7       8       9      10 Deep/undisturbed 
Recovery 
Please rate how well you think you have recovered since the exercise 
 
Unrecovered   0       1       2       3       4       5       6       7       8       9      10     Recovered  
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Feeling Scale 
      
+5 Very Good 
     +4 
+3 Good 
+2 
+1 Fairly Good 
0 Neutral 
-1 Fairly Bad 
-2 
-3 Bad 
-4 
-5 Very Bad 
 
 
Felt Arousal 
 
Please rate your arousal (motivation) since the exercise 
 
0             1             2             3             4             5             6 
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Day 1: Please fill out this page 24 hours after run 
Perceived Comfort 
If you have worn compression please rate out of 10 how comfortable you found them 
 
Unbearable    0       1       2       3       4       5       6       7       8       9      10   Total Comfort 
If you completed the ice protocol please rate out of 10 how effective you thought it was 
 
Unbearable    0       1       2       3       4       5       6       7       8       9      10   Total Comfort 
Pain 
Please rate the pain in your Tib Ant, calf, Hamstrings and Quadriceps 
Tib Ant 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Calf 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Hamstrings 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Quadriceps 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Max performance 
Please rate at what percentage of you maximum you think you could perform now 
 
Unable       0      10      20     30     40     50     60     70     80     90    100% maximum  
Sleep 
Please rate your last night sleep out of 10 
 
No Sleep       0       1       2       3       4       5       6       7       8       9      10 Deep/undisturbed 
Recovery 
Please rate how well you think you have recovered since the exercise 
 
Unrecovered   0       1       2       3       4       5       6       7       8       9      10     Recovered  
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Feeling Scale 
      
+5 Very Good 
     +4 
+3 Good 
+2 
+1 Fairly Good 
0 Neutral 
-1 Fairly Bad 
-2 
-3 Bad 
-4 
-5 Very Bad 
 
 
Felt Arousal 
 
Please rate your arousal (motivation) since the exercise 
 
0             1             2             3             4             5             6 
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Day 2 
Please fill out this page 48 hours after run 
Pain 
Please rate the pain in your Tib Ant, Calf, Hamstrings and Quadriceps 
Tib Ant 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Calf 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Hamstrings 
 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Quadriceps 
 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Max performance 
Please rate at what percentage of you maximum you think you could perform now 
 
Unable       0      10      20     30     40     50     60     70     80     90    100% maximum  
Sleep 
Please rate your last night sleep out of 10 
   
No Sleep       0       1       2       3       4       5       6       7       8       9      10 Deep/undisturbed 
Recovery 
Please rate how well you think you have recovered since the exercise 
 
Unrecovered   0       1       2       3       4       5       6       7       8       9      10     Recovered 
  
 182 
 
Feeling Scale 
      
+5 Very Good 
     +4 
+3 Good 
+2 
+1 Fairly Good 
0 Neutral 
-1 Fairly Bad 
-2 
-3 Bad 
-4 
-5 Very Bad 
 
 
Felt Arousal 
 
Please rate your arousal (motivation) since the exercise 
 
0             1             2             3             4             5             6 
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Day 3  
Please fill out this page 72 hours after run 
Pain 
Please rate the pain in your Tib Ant, Calf, Hamstrings and Quadriceps 
Tib Ant 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Calf 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Hamstrings 
 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
 
Quadriceps 
 
No Pain     0       1       2       3       4       5       6       7       8       9      10   Unbearable 
Max performance 
Please rate at what percentage of you maximum you think you could perform now 
 
Unable       0      10      20     30     40     50     60     70     80     90    100% maximum  
Sleep 
Please rate your last night sleep out of 10 
   
No Sleep       0       1       2       3       4       5       6       7       8       9      10 Deep/undisturbed 
Recovery 
Please rate how well you think you have recovered since the exercise 
 
Unrecovered   0       1       2       3       4       5       6       7       8       9      10     Recovered 
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Feeling Scale 
      
+5 Very Good 
     +4 
+3 Good 
+2 
+1 Fairly Good 
0 Neutral 
-1 Fairly Bad 
-2 
-3 Bad 
-4 
-5 Very Bad 
 
 
Felt Arousal 
 
Please rate your arousal (motivation) since the exercise 
 
 Low Arousal                                                                                                  High Arousal 
0             1             2             3             4             5             6 
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Appendix 19: Example of Bent Leg Calf Raise Angle 
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Appendix 20: Ankle to Calf Ratios 
Compression size, ankle girth, calf girth, and ankle to calf circumference ratio for participant in 
chapters 5 and 6 combined (mean ± SD, n = 22). 
Participant 
Compression Ankle Girth Calf Girth Ankle-Calf 
Size (mm) (mm) Ratio 
1 2 20.5 34.5 1.68 
2 2 20.4 34.7 1.70 
3 2 20.4 34.7 1.70 
4 2 20.4 34.7 1.70 
5 2 19.3 34.2 1.77 
6 2 19.2 34.6 1.80 
     7 3 23.4 35.5 1.52 
8 3 23 35.5 1.54 
9 3 22.3 36.5 1.64 
10 3 22.3 36.8 1.65 
11 3 22.7 37.6 1.66 
12 3 21.3 35.6 1.67 
13 3 21.5 36.5 1.70 
14 3 21.4 36.8 1.72 
15 3 21.5 38.1 1.77 
16 3 21.1 38.1 1.81 
     17 4 25 40 1.60 
18 4 24.2 41.4 1.71 
19 4 22.1 38.4 1.74 
20 4 23.1 40.4 1.75 
21 4 22.9 40.5 1.77 
22 4 23.7 42.5 1.79 
 
 
